<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Neuroendocrine tumor - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"4d4ab122-d01d-4b3d-b0fe-431032aa211f","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Neuroendocrine_tumor","wgTitle":"Neuroendocrine tumor","wgCurRevisionId":980427152,"wgRevisionId":980427152,"wgArticleId":5615288,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: DOI inactive as of August 2020","Webarchive template wayback links","CS1 maint: multiple names: authors list","All articles with unsourced statements","Articles with unsourced statements from June 2013","Articles with unsourced statements from November 2015",
"Articles needing additional references from November 2015","All articles needing additional references","Articles with unsourced statements from May 2011","Articles with unsourced statements from October 2012","Articles with unsourced statements from January 2012","Commons category link is on Wikidata","Articles with Curlie links","Nervous system neoplasia","Endocrine neoplasia","Pancreatic cancer","Infectious causes of cancer","Neuroendocrinology"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Neuroendocrine_tumor","wgRelevantArticleId":5615288,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgRedirectedFrom":"Neuroendocrine_cancer","wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},
"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgInternalRedirectTargetUrl":"/wiki/Neuroendocrine_tumor","wgCentralAuthMobileDomain":!1,"wgEditSubmitButtonLabelPublish":!0,"wgULSPosition":"interlanguage","wgWikibaseItemId":"Q1981276"};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","noscript":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.vector.styles.legacy":"ready","jquery.makeCollapsible.styles":"ready","mediawiki.toc.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["mediawiki.action.view.redirect","ext.cite.ux-enhancements","site","mediawiki.page.ready","jquery.makeCollapsible",
"mediawiki.toc","skins.vector.legacy.js","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.refToolbar","ext.gadget.switcher","ext.centralauth.centralautologin","mmv.head","mmv.bootstrap.autostart","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.compactlinks","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cmediawiki.toc.styles%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector"></script>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector"/>
<meta name="generator" content="MediaWiki 1.36.0-wmf.13"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Small_intestine_neuroendocrine_tumour_high_mag.jpg/1200px-Small_intestine_neuroendocrine_tumour_high_mag.jpg"/>
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Neuroendocrine_tumor"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Neuroendocrine_tumor"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Neuroendocrine_tumor rootpage-Neuroendocrine_tumor skin-vector action-view skin-vector-legacy"><div id="mw-page-base" class="noprint"></div>
<div id="mw-head-base" class="noprint"></div>
<div id="content" class="mw-body" role="main">
	<a id="top"></a>
	<div id="siteNotice" class="mw-body-content"><!-- CentralNotice --></div>
	<div class="mw-indicators mw-body-content">
	</div>
	<h1 id="firstHeading" class="firstHeading" lang="en">Neuroendocrine tumor</h1>
	<div id="bodyContent" class="mw-body-content">
		<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
		<div id="contentSub"><span class="mw-redirectedfrom">&#160;&#160;(Redirected from <a href="/w/index.php?title=Neuroendocrine_cancer&amp;redirect=no" class="mw-redirect" title="Neuroendocrine cancer">Neuroendocrine cancer</a>)</span></div>
		<div id="contentSub2"></div>
		
		<div id="jump-to-nav"></div>
		<a class="mw-jump-link" href="#mw-head">Jump to navigation</a>
		<a class="mw-jump-link" href="#searchInput">Jump to search</a>
		<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><table class="infobox" style="width:22em"><tbody><tr><th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background:#ccc">Neuroendocrine tumor</th></tr><tr><td colspan="2" style="text-align:center"><a href="/wiki/File:Small_intestine_neuroendocrine_tumour_high_mag.jpg" class="image"><img alt="Small intestine neuroendocrine tumour high mag.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Small_intestine_neuroendocrine_tumour_high_mag.jpg/300px-Small_intestine_neuroendocrine_tumour_high_mag.jpg" decoding="async" width="300" height="450" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Small_intestine_neuroendocrine_tumour_high_mag.jpg/450px-Small_intestine_neuroendocrine_tumour_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Small_intestine_neuroendocrine_tumour_high_mag.jpg/600px-Small_intestine_neuroendocrine_tumour_high_mag.jpg 2x" data-file-width="2848" data-file-height="4272" /></a></td></tr><tr><td colspan="2" style="text-align:center"><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of a neuroendocrine tumor. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a></td></tr><tr><th scope="row"><a href="/wiki/Specialty_(medicine)" class="mw-redirect" title="Specialty (medicine)">Specialty</a></th><td><a href="/wiki/Endocrine_oncology" title="Endocrine oncology">Endocrine oncology</a>&#160;<span class="penicon"><a href="https://www.wikidata.org/wiki/Q1981276?uselang=en#P1995" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></span></td></tr></tbody></table>
<p><b>Neuroendocrine tumors</b> (<b>NETs</b>) are <a href="/wiki/Neoplasm" title="Neoplasm">neoplasms</a> that arise from cells of the <a href="/wiki/Endocrine" class="mw-redirect" title="Endocrine">endocrine</a> (<a href="/wiki/Hormonal" class="mw-redirect" title="Hormonal">hormonal</a>) and <a href="/wiki/Nervous_system" title="Nervous system">nervous systems</a>. They most commonly occur in the intestine, where they are often called <a href="/wiki/Carcinoid" title="Carcinoid">carcinoid</a> tumors, but they are also found in the pancreas, lung and the rest of the body.
</p><p>Although there are many kinds of NETs, they are treated as a group of tissue because the cells of these neoplasms share common features, such as looking similar, having special <a href="/wiki/Secretory_granule" class="mw-redirect" title="Secretory granule">secretory granules</a>, and often producing biogenic <a href="/wiki/Amines" class="mw-redirect" title="Amines">amines</a> and <a href="/wiki/Polypeptide" class="mw-redirect" title="Polypeptide">polypeptide</a> <a href="/wiki/Hormone" title="Hormone">hormones</a>.<sup id="cite_ref-Ramage2005_1-0" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#WHO"><span class="tocnumber">1.1</span> <span class="toctext">WHO</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Anatomic_distribution"><span class="tocnumber">1.2</span> <span class="toctext">Anatomic distribution</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Grading"><span class="tocnumber">1.3</span> <span class="toctext">Grading</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Staging"><span class="tocnumber">1.4</span> <span class="toctext">Staging</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-7"><a href="#Gastroenteropancreatic"><span class="tocnumber">2.1</span> <span class="toctext">Gastroenteropancreatic</span></a>
<ul>
<li class="toclevel-3 tocsection-8"><a href="#Carcinoid_tumors"><span class="tocnumber">2.1.1</span> <span class="toctext">Carcinoid tumors</span></a></li>
<li class="toclevel-3 tocsection-9"><a href="#Pancreatic_neuroendocrine_tumors"><span class="tocnumber">2.1.2</span> <span class="toctext">Pancreatic neuroendocrine tumors</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-10"><a href="#Other"><span class="tocnumber">2.2</span> <span class="toctext">Other</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Familial_syndromes"><span class="tocnumber">2.3</span> <span class="toctext">Familial syndromes</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-14"><a href="#Markers"><span class="tocnumber">4.1</span> <span class="toctext">Markers</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Imaging"><span class="tocnumber">4.2</span> <span class="toctext">Imaging</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Histopathology"><span class="tocnumber">4.3</span> <span class="toctext">Histopathology</span></a>
<ul>
<li class="toclevel-3 tocsection-17"><a href="#Features_in_common"><span class="tocnumber">4.3.1</span> <span class="toctext">Features in common</span></a></li>
<li class="toclevel-3 tocsection-18"><a href="#Argentaffin_and_hormone_secretion"><span class="tocnumber">4.3.2</span> <span class="toctext">Argentaffin and hormone secretion</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-20"><a href="#Surgery"><span class="tocnumber">5.1</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Symptomatic_relief"><span class="tocnumber">5.2</span> <span class="toctext">Symptomatic relief</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Chemotherapy"><span class="tocnumber">5.3</span> <span class="toctext">Chemotherapy</span></a>
<ul>
<li class="toclevel-3 tocsection-23"><a href="#Gastrointestinal_neuroendocrine_tumors"><span class="tocnumber">5.3.1</span> <span class="toctext">Gastrointestinal neuroendocrine tumors</span></a></li>
<li class="toclevel-3 tocsection-24"><a href="#PanNETs"><span class="tocnumber">5.3.2</span> <span class="toctext">PanNETs</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-25"><a href="#Radionuclide_therapy"><span class="tocnumber">5.4</span> <span class="toctext">Radionuclide therapy</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Hepatic_artery"><span class="tocnumber">5.5</span> <span class="toctext">Hepatic artery</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Other_therapies"><span class="tocnumber">5.6</span> <span class="toctext">Other therapies</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-28"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-29"><a href="#History"><span class="tocnumber">7</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-31"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="WHO">WHO</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=2" title="Edit section: WHO">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) classification scheme places neuroendocrine tumors into three main categories, which emphasize the <a href="/wiki/Grading_(tumors)" title="Grading (tumors)">tumor grade</a> rather than the <a href="/wiki/Anatomy" title="Anatomy">anatomical origin</a>:<sup id="cite_ref-Klimstra2010_2-0" class="reference"><a href="#cite_note-Klimstra2010-2">&#91;2&#93;</a></sup><sup id="cite_ref-Tan2011_3-0" class="reference"><a href="#cite_note-Tan2011-3">&#91;3&#93;</a></sup>
</p>
<ul><li>well-differentiated neuroendocrine tumours, further subdivided into tumors with benign and those with uncertain behavior</li>
<li>well-differentiated (low grade) neuroendocrine carcinomas with low-grade malignant behavior</li>
<li>poorly differentiated (high grade) neuroendocrine carcinomas, which are the large cell neuroendocrine and small cell carcinomas.</li></ul>
<p>Additionally, the WHO scheme recognizes mixed tumors with both neuroendocrine and <a href="/wiki/Epithelial" class="mw-redirect" title="Epithelial">epithelial</a> carcinoma features, such as <a href="/wiki/Goblet_cell_carcinoid" title="Goblet cell carcinoid">goblet cell cancer</a>, a rare <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract">gastrointestinal tract</a> <a href="/wiki/Tumor" class="mw-redirect" title="Tumor">tumor</a>.<sup id="cite_ref-vanEeden2007_4-0" class="reference"><a href="#cite_note-vanEeden2007-4">&#91;4&#93;</a></sup>
</p><p>Placing a given tumor into one of these categories depends on well-defined <a href="/wiki/Histology" title="Histology">histological</a> features: size, <a href="/wiki/Lymphovascular_invasion" title="Lymphovascular invasion">lymphovascular invasion</a>, <a href="/wiki/Mitosis" title="Mitosis">mitotic</a> counts, <a href="/wiki/Ki-67_(protein)" title="Ki-67 (protein)">Ki-67</a> labelling index, invasion of adjacent organs, presence of <a href="/wiki/Metastasis" title="Metastasis">metastases</a> and whether they produce <a href="/wiki/Hormone" title="Hormone">hormones</a>.<sup id="cite_ref-Klimstra2010_2-1" class="reference"><a href="#cite_note-Klimstra2010-2">&#91;2&#93;</a></sup><sup id="cite_ref-Tan2011_3-1" class="reference"><a href="#cite_note-Tan2011-3">&#91;3&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Anatomic_distribution">Anatomic distribution</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=3" title="Edit section: Anatomic distribution">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Traditionally, neuroendocrine tumors have been classified by their anatomic site of origin. NETs can arise in many different areas of the body, and are most often located in the <a href="/wiki/Intestine" class="mw-redirect" title="Intestine">intestine</a>, <a href="/wiki/Pancreas" title="Pancreas">pancreas</a> or the <a href="/wiki/Pulmonary_neuroendocrine_tumor" title="Pulmonary neuroendocrine tumor">lungs</a>. The various kinds of cells that can give rise to NETs are present in <a href="/wiki/Endocrine_gland" title="Endocrine gland">endocrine glands</a> and are also diffusely distributed throughout the body, most commonly <a href="/wiki/Enterochromaffin_cell" title="Enterochromaffin cell">Kulchitsky cells</a> or similar <a href="/wiki/Enterochromaffin-like_cell" title="Enterochromaffin-like cell">enterochromaffin-like cells</a>, that are relatively more common in the gastrointestinal and pulmonary systems.<sup id="cite_ref-Liu2001_5-0" class="reference"><a href="#cite_note-Liu2001-5">&#91;5&#93;</a></sup>
</p><p>NETs include certain tumors of the gastrointestinal tract and of the pancreatic <a href="/wiki/Islet_cell" class="mw-redirect" title="Islet cell">islet cells</a>,<sup id="cite_ref-Ramage2005_1-1" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup> certain thymus and lung tumors, and <a href="/wiki/Medullary_thyroid_cancer" title="Medullary thyroid cancer">medullary carcinoma</a> of the <a href="/wiki/Parafollicular" class="mw-redirect" title="Parafollicular">parafollicular</a> cells of the <a href="/wiki/Thyroid" title="Thyroid">thyroid</a>.<sup id="cite_ref-Ramage2005_1-2" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup> Tumors with similar cellular characteristics in the <a href="/wiki/Pituitary" class="mw-redirect" title="Pituitary">pituitary</a>, <a href="/wiki/Parathyroid" class="mw-redirect" title="Parathyroid">parathyroid</a>, and <a href="/wiki/Adrenal" class="mw-redirect" title="Adrenal">adrenomedullary</a> glands are sometimes included<sup id="cite_ref-Rufini_6-0" class="reference"><a href="#cite_note-Rufini-6">&#91;6&#93;</a></sup> or excluded.<sup id="cite_ref-Ramage2005_1-3" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup>
</p><p>Within the broad category of neuroendocrine tumors there are many different tumor types:<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">&#91;7&#93;</a></sup> this outline is presented to facilitate retrieving information. Neuroendocrine tumors are uncommon in many of these areas, and frequently represent only a very small proportion of the tumors or cancers at these locations.
</p>
<ul><li><a href="/wiki/Pituitary_gland" title="Pituitary gland">Pituitary gland</a>: Neuroendocrine tumor of the anterior <a href="/wiki/Pituitary" class="mw-redirect" title="Pituitary">pituitary</a></li>
<li><a href="/wiki/Thyroid_gland" class="mw-redirect" title="Thyroid gland">Thyroid gland</a>: Neuroendocrine thyroid tumors, particularly <a href="/wiki/Medullary_thyroid_cancer" title="Medullary thyroid cancer">medullary carcinoma</a></li>
<li>Parathyroid tumors</li>
<li>Thymus and mediastinal carcinoid tumors<sup id="cite_ref-Soga1999_8-0" class="reference"><a href="#cite_note-Soga1999-8">&#91;8&#93;</a></sup><sup id="cite_ref-Öberg2008-BronchThymusESMO_9-0" class="reference"><a href="#cite_note-Öberg2008-BronchThymusESMO-9">&#91;9&#93;</a></sup></li>
<li><a href="/wiki/Pulmonary_neuroendocrine_tumor" title="Pulmonary neuroendocrine tumor">Pulmonary neuroendocrine tumors</a><sup id="cite_ref-Beasley2005_10-0" class="reference"><a href="#cite_note-Beasley2005-10">&#91;10&#93;</a></sup><sup id="cite_ref-Gustafsson2008_11-0" class="reference"><a href="#cite_note-Gustafsson2008-11">&#91;11&#93;</a></sup>
<ul><li>bronchus<sup id="cite_ref-Öberg2008-BronchThymusESMO_9-1" class="reference"><a href="#cite_note-Öberg2008-BronchThymusESMO-9">&#91;9&#93;</a></sup></li>
<li>pulmonary carcinoid tumors: typical carcinoid (TC; low-grade); atypical carcinoid (AC; intermediate-grade)</li>
<li>small-cell <a href="/wiki/Lung_cancer" title="Lung cancer">lung cancer</a> (SCLC)</li>
<li><a href="/wiki/Large_cell_neuroendocrine_carcinoma_of_the_lung" title="Large cell neuroendocrine carcinoma of the lung">large cell neuroendocrine carcinoma of the lung</a> (LCNEC)<sup id="cite_ref-Wick1992_12-0" class="reference"><a href="#cite_note-Wick1992-12">&#91;12&#93;</a></sup></li></ul></li>
<li>Extrapulmonary small cell carcinomas (ESCC or EPSCC)</li>
<li>Gastroenteropancreatic neuroendocrine tumors (GEP-NET)<sup id="cite_ref-Massironi2008_13-0" class="reference"><a href="#cite_note-Massironi2008-13">&#91;13&#93;</a></sup><sup id="cite_ref-Modlin2008_14-0" class="reference"><a href="#cite_note-Modlin2008-14">&#91;14&#93;</a></sup>
<ul><li><a href="/wiki/Foregut" title="Foregut">Foregut</a> GEP-NET (foregut tumors can conceptually encompasses not only NETs of the stomach and proximal duodenum, but also the pancreas, and even thymus, lung and bronchus)<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (June 2013)">citation needed</span></a></i>&#93;</sup>
<ul><li>Pancreatic endocrine tumors (if considered separately from foregut GEP-NET)<sup id="cite_ref-Metz2008_15-0" class="reference"><a href="#cite_note-Metz2008-15">&#91;15&#93;</a></sup></li></ul></li>
<li><a href="/wiki/Midgut" title="Midgut">Midgut</a> GEP-NET (from distal half of 2nd part of the duodenum to the proximal two-thirds of the transverse colon)
<ul><li>appendix,<sup id="cite_ref-Griniatsos2010_16-0" class="reference"><a href="#cite_note-Griniatsos2010-16">&#91;16&#93;</a></sup> including well differentiated NETs (benign); well differentiated NETs (uncertain malignant potential); well differentiated neuroendocrine carcinoma (with low malignant potential); mixed exocrine-neuroendocrine carcinoma (goblet cell carcinoma, also called adenocarcinoid and mucous adenocarcinoid)</li></ul></li>
<li><a href="/wiki/Hindgut" title="Hindgut">Hindgut</a> GEP-NET<sup id="cite_ref-Ni2010_17-0" class="reference"><a href="#cite_note-Ni2010-17">&#91;17&#93;</a></sup><sup id="cite_ref-Konishi2010_18-0" class="reference"><a href="#cite_note-Konishi2010-18">&#91;18&#93;</a></sup></li></ul></li>
<li>Liver<sup id="cite_ref-Soga2002_19-0" class="reference"><a href="#cite_note-Soga2002-19">&#91;19&#93;</a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup> and gallbladder<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup></li>
<li>Adrenal tumors, particularly adrenomedullary tumors</li>
<li><a href="/wiki/Pheochromocytoma" title="Pheochromocytoma">Pheochromocytoma</a></li>
<li><a href="/wiki/Peripheral_nervous_system" title="Peripheral nervous system">Peripheral nervous system</a> tumors, such as:
<ul><li><a href="/wiki/Schwannoma" title="Schwannoma">Schwannoma</a></li>
<li><a href="/wiki/Paraganglioma" title="Paraganglioma">paraganglioma</a></li>
<li><a href="/wiki/Neuroblastoma" title="Neuroblastoma">neuroblastoma</a></li></ul></li>
<li>Breast<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup></li>
<li>Genitourinary tract
<ul><li>urinary tract carcinoid tumor and neuroendocrine carcinoma<sup id="cite_ref-Murali2006_24-0" class="reference"><a href="#cite_note-Murali2006-24">&#91;24&#93;</a></sup><sup id="cite_ref-Mikuz1993_25-0" class="reference"><a href="#cite_note-Mikuz1993-25">&#91;25&#93;</a></sup></li>
<li>ovary</li>
<li>neuroendocrine tumor of the cervix<sup id="cite_ref-Soga2001Cerv_26-0" class="reference"><a href="#cite_note-Soga2001Cerv-26">&#91;26&#93;</a></sup></li>
<li><a href="/wiki/Prostate_cancer" title="Prostate cancer">Prostate tumor</a> with neuroendocrine differentiation<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup></li>
<li>testes</li></ul></li>
<li><a href="/wiki/Merkel_cell" title="Merkel cell">Merkel cell</a> <a href="/wiki/Merkel_cell_carcinoma" class="mw-redirect" title="Merkel cell carcinoma">carcinoma</a> of skin (trabecular cancer)</li>
<li>Several inherited conditions:<sup id="cite_ref-Jensen2008_29-0" class="reference"><a href="#cite_note-Jensen2008-29">&#91;29&#93;</a></sup>
<ul><li><a href="/wiki/Multiple_endocrine_neoplasia_type_1" title="Multiple endocrine neoplasia type 1">multiple endocrine neoplasia type 1</a> (MEN1)</li>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_2" title="Multiple endocrine neoplasia type 2">multiple endocrine neoplasia type 2</a> (MEN2)</li>
<li><a href="/wiki/Von_Hippel-Lindau" class="mw-redirect" title="Von Hippel-Lindau">von Hippel-Lindau</a> (VHL) disease<sup id="cite_ref-Jensen2008_29-1" class="reference"><a href="#cite_note-Jensen2008-29">&#91;29&#93;</a></sup></li>
<li><a href="/wiki/Neurofibromatosis" title="Neurofibromatosis">neurofibromatosis</a> type 1<sup id="cite_ref-Hirsch2001_30-0" class="reference"><a href="#cite_note-Hirsch2001-30">&#91;30&#93;</a></sup><sup id="cite_ref-Lodish2010_31-0" class="reference"><a href="#cite_note-Lodish2010-31">&#91;31&#93;</a></sup></li>
<li><a href="/wiki/Tuberous_sclerosis" title="Tuberous sclerosis">tuberous sclerosis</a><sup id="cite_ref-Lodish2010_31-1" class="reference"><a href="#cite_note-Lodish2010-31">&#91;31&#93;</a></sup><sup id="cite_ref-Dworakowska2008_32-0" class="reference"><a href="#cite_note-Dworakowska2008-32">&#91;32&#93;</a></sup></li>
<li><a href="/wiki/Carney%27s_complex" class="mw-redirect" title="Carney&#39;s complex">Carney complex</a><sup id="cite_ref-OMIM160980_33-0" class="reference"><a href="#cite_note-OMIM160980-33">&#91;33&#93;</a></sup><sup id="cite_ref-OMIM605244_34-0" class="reference"><a href="#cite_note-OMIM605244-34">&#91;34&#93;</a></sup></li></ul></li></ul>
<h3><span class="mw-headline" id="Grading">Grading</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=4" title="Edit section: Grading">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Neuroendocrine lesions are graded histologically according to markers of cellular proliferation, rather than cellular polymorphism. The following grading scheme is currently recommended for all gastroenteropancreatic neuroendocrine neoplasms by the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a>:<sup id="cite_ref-WHO_grade_35-0" class="reference"><a href="#cite_note-WHO_grade-35">&#91;35&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Mitoses_in_neuroendocrine_tumor.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/37/Mitoses_in_neuroendocrine_tumor.jpg/220px-Mitoses_in_neuroendocrine_tumor.jpg" decoding="async" width="220" height="186" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/37/Mitoses_in_neuroendocrine_tumor.jpg/330px-Mitoses_in_neuroendocrine_tumor.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/37/Mitoses_in_neuroendocrine_tumor.jpg/440px-Mitoses_in_neuroendocrine_tumor.jpg 2x" data-file-width="769" data-file-height="649" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Mitoses_in_neuroendocrine_tumor.jpg" class="internal" title="Enlarge"></a></div>Mitoses in a neuroendocrine tumor.</div></div></div>
<table class="wikitable">

<tbody><tr>
<th>G</th>
<th>Mitotic count (per 10 <a href="/wiki/High-power_field" title="High-power field">HPF</a>)</th>
<th>Ki-67 index (%)
</th></tr>
<tr>
<td>GX</td>
<td colspan="2">Grade cannot be assessed
</td></tr>
<tr>
<td>G1</td>
<td>&lt; 2</td>
<td>&lt; 3%
</td></tr>
<tr>
<td>G2</td>
<td>2 to 20</td>
<td>3–20%
</td></tr>
<tr>
<td>G3</td>
<td>&gt; 20</td>
<td>&gt; 20%
</td></tr></tbody></table>
<p>If <a href="/wiki/Proliferative_index" title="Proliferative index">mitotic count</a> and <a href="/wiki/Ki-67_(protein)" title="Ki-67 (protein)">Ki-67</a> are discordant, the figure which gives the highest grade is used.
</p><p>G1 and G2 neuroendocrine neoplasms are called neuroendocrine tumors (NETs) – formerly called carcinoid tumours. G3 neoplasms are called neuroendocrine carcinomas (NECs).
</p><p>It has been proposed that the current G3 category be further separated into histologically well-differentiated and poorly-differentiated neoplasms to better reflect prognosis.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Staging">Staging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=5" title="Edit section: Staging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Lymph_node_metastasis_from_neuroendocrine_tumor.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Lymph_node_metastasis_from_neuroendocrine_tumor.jpg/220px-Lymph_node_metastasis_from_neuroendocrine_tumor.jpg" decoding="async" width="220" height="263" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Lymph_node_metastasis_from_neuroendocrine_tumor.jpg/330px-Lymph_node_metastasis_from_neuroendocrine_tumor.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ea/Lymph_node_metastasis_from_neuroendocrine_tumor.jpg/440px-Lymph_node_metastasis_from_neuroendocrine_tumor.jpg 2x" data-file-width="969" data-file-height="1159" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Lymph_node_metastasis_from_neuroendocrine_tumor.jpg" class="internal" title="Enlarge"></a></div>Lymph node metastasis of a neuroendocrine tumor.</div></div></div>
<p>Currently there is no one staging system for all neuroendocrine neoplasms. Well differentiated lesions generally have their own staging system based on anatomical location, whereas poorly differentiated and mixed lesions are staged as carcinomas of that location. For example, gastric NEC and mixed adenoneuroendocrine cancers are staged as a primary carcinoma of the stomach.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup>
</p><p>TNM staging of gastroenteropancreatic Grade 1 and Grade 2 neuroendocrine tumors is as follows:
</p>
<table class="wikitable mw-collapsible mw-collapsed">
<caption class="nowrap" style="text-align: left;">Stomach<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup>
</caption>
<tbody><tr>
<th scope="col" colspan="2" style="background: #D8F8FB;">Primary Tumor (T)
</th></tr>

<tr>
<th scope="col">T Category
</th>
<th scope="col">Tumor Criteria
</th></tr>
<tr>
<td>TX</td>
<td>Primary tumour cannot be assessed
</td></tr>
<tr>
<td>T0</td>
<td>No evidence of primary tumour
</td></tr>
<tr>
<td>T1</td>
<td>Invades the lamina propria or submucosa, and less than or equal to 1&#160;cm in size
</td></tr>
<tr>
<td>T2</td>
<td>Invades the muscularis propria, or greater than 1&#160;cm in size
</td></tr>
<tr>
<td>T3</td>
<td>Invades through the muscularis propria into subserosal tissue without penetration of overlying serosa
</td></tr>
<tr>
<td>T4</td>
<td>Invades visceral peritoneum (serosal) or other organs or adjacent structures
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #F8E147;">Regional Lymph Node (N)
</th></tr>

<tr>
<th scope="col">N Category
</th>
<th scope="col">N Criteria
</th></tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed
</td></tr>
<tr>
<td>N0</td>
<td>No regional lymph node metastasis
</td></tr>
<tr>
<td>N1</td>
<td>Regional lymph node metastasis
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #B0FD70;">Distant Metastasis (M)
</th></tr>

<tr>
<th scope="col">M Category
</th>
<th scope="col">M Criteria
</th></tr>
<tr>
<td>M0</td>
<td>No distant metastasis
</td></tr>
<tr>
<td>M1</td>
<td>Distant metastasis
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1a</td>
<td>Metastasis confined to liver
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1b</td>
<td>Metastasis in at least one extra-hepatic site
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1c</td>
<td>Both hepatic and extra-hepatic metastases
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #FDD1CE;">AJCC Prognostic Stage Groups
</th></tr>

<tr>
<th scope="col">Stage
</th>
<th scope="col">Criteria
</th></tr>
<tr>
<td>I</td>
<td>T1, N0, M0
</td></tr>
<tr>
<td>II</td>
<td>T2 or T3, N0, M0
</td></tr>
<tr>
<td>III</td>
<td>Any T, N1, M0; T4, N0, M0
</td></tr>
<tr>
<td>IV</td>
<td>Any T, any N, M1
</td></tr></tbody></table>
<table class="wikitable mw-collapsible mw-collapsed">
<caption class="nowrap" style="text-align: left;">Duodenum / Ampulla of Vater<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">&#91;39&#93;</a></sup>
</caption>
<tbody><tr>
<th scope="col" colspan="2" style="background: #D8F8FB;">Primary Tumor (T)
</th></tr>

<tr>
<th scope="col">T Category
</th>
<th scope="col">Tumor Criteria
</th></tr>
<tr>
<td>TX</td>
<td>Primary tumour cannot be assessed
</td></tr>
<tr>
<td>T1</td>
<td>Invades the mucosa or submucosa only, and less than or equal to 1&#160;cm in size (duodenal tumors)<br />Confined within the sphincter of Oddi, and less than or equal to 1&#160;cm in size (ampullary tumors)
</td></tr>
<tr>
<td>T2</td>
<td>Invades the muscularis propria, or is &gt; 1&#160;cm (duodenal)<br />Invades through sphincter into duodenal submucosa or muscularis propria, or is &gt; 1&#160;cm (ampullary)
</td></tr>
<tr>
<td>T3</td>
<td>Invades the pancreas or peripancreatic adipose tissue
</td></tr>
<tr>
<td>T4</td>
<td>Invades visceral peritoneum (serosal) or other organs
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #F8E147;">Regional Lymph Node (N)
</th></tr>

<tr>
<th scope="col">N Category
</th>
<th scope="col">N Criteria
</th></tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed
</td></tr>
<tr>
<td>N0</td>
<td>No regional lymph node metastasis
</td></tr>
<tr>
<td>N1</td>
<td>Regional lymph node metastasis
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #B0FD70;">Distant Metastasis (M)
</th></tr>

<tr>
<th scope="col">M Category
</th>
<th scope="col">M Criteria
</th></tr>
<tr>
<td>M0</td>
<td>No distant metastasis
</td></tr>
<tr>
<td>M1</td>
<td>Distant metastasis
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1a</td>
<td>Metastasis confined to liver
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1b</td>
<td>Metastasis in at least one extra-hepatic site
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1c</td>
<td>Both hepatic and extra-hepatic metastases
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #FDD1CE;">AJCC Prognostic Stage Groups
</th></tr>

<tr>
<th scope="col">Stage
</th>
<th scope="col">Criteria
</th></tr>
<tr>
<td>I</td>
<td>T1, N0, M0
</td></tr>
<tr>
<td>II</td>
<td>T2 or T3, N0, M0
</td></tr>
<tr>
<td>III</td>
<td>T4, N0, M0; Any T, N1, M0
</td></tr>
<tr>
<td>IV</td>
<td>Any T, any N, M1
</td></tr></tbody></table>
<table class="wikitable mw-collapsible mw-collapsed">
<caption class="nowrap" style="text-align: left;">Jejunum and Ileum<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup>
</caption>
<tbody><tr>
<th scope="col" colspan="2" style="background: #D8F8FB;">Primary Tumor (T)
</th></tr>

<tr>
<th scope="col">T Category
</th>
<th scope="col">Tumor Criteria
</th></tr>
<tr>
<td>TX</td>
<td>Primary tumour cannot be assessed
</td></tr>
<tr>
<td>T0</td>
<td>No evidence of primary tumour
</td></tr>
<tr>
<td>T1</td>
<td>Invades the lamina propria or submucosa, and less than or equal to 1&#160;cm in size
</td></tr>
<tr>
<td>T2</td>
<td>Invades the muscularis propria, or greater than 1&#160;cm in size
</td></tr>
<tr>
<td>T3</td>
<td>Invades through the muscularis propria into subserosal tissue without penetration of overlying serosa
</td></tr>
<tr>
<td>T4</td>
<td>Invades visceral peritoneum (serosal) or other organs or adjacent structures
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #F8E147;">Regional Lymph Node (N)
</th></tr>

<tr>
<th scope="col">N Category
</th>
<th scope="col">N Criteria
</th></tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed
</td></tr>
<tr>
<td>N0</td>
<td>No regional lymph node metastasis
</td></tr>
<tr>
<td>N1</td>
<td>Regional lymph node metastasis less than 12 nodes
</td></tr>
<tr>
<td>N2</td>
<td>Large mesenteric masses (&gt; 2&#160;cm) and / or extensive nodal deposits (12 or greater), especially those that encase the superior mesenteric vessels
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #B0FD70;">Distant Metastasis (M)
</th></tr>

<tr>
<th scope="col">M Category
</th>
<th scope="col">M Criteria
</th></tr>
<tr>
<td>M0</td>
<td>No distant metastasis
</td></tr>
<tr>
<td>M1</td>
<td>Distant metastasis
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1a</td>
<td>Metastasis confined to liver
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1b</td>
<td>Metastasis in at least one extra-hepatic site
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1c</td>
<td>Both hepatic and extra-hepatic metastases
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #FDD1CE;">AJCC Prognostic Stage Groups
</th></tr>

<tr>
<th scope="col">Stage
</th>
<th scope="col">Criteria
</th></tr>
<tr>
<td>I</td>
<td>T1, N0, M0
</td></tr>
<tr>
<td>II</td>
<td>T2 or T3, N0, M0
</td></tr>
<tr>
<td>III</td>
<td>Any T, N1 or N2, M0; T4, N0, M0;
</td></tr>
<tr>
<td>IV</td>
<td>Any T, any N, M1
</td></tr></tbody></table>
<table class="wikitable mw-collapsible mw-collapsed">
<caption class="nowrap" style="text-align: left;">Appendix<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup>
</caption>
<tbody><tr>
<th scope="col" colspan="2" style="background: #D8F8FB;">Primary Tumor (T)
</th></tr>

<tr>
<th scope="col">T Category
</th>
<th scope="col">Tumor Criteria
</th></tr>
<tr>
<td>TX</td>
<td>Primary tumour cannot be assessed
</td></tr>
<tr>
<td>T0</td>
<td>No evidence of primary tumour
</td></tr>
<tr>
<td>T1</td>
<td>2&#160;cm or less in greatest dimension
</td></tr>
<tr>
<td>T2</td>
<td>Tumor more than 2&#160;cm but less than or equal to 4&#160;cm
</td></tr>
<tr>
<td>T3</td>
<td>Tumor more than 4&#160;cm or with subserosal invasion or involvement of the mesoappendix
</td></tr>
<tr>
<td>T4</td>
<td>Perforates the peritoneum or directly invades other organs or structures (excluding direct mural extension to adjacent subserosa of adjacent bowel)
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #F8E147;">Regional Lymph Node (N)
</th></tr>

<tr>
<th scope="col">N Category
</th>
<th scope="col">N Criteria
</th></tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed
</td></tr>
<tr>
<td>N0</td>
<td>No regional lymph node metastasis
</td></tr>
<tr>
<td>N1</td>
<td>Regional lymph node metastasis
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #B0FD70;">Distant Metastasis (M)
</th></tr>

<tr>
<th scope="col">M Category
</th>
<th scope="col">M Criteria
</th></tr>
<tr>
<td>M0</td>
<td>No distant metastasis
</td></tr>
<tr>
<td>M1</td>
<td>Distant metastasis
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1a</td>
<td>Metastasis confined to liver
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1b</td>
<td>Metastasis in at least one extra-hepatic site
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1c</td>
<td>Both hepatic and extra-hepatic metastases
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #FDD1CE;">AJCC Prognostic Stage Groups
</th></tr>

<tr>
<th scope="col">Stage
</th>
<th scope="col">Criteria
</th></tr>
<tr>
<td>I</td>
<td>T1, N0, M0
</td></tr>
<tr>
<td>II</td>
<td>T2 or T3, N0, M0
</td></tr>
<tr>
<td>III</td>
<td>Any T, N1, M0; T4, N1, M0
</td></tr>
<tr>
<td>IV</td>
<td>Any T, any N, M1
</td></tr></tbody></table>
<table class="wikitable mw-collapsible mw-collapsed">
<caption class="nowrap" style="text-align: left;">Colon and Rectum<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">&#91;42&#93;</a></sup>
</caption>
<tbody><tr>
<th scope="col" colspan="2" style="background: #D8F8FB;">Primary Tumor (T)
</th></tr>

<tr>
<th scope="col">T Category
</th>
<th scope="col">Tumor Criteria
</th></tr>
<tr>
<td>TX</td>
<td>Primary tumour cannot be assessed
</td></tr>
<tr>
<td>T0</td>
<td>No evidence of primary tumour
</td></tr>
<tr>
<td>T1</td>
<td>Invades the lamina propria or submucosa, and less than or equal to 2&#160;cm
</td></tr>
<tr>
<td>&#160;&#160;&#160;T1a</td>
<td>Less than 1&#160;cm in greatest dimension
</td></tr>
<tr>
<td>&#160;&#160;&#160;T1b</td>
<td>1–2&#160;cm in greatest dimension
</td></tr>
<tr>
<td>T2</td>
<td>Invades the muscularis propria, or greater than 2&#160;cm in size with invasion of the lamina propria or submucosa
</td></tr>
<tr>
<td>T3</td>
<td>Invades through the muscularis propria into subserosal tissue without penetration of overlying serosa
</td></tr>
<tr>
<td>T4</td>
<td>Invades visceral peritoneum (serosal) or other organs or adjacent structures
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #F8E147;">Regional Lymph Node (N)
</th></tr>

<tr>
<th scope="col">N Category
</th>
<th scope="col">N Criteria
</th></tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed
</td></tr>
<tr>
<td>N0</td>
<td>No regional lymph node metastasis
</td></tr>
<tr>
<td>N1</td>
<td>Regional lymph node metastasis
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #B0FD70;">Distant Metastasis (M)
</th></tr>

<tr>
<th scope="col">M Category
</th>
<th scope="col">M Criteria
</th></tr>
<tr>
<td>M0</td>
<td>No distant metastasis
</td></tr>
<tr>
<td>M1</td>
<td>Distant metastasis
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1a</td>
<td>Metastasis confined to liver
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1b</td>
<td>Metastasis in at least one extra-hepatic site
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1c</td>
<td>Both hepatic and extra-hepatic metastases
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #FDD1CE;">AJCC Prognostic Stage Groups
</th></tr>

<tr>
<th scope="col">Stage
</th>
<th scope="col">Criteria
</th></tr>
<tr>
<td>I</td>
<td>T1, N0, M0
</td></tr>
<tr>
<td>IIA</td>
<td>T2, N0, M0
</td></tr>
<tr>
<td>IIB</td>
<td>T3, N0, M0
</td></tr>
<tr>
<td>IIIA</td>
<td>T4, N0, M0
</td></tr>
<tr>
<td>IIIB</td>
<td>Any T, N1, M0
</td></tr>
<tr>
<td>IV</td>
<td>Any T, any N, M1
</td></tr></tbody></table>
<table class="wikitable mw-collapsible mw-collapsed">
<caption class="nowrap" style="text-align: left;">Pancreas<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">&#91;43&#93;</a></sup>
</caption>
<tbody><tr>
<th scope="col" colspan="2" style="background: #D8F8FB;">Primary Tumor (T)
</th></tr>

<tr>
<th scope="col">T Category
</th>
<th scope="col">Tumor Criteria
</th></tr>
<tr>
<td>TX</td>
<td>Primary tumour cannot be assessed
</td></tr>
<tr>
<td>T1</td>
<td>Limited to the pancreas, less than or equal to 2&#160;cm in size
</td></tr>
<tr>
<td>T2</td>
<td>Limited to the pancreas, 2–4&#160;cm in size
</td></tr>
<tr>
<td>T3</td>
<td>Limited to the pancreas, &gt; 4&#160;cm; or invading the duodenum or bile duct
</td></tr>
<tr>
<td>T4</td>
<td>Invading adjacent organs or the wall of large vessels
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #F8E147;">Regional Lymph Node (N)
</th></tr>

<tr>
<th scope="col">N Category
</th>
<th scope="col">N Criteria
</th></tr>
<tr>
<td>NX</td>
<td>Regional lymph nodes cannot be assessed
</td></tr>
<tr>
<td>N0</td>
<td>No regional lymph node involvement
</td></tr>
<tr>
<td>N1</td>
<td>Regional lymph node involvement
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #B0FD70;">Distant Metastasis (M)
</th></tr>

<tr>
<th scope="col">M Category
</th>
<th scope="col">M Criteria
</th></tr>
<tr>
<td>M0</td>
<td>No distant metastasis
</td></tr>
<tr>
<td>M1</td>
<td>Distant metastasis
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1a</td>
<td>Metastasis confined to liver
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1b</td>
<td>Metastasis in at least one extra-hepatic site
</td></tr>
<tr>
<td>&#160;&#160;&#160;M1c</td>
<td>Both hepatic and extra-hepatic metastases
</td></tr>
<tr>
<th scope="col" colspan="2" style="background: #FDD1CE;">AJCC Prognostic Stage Groups
</th></tr>

<tr>
<th scope="col">Stage
</th>
<th scope="col">Criteria
</th></tr>
<tr>
<td>I</td>
<td>T1, N0, M0
</td></tr>
<tr>
<td>II</td>
<td>T2 or T3, N0, M0
</td></tr>
<tr>
<td>III</td>
<td>Any T, N1, M0; T4, N0, M0
</td></tr>
<tr>
<td>IV</td>
<td>Any T, any N, M1
</td></tr></tbody></table>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=6" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Gastroenteropancreatic">Gastroenteropancreatic</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=7" title="Edit section: Gastroenteropancreatic">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Conceptually, there are two main types of NET within the gastroenteropancreatic neuroendocrine tumors (GEP-NET) category: those which arise from the <a href="/wiki/Intestine" class="mw-redirect" title="Intestine">gastrointestinal</a> (GI) system and those that arise from the <a href="/wiki/Pancreas" title="Pancreas">pancreas</a>. In usage, the term "carcinoid" has often been applied to both, although sometimes it is restrictively applied to NETs of GI origin (as herein), or alternatively to those tumors which secrete functional <a href="/wiki/Hormone" title="Hormone">hormones</a> or <a href="/wiki/Polypeptide" class="mw-redirect" title="Polypeptide">polypeptides</a> associated with clinical symptoms, as discussed.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p>
<h4><span class="mw-headline" id="Carcinoid_tumors">Carcinoid tumors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=8" title="Edit section: Carcinoid tumors">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Carcinoid" title="Carcinoid">Carcinoid</a></div>
<p><a href="/wiki/Carcinoid" title="Carcinoid">Carcinoids</a> most commonly affect the small bowel, particularly the ileum, and are the most common malignancy of the <a href="/wiki/Vermiform_appendix" class="mw-redirect" title="Vermiform appendix">appendix</a>. Many carcinoids are asymptomatic and are discovered only upon surgery for unrelated causes. These coincidental carcinoids are common; one study found that one person in ten has them.<sup id="cite_ref-Kimura1991_44-0" class="reference"><a href="#cite_note-Kimura1991-44">&#91;44&#93;</a></sup> Many tumors do not cause symptoms even when they have metastasized.<sup id="cite_ref-Arnold_45-0" class="reference"><a href="#cite_note-Arnold-45">&#91;45&#93;</a></sup> Other tumors even if very small can produce adverse effects by secreting hormones.<sup id="cite_ref-Pommier_46-0" class="reference"><a href="#cite_note-Pommier-46">&#91;46&#93;</a></sup>
</p><p>Ten per cent (10%)<sup id="cite_ref-HC_47-0" class="reference"><a href="#cite_note-HC-47">&#91;47&#93;</a></sup> or less of carcinoids, primarily some midgut carcinoids, secrete excessive levels of a range of <a href="/wiki/Hormone" title="Hormone">hormones</a>, most notably <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> (5-HT) or <a href="/wiki/Substance_P" title="Substance P">substance P</a>,<sup id="cite_ref-Kvols_48-0" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> causing a constellation of symptoms called <a href="/wiki/Carcinoid_syndrome" title="Carcinoid syndrome">carcinoid syndrome</a>:
</p>
<ul><li><a href="/wiki/Flushing_(physiology)" title="Flushing (physiology)">flushing</a></li>
<li><a href="/wiki/Diarrhea" title="Diarrhea">diarrhea</a></li>
<li><a href="/wiki/Asthma" title="Asthma">asthma</a> or wheezing</li>
<li><a href="/wiki/Congestive_heart_failure" class="mw-redirect" title="Congestive heart failure">congestive heart failure</a> (CHF)</li>
<li>abdominal cramping</li>
<li><a href="/wiki/Peripheral_edema" title="Peripheral edema">peripheral edema</a></li>
<li>heart palpitations</li></ul>
<p>A carcinoid crisis with profound flushing, bronchospasm, tachycardia, and widely and rapidly fluctuating blood pressure<sup id="cite_ref-Ramage2005_1-4" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup> can occur if large amounts of hormone are acutely secreted,<sup id="cite_ref-Kvols_48-1" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> which is occasionally triggered by factors such as diet,<sup id="cite_ref-Kvols_48-2" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> alcohol,<sup id="cite_ref-Kvols_48-3" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> surgery<sup id="cite_ref-Ramage2005_1-5" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup><sup id="cite_ref-Kvols_48-4" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> chemotherapy,<sup id="cite_ref-Kvols_48-5" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> embolization therapy or radiofrequency ablation.<sup id="cite_ref-Ramage2005_1-6" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup>
</p><p>Chronic exposure to high levels of serotonin causes thickening of the <a href="/wiki/Heart_valves" class="mw-redirect" title="Heart valves">heart valves</a>, particularly the <a href="/wiki/Tricuspid" class="mw-redirect" title="Tricuspid">tricuspid</a> and the <a href="/wiki/Pulmonic" class="mw-redirect" title="Pulmonic">pulmonic</a> valves, and over a long period can lead to <a href="/wiki/Congestive_heart_failure" class="mw-redirect" title="Congestive heart failure">congestive heart failure</a>.<sup id="cite_ref-Kvols_48-6" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> However, valve replacement is rarely needed.<sup id="cite_ref-Benson2010_49-0" class="reference"><a href="#cite_note-Benson2010-49">&#91;49&#93;</a></sup> The excessive outflow of serotonin can cause a depletion of <a href="/wiki/Tryptophan" title="Tryptophan">tryptophan</a> leading to <a href="/wiki/Niacin" title="Niacin">niacin</a> deficiency, and thus <a href="/wiki/Pellagra" title="Pellagra">pellagra</a>,<sup id="cite_ref-Ramage2005_1-7" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup> which is associated with dermatitis, dementia, and diarrhea. Many other hormones can be secreted by some of these tumors, most commonly <a href="/wiki/Growth_hormone" title="Growth hormone">growth hormone</a> that can cause <a href="/wiki/Acromegaly" title="Acromegaly">acromegaly</a>, or cortisol, that can cause <a href="/wiki/Cushing%27s_syndrome" title="Cushing&#39;s syndrome">Cushing's syndrome</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>Occasionally, <a href="/wiki/Haemorrhage" class="mw-redirect" title="Haemorrhage">haemorrhage</a> or the effects of tumor bulk are the presenting symptoms. <a href="/wiki/Bowel_obstruction" title="Bowel obstruction">Bowel obstruction</a> can occur, sometimes due to <a href="/wiki/Fibrosis" title="Fibrosis">fibrosing</a> effects of NET secretory products<sup id="cite_ref-Pommier_46-1" class="reference"><a href="#cite_note-Pommier-46">&#91;46&#93;</a></sup> with an intense desmoplastic reaction at the tumor site, or of the <a href="/wiki/Mesentery" title="Mesentery">mesentery</a>.
</p>
<h4><span class="mw-headline" id="Pancreatic_neuroendocrine_tumors">Pancreatic neuroendocrine tumors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=9" title="Edit section: Pancreatic neuroendocrine tumors">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Pancreatic_neuroendocrine_tumor" title="Pancreatic neuroendocrine tumor">Pancreatic neuroendocrine tumor</a></div>
<p>Pancreatic neuroendocrine tumors (PanNETs) are often referred to as "islet cell tumors",<sup id="cite_ref-PDQ_50-0" class="reference"><a href="#cite_note-PDQ-50">&#91;50&#93;</a></sup><sup id="cite_ref-Burns2012_51-0" class="reference"><a href="#cite_note-Burns2012-51">&#91;51&#93;</a></sup> or "pancreatic endocrine tumors"<sup id="cite_ref-Klimstra2010_2-2" class="reference"><a href="#cite_note-Klimstra2010-2">&#91;2&#93;</a></sup>
</p><p>The PanNET denomination is in line with current <a href="/wiki/WHO" class="mw-redirect" title="WHO">WHO</a> guidelines. Historically, PanNETs have also been referred to by a variety of terms, and are still often called "islet cell tumors" or "pancreatic endocrine tumors".<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">&#91;52&#93;</a></sup> originate within the pancreas. PanNETs are quite distinct from the usual form of <a href="/wiki/Pancreatic_cancer" title="Pancreatic cancer">pancreatic cancer</a>, adenocarcinoma, which arises in the exocrine pancreas. About 95 percent of pancreatic tumors are adenocarcinoma; only 1 or 2% of clinically significant pancreas neoplasms are GEP-NETs.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>Well or intermediately differentiated PanNETs are sometimes called <a href="/wiki/Islet_cell" class="mw-redirect" title="Islet cell">islet cell</a> tumors; neuroendocrine cancer (NEC) (synonymous with islet cell carcinoma) is more aggressive. Up to 60% of PanNETs are nonsecretory or nonfunctional, which either don’t secrete, or the quantity or type of products such as <a href="/wiki/Pancreatic_polypeptide" title="Pancreatic polypeptide">pancreatic polypeptide</a> (PPoma), <a href="/wiki/Chromogranin" class="mw-redirect" title="Chromogranin">chromogranin</a> A, and <a href="/wiki/Neurotensin" title="Neurotensin">neurotensin</a> do not cause a clinical syndrome, although blood levels may be elevated.<sup id="cite_ref-Jensen2008_29-2" class="reference"><a href="#cite_note-Jensen2008-29">&#91;29&#93;</a></sup> Functional tumors are often classified by the hormone most strongly secreted by the <a href="/wiki/Pancreatic_neuroendocrine_tumor" title="Pancreatic neuroendocrine tumor">pancreatic neuroendocrine tumor</a>, as discussed in that main article.
</p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=10" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In addition to the two main categories of GEP-NET, there are rarer forms of neuroendocrine tumors that arise anywhere in the body, including within the <a href="/wiki/Pulmonary_neuroendocrine_tumor" title="Pulmonary neuroendocrine tumor">lung</a>, thymus and parathyroid. Bronchial carcinoid can cause airway obstruction, <a href="/wiki/Pneumonia" title="Pneumonia">pneumonia</a>, <a href="/wiki/Pleurisy" title="Pleurisy">pleurisy</a>, difficulty with breathing, cough, and <a href="/wiki/Hemoptysis" title="Hemoptysis">hemoptysis</a>, or may be associated with weakness, nausea, weight loss, night sweats, neuralgia, and Cushing's syndrome. Some are asymptomatic.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>Animal neuroendocrine tumors include neuroendocrine cancer of the liver in dogs, and <a href="/wiki/Devil_facial_tumor_disease" class="mw-redirect" title="Devil facial tumor disease">devil facial tumor disease</a> in <a href="/wiki/Tasmanian_devil" title="Tasmanian devil">Tasmanian devils</a>.<sup id="cite_ref-Bostanci_53-0" class="reference"><a href="#cite_note-Bostanci-53">&#91;53&#93;</a></sup><sup id="cite_ref-BBC_2010_54-0" class="reference"><a href="#cite_note-BBC_2010-54">&#91;54&#93;</a></sup><sup id="cite_ref-Time_2010_55-0" class="reference"><a href="#cite_note-Time_2010-55">&#91;55&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Familial_syndromes">Familial syndromes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=11" title="Edit section: Familial syndromes">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Most pancreatic NETs are sporadic.<sup id="cite_ref-PDQ_50-1" class="reference"><a href="#cite_note-PDQ-50">&#91;50&#93;</a></sup> However, neuroendocrine tumors can be seen in several inherited familial syndromes, including:<sup id="cite_ref-Jensen2008_29-3" class="reference"><a href="#cite_note-Jensen2008-29">&#91;29&#93;</a></sup>
</p>
<ul><li><a href="/wiki/Multiple_endocrine_neoplasia_type_1" title="Multiple endocrine neoplasia type 1">multiple endocrine neoplasia type 1</a> (MEN1)</li>
<li><a href="/wiki/Multiple_endocrine_neoplasia_type_2" title="Multiple endocrine neoplasia type 2">multiple endocrine neoplasia type 2</a> (MEN2)</li>
<li><a href="/wiki/Von_Hippel-Lindau" class="mw-redirect" title="Von Hippel-Lindau">von Hippel-Lindau</a> (VHL) disease<sup id="cite_ref-Jensen2008_29-4" class="reference"><a href="#cite_note-Jensen2008-29">&#91;29&#93;</a></sup></li>
<li><a href="/wiki/Neurofibromatosis" title="Neurofibromatosis">neurofibromatosis</a> type 1<sup id="cite_ref-Hirsch2001_30-1" class="reference"><a href="#cite_note-Hirsch2001-30">&#91;30&#93;</a></sup></li>
<li><a href="/wiki/Tuberous_sclerosis" title="Tuberous sclerosis">tuberous sclerosis</a><sup id="cite_ref-Lodish2010_31-2" class="reference"><a href="#cite_note-Lodish2010-31">&#91;31&#93;</a></sup><sup id="cite_ref-Dworakowska2008_32-1" class="reference"><a href="#cite_note-Dworakowska2008-32">&#91;32&#93;</a></sup></li>
<li><a href="/wiki/Carney%27s_complex" class="mw-redirect" title="Carney&#39;s complex">Carney complex</a><sup id="cite_ref-OMIM160980_33-1" class="reference"><a href="#cite_note-OMIM160980-33">&#91;33&#93;</a></sup><sup id="cite_ref-OMIM605244_34-1" class="reference"><a href="#cite_note-OMIM605244-34">&#91;34&#93;</a></sup></li></ul>
<p>Given these associations, recommendations in NET include family history evaluation, evaluation for second tumors, and in selected circumstances testing for germline mutations such as for MEN1.<sup id="cite_ref-Ramage2005_1-8" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=12" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>NETs are believed to arise from various <a href="/wiki/Neuroendocrine_cell" title="Neuroendocrine cell">neuroendocrine cells</a> whose normal function is to serve at the <a href="/wiki/Neuroendocrinology" title="Neuroendocrinology">neuroendocrine</a> interface. Neuroendocrine cells are present not only in <a href="/wiki/Endocrine" class="mw-redirect" title="Endocrine">endocrine</a> glands throughout the body that produce <a href="/wiki/Hormone" title="Hormone">hormones</a>, but are found in all body tissues.<sup id="cite_ref-Langley1994_56-0" class="reference"><a href="#cite_note-Langley1994-56">&#91;56&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=13" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="box-More_citations_needed_section plainlinks metadata ambox ambox-content ambox-Refimprove" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" decoding="async" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="512" data-file-height="399" /></a></div></td><td class="mbox-text"><div class="mbox-text-span">This section <b>needs additional citations for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a></b>.<span class="hide-when-compact"> Please help <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Neuroendocrine_tumor&amp;action=edit">improve this article</a> by <a href="/wiki/Help:Referencing_for_beginners" title="Help:Referencing for beginners">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small class="date-container"><i>(<span class="date">November 2015</span>)</i></small><small class="hide-when-compact"><i> (<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>
<h3><span class="mw-headline" id="Markers">Markers</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=14" title="Edit section: Markers">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Symptoms from secreted hormones may prompt measurement of the corresponding hormones in the blood or their associated urinary products, for initial diagnosis or to assess the interval change in the tumor. Secretory activity of the tumor cells is sometimes dissimilar to the tissue immunoreactivity to particular hormones.<sup id="cite_ref-Ferolla2008_57-0" class="reference"><a href="#cite_note-Ferolla2008-57">&#91;57&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg/220px-Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg" decoding="async" width="220" height="237" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg/330px-Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/7e/Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg/440px-Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg 2x" data-file-width="1665" data-file-height="1793" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Synaptophysin_immunohistochemistry_of_neuroendocrine_tumor.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Synaptophysin" title="Synaptophysin">Synaptophysin</a> immunohistochemistry of neuroendocrine tumor, staining positively.</div></div></div>
<p>Given the diverse secretory activity of NETs there are many other potential markers, but a limited panel is usually sufficient for clinical purposes.<sup id="cite_ref-Ramage2005_1-9" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup> Aside from the hormones of secretory tumors, the most important markers are:
</p>
<ul><li><a href="/wiki/Chromogranin" class="mw-redirect" title="Chromogranin">chromogranin</a> A (CgA), present in 99% of metastatic carcinoid tumors<sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;58&#93;</a></sup></li>
<li>urine <a href="/wiki/5-hydroxyindoleacetic_acid" class="mw-redirect" title="5-hydroxyindoleacetic acid">5-hydroxyindoleacetic acid</a> (5-HIAA)</li>
<li><a href="/wiki/Neuron-specific_enolase" class="mw-redirect" title="Neuron-specific enolase">neuron-specific enolase</a> (NSE, gamma-gamma dimer)</li>
<li><a href="/wiki/Synaptophysin" title="Synaptophysin">synaptophysin</a> (P38)</li></ul>
<p>Newer markers include <a href="/wiki/N-terminal" class="mw-redirect" title="N-terminal">N-terminally</a> truncated variant of <a href="/wiki/Hsp70" title="Hsp70">Hsp70</a> is present in NETs but absent in normal pancreatic islets.<sup id="cite_ref-Öberg2005b_59-0" class="reference"><a href="#cite_note-Öberg2005b-59">&#91;59&#93;</a></sup> High levels of <a href="/wiki/CDX2" title="CDX2">CDX2</a>, a <a href="/wiki/Homeobox" title="Homeobox">homeobox</a> gene product essential for intestinal development and differentiation, are seen in intestinal NETs. Neuroendocrine secretory protein-55, a member of the <a href="/wiki/Chromogranin" class="mw-redirect" title="Chromogranin">chromogranin</a> family, is seen in pancreatic endocrine tumors but not intestinal NETs.<sup id="cite_ref-Öberg2005b_59-1" class="reference"><a href="#cite_note-Öberg2005b-59">&#91;59&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Imaging">Imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=15" title="Edit section: Imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>For morphological imaging, <a href="/wiki/CT-scans" class="mw-redirect" title="CT-scans">CT-scans</a>, <a href="/wiki/MRIs" class="mw-redirect" title="MRIs">MRIs</a>, <a href="/wiki/Sonography" class="mw-redirect" title="Sonography">sonography</a> (ultrasound), and <a href="/wiki/Endoscopy" title="Endoscopy">endoscopy</a> (including endoscopic ultrasound) are commonly used. Multiphase CT and MRI are typically used both for diagnostics and for evaluation of therapy. The multiphase CT should be performed before and after an intravenous injection of an iodine-based contrast agent, both in the late arterial phase and in the portal venous phase (triple-phase study). While MRI is generally superior to CT, both for detection of the primary tumor and for evaluation of metastases, CECT is more widely available, even at academic institutions. Therefore, multiphase CT is often the modality of choice.<sup id="cite_ref-Tan2011_3-2" class="reference"><a href="#cite_note-Tan2011-3">&#91;3&#93;</a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;60&#93;</a></sup>
</p><p>Advances in nuclear medicine imaging, also known as molecular imaging, has improved diagnostic and treatment paradigms in patients with neuroendocrine tumors. This is because of its ability to not only identify sites of disease but also characterize them. Neuronedocrine tumours express somatostatin receptors providing a unique target for imaging. Octreotide is a synthetic modifications of somatostatin with a longer half-life.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup> OctreoScan, also called somatostatin receptor <a href="/wiki/Scintigraphy" title="Scintigraphy">scintigraphy</a> (SRS or SSRS), utilizes <a href="/wiki/Intravenous" class="mw-redirect" title="Intravenous">intravenously</a> administered octreotide that is chemically bound to a radioactive substance, often <a href="/wiki/Indium" title="Indium">indium</a>-111, to detect larger lesions with tumor cells that are avid for octreotide.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>Somatostatin receptor imaging can now be performed with positron emission tomography (PET) which offers higher resolution, three-dimensional and more rapid imaging. <a href="/wiki/Gallium" title="Gallium">Gallium</a>-68 receptor <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">PET</a>-CT is much more accurate than an OctreoScan.<sup id="cite_ref-Ga68SSTR_61-0" class="reference"><a href="#cite_note-Ga68SSTR-61">&#91;61&#93;</a></sup>
</p><p>Imaging with fluorine-18 fluorodeoxyglucose (FDG) PET may be valuable to image some neuroendocrine tumors.<sup id="cite_ref-FDGPET_62-0" class="reference"><a href="#cite_note-FDGPET-62">&#91;62&#93;</a></sup> This scan is performed by injected radioactive sugar intravenously. Tumors that grow more quickly use more sugar. Using this scan, the aggressiveness of the tumor can be assessed.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>The combination of somatostatin receptor and FDG PET imaging is able to quantify somatostatin receptor cell surface (SSTR) expression and glycolytic metabolism, respectively.<sup id="cite_ref-FDGPET_62-1" class="reference"><a href="#cite_note-FDGPET-62">&#91;62&#93;</a></sup> The ability to perform this as a whole body study is highlighting the limitations of relying on histopathology obtained from a single site. This is enabling better selection of the most appropriate therapy for an individual patient.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">&#91;63&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Histopathology">Histopathology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=16" title="Edit section: Histopathology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:202px;"><a href="/wiki/File:Small_intestine_neuroendocrine_tumour_low_mag.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5e/Small_intestine_neuroendocrine_tumour_low_mag.jpg/200px-Small_intestine_neuroendocrine_tumour_low_mag.jpg" decoding="async" width="200" height="300" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5e/Small_intestine_neuroendocrine_tumour_low_mag.jpg/300px-Small_intestine_neuroendocrine_tumour_low_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5e/Small_intestine_neuroendocrine_tumour_low_mag.jpg/400px-Small_intestine_neuroendocrine_tumour_low_mag.jpg 2x" data-file-width="2848" data-file-height="4272" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Small_intestine_neuroendocrine_tumour_low_mag.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Small_intestine" title="Small intestine">Small intestinal</a> neuroendocrine tumor at bottom third of image, showing the typical <a href="/wiki/Intramural" class="mw-redirect" title="Intramural">intramural</a> (within the wall) location, and overlying intact <a href="/wiki/Epithelium" title="Epithelium">epithelium</a>. <a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a></div></div></div>
<h4><span class="mw-headline" id="Features_in_common">Features in common</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=17" title="Edit section: Features in common">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Neuroendocrine tumors, despite differing <a href="/wiki/Embryology" title="Embryology">embryological</a> origin, have common <a href="/wiki/Phenotypic" class="mw-redirect" title="Phenotypic">phenotypic</a> characteristics. NETs show <a href="/wiki/Tissue_(biology)" title="Tissue (biology)">tissue</a> immunoreactivity for markers of neuroendocrine <a href="/wiki/Cellular_differentiation" title="Cellular differentiation">differentiation</a> (pan-neuroendocrine tissue markers) and may secrete various peptides and hormones. There is a lengthy list of potential markers in neuroendocrine tumors; several reviews provide assistance in understanding these markers.<sup id="cite_ref-Berretta2010_64-0" class="reference"><a href="#cite_note-Berretta2010-64">&#91;64&#93;</a></sup><sup id="cite_ref-Ferolla2008_57-1" class="reference"><a href="#cite_note-Ferolla2008-57">&#91;57&#93;</a></sup> Widely used neuroendocrine tissue markers are various <a href="/wiki/Chromogranin" class="mw-redirect" title="Chromogranin">chromogranins</a>, <a href="/wiki/Synaptophysin" title="Synaptophysin">synaptophysin</a> and <a href="/wiki/PGP9.5" class="mw-redirect" title="PGP9.5">PGP9.5</a>. <a href="/wiki/Neuron-specific_enolase" class="mw-redirect" title="Neuron-specific enolase">Neuron-specific enolase</a> (NSE) is less <a href="/wiki/Sensitivity_and_specificity" title="Sensitivity and specificity">specific</a>.<sup id="cite_ref-Ramage2005_1-10" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup><sup id="cite_ref-Liu2001_5-1" class="reference"><a href="#cite_note-Liu2001-5">&#91;5&#93;</a></sup> The nuclear neuroendocrine marker insulinoma-associated protein-1 (INSM1) has proven to be sensitive as well as highly specific for neuroendocrine differentiation.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">&#91;65&#93;</a></sup>
</p><p>NETs are often small, yellow or tan masses, often located in the <a href="/wiki/Submucosa" title="Submucosa">submucosa</a> or more deeply intramurally, and they can be very firm due to an accompanying intense <a href="/wiki/Desmoplasia" title="Desmoplasia">desmoplastic</a> reaction. The overlying mucosa may be either intact or <a href="/wiki/Ulcer_(dermatology)" title="Ulcer (dermatology)">ulcerated</a>. Some GEP-NETs invade deeply to involve the <a href="/wiki/Mesentery" title="Mesentery">mesentery</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup> Histologically, NETs are an example of "small blue cell tumors," showing uniform cells which have a round to oval stippled nucleus and scant, pink granular cytoplasm. The cells may align variously in islands, glands or sheets. High power examination shows bland cytopathology. Electron microscopy can identify secretory granules. There is usually minimal <a href="/wiki/Pleomorphism_(cytology)" title="Pleomorphism (cytology)">pleomorphism</a> but less commonly there can be <a href="/wiki/Anaplasia" title="Anaplasia">anaplasia</a>, <a href="/wiki/Mitosis" title="Mitosis">mitotic</a> activity, and <a href="/wiki/Necrosis" title="Necrosis">necrosis</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>Some neuroendocrine tumor cells possess especially strong <a href="/wiki/Hormone" title="Hormone">hormone</a> <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptors</a>, such as <a href="/wiki/Somatostatin" title="Somatostatin">somatostatin</a> receptors and uptake hormones strongly. This <a href="/wiki/Avidity" title="Avidity">avidity</a> can assist in diagnosis and may make some tumors vulnerable to hormone targeted therapies.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p>
<h4><span class="mw-headline" id="Argentaffin_and_hormone_secretion">Argentaffin and hormone secretion</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=18" title="Edit section: Argentaffin and hormone secretion">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<table class="box-More_citations_needed_section plainlinks metadata ambox ambox-content ambox-Refimprove" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><a href="/wiki/File:Question_book-new.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" decoding="async" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="512" data-file-height="399" /></a></div></td><td class="mbox-text"><div class="mbox-text-span">This section <b>needs additional citations for <a href="/wiki/Wikipedia:Verifiability" title="Wikipedia:Verifiability">verification</a></b>.<span class="hide-when-compact"> Please help <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Neuroendocrine_tumor&amp;action=edit">improve this article</a> by <a href="/wiki/Help:Referencing_for_beginners" title="Help:Referencing for beginners">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small class="date-container"><i>(<span class="date">November 2015</span>)</i></small><small class="hide-when-compact"><i> (<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>
<p>NETs from a particular anatomical origin often show similar behavior as a group, such as the <a href="/wiki/Foregut" title="Foregut">foregut</a> (which conceptually includes pancreas, and even thymus, airway and lung NETs), <a href="/wiki/Midgut" title="Midgut">midgut</a> and <a href="/wiki/Hindgut" title="Hindgut">hindgut</a>; individual tumors within these sites can differ from these group benchmarks:
</p>
<ul><li>Foregut NETs are <a href="/wiki/Argentaffin" title="Argentaffin">argentaffin</a> negative. Despite low serotonin content, they often secrete <a href="/wiki/5-hydroxytryptophan" class="mw-redirect" title="5-hydroxytryptophan">5-hydroxytryptophan</a> (5-HTP), histamine, and several polypeptide hormones. There may be associated atypical carcinoid syndrome, acromegaly, Cushing disease, other endocrine disorders, telangiectasia, or hypertrophy of the skin in the face and upper neck.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">&#91;66&#93;</a></sup>&#160; These tumors can metastasize to bone.</li>
<li>Midgut NETs are argentaffin positive, can produce high levels of serotonin 5-hydroxytryptamine (5-HT), kinins, prostaglandins, substance P (SP), and other vasoactive peptides, and sometimes produce corticotropic hormone (previously adrenocorticotropic hormone [ACTH]). Bone metastasis is uncommon.</li>
<li>Hindgut NETs are argentaffin negative and rarely secrete 5-HT, 5-HTP, or any other vasoactive peptides. Bone metastases are not uncommon.</li></ul>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=19" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Several issues help define appropriate treatment of a neuroendocrine tumor, including its location, invasiveness, hormone secretion, and metastasis. Treatments may be aimed at curing the disease or at relieving symptoms (<a href="/wiki/Palliation" class="mw-redirect" title="Palliation">palliation</a>). Observation may be feasible for non-functioning low grade neuroendocrine tumors. If the tumor is locally advanced or has metastasized, but is nonetheless slowly growing, treatment that relieves symptoms may often be preferred over immediate challenging surgeries.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (May 2011)">citation needed</span></a></i>&#93;</sup>
</p><p>Intermediate and high grade tumors (noncarcinoids) are usually best treated by various early interventions (active therapy) rather than observation (wait-and-see approach).<sup id="cite_ref-Warner_67-0" class="reference"><a href="#cite_note-Warner-67">&#91;67&#93;</a></sup>
</p><p>Treatments have improved over the past several decades, and outcomes are improving.<sup id="cite_ref-Pommier_46-2" class="reference"><a href="#cite_note-Pommier-46">&#91;46&#93;</a></sup> In malignant carcinoid tumors with carcinoid syndrome, the <a href="/wiki/Median" title="Median">median</a> survival has improved from two years to more than eight years.<sup id="cite_ref-Öberg1998_68-0" class="reference"><a href="#cite_note-Öberg1998-68">&#91;68&#93;</a></sup>
</p><p>Detailed guidelines for managing neuroendocrine tumors are available from <a href="/wiki/European_Society_for_Medical_Oncology" title="European Society for Medical Oncology">ESMO</a>,<sup id="cite_ref-ESMO-NEC2010_69-0" class="reference"><a href="#cite_note-ESMO-NEC2010-69">&#91;69&#93;</a></sup> <a href="/wiki/National_Comprehensive_Cancer_Network" title="National Comprehensive Cancer Network">NCCN</a><sup id="cite_ref-NCCN-NEC2011-1_70-0" class="reference"><a href="#cite_note-NCCN-NEC2011-1-70">&#91;70&#93;</a></sup> and a UK panel.<sup id="cite_ref-Ramage2005_1-11" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup> The <a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">NCI</a> has guidelines for several categories of NET: islet cell tumors of the pancreas,<sup id="cite_ref-NCI-ICT_71-0" class="reference"><a href="#cite_note-NCI-ICT-71">&#91;71&#93;</a></sup> gastrointestinal carcinoids,<sup id="cite_ref-NCI-GICarcin_72-0" class="reference"><a href="#cite_note-NCI-GICarcin-72">&#91;72&#93;</a></sup> <a href="/wiki/Merkel_cell" title="Merkel cell">Merkel cell</a> tumors<sup id="cite_ref-NCI-Merkel_73-0" class="reference"><a href="#cite_note-NCI-Merkel-73">&#91;73&#93;</a></sup> and <a href="/wiki/Pheochromocytoma" title="Pheochromocytoma">pheochromocytoma</a>/<a href="/wiki/Paraganglioma" title="Paraganglioma">paraganglioma</a>.<sup id="cite_ref-NCI-PheoParag_74-0" class="reference"><a href="#cite_note-NCI-PheoParag-74">&#91;74&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Surgery">Surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=20" title="Edit section: Surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Even if the tumor has advanced and metastasized, making curative surgery infeasible, surgery often has a role in neuroendocrine cancers for <a href="/wiki/Palliation" class="mw-redirect" title="Palliation">palliation</a> of symptoms and possibly increased lifespan.<sup id="cite_ref-Warner_67-1" class="reference"><a href="#cite_note-Warner-67">&#91;67&#93;</a></sup>
</p><p>Cholecystectomy is recommended if there is a consideration of long-term treatment with <a href="/wiki/Somatostatin" title="Somatostatin">somatostatin</a> <a href="/wiki/Structural_analog" title="Structural analog">analogs</a>.<sup id="cite_ref-NCCN_NET201501_75-0" class="reference"><a href="#cite_note-NCCN_NET201501-75">&#91;75&#93;</a></sup><sup class="reference" style="white-space:nowrap;">:<span>46</span></sup>
</p>
<h3><span class="mw-headline" id="Symptomatic_relief">Symptomatic relief</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=21" title="Edit section: Symptomatic relief">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In secretory tumors, somatostatin analogs given subcutaneously or intramuscularly alleviate symptoms by blocking hormone release. A consensus review has reported on the use of somatostatin analogs for GEP-NETs.<sup id="cite_ref-Öberg2004_76-0" class="reference"><a href="#cite_note-Öberg2004-76">&#91;76&#93;</a></sup>
</p><p>These medications may also anatomically stabilize or shrink tumors, as suggested by the PROMID study (Placebo-controlled prospective randomized study on the antiproliferative efficacy of Octreotide LAR in patients with metastatic neuroendocrine MIDgut tumors): at least in this subset of NETs, average tumor stabilization was 14.3 months compared to 6 months for <a href="/wiki/Placebo" title="Placebo">placebo</a>.<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">&#91;77&#93;</a></sup>
</p><p>The CLARINET study (a randomized, double-blind, placebo-controlled study on the antiproliferative effects of lanreotide in patients with enteropancreatic neuroendocrine tumors) further demonstrated the antiproliferative potential of lanreotide, a somatostatin analog and recently approved FDA treatment for GEP-NETS. In this study, lanreotide showed a statistically significant improvement in progression-free survival, meeting its primary endpoint. The disease in sixty five percent of patients treated with lanreotide in the study had not progressed or caused death at 96 weeks, the same was true of 33% of patients on placebo. This represented a 53% reduction in risk of disease progression or death with lanreotide based on a hazard ratio of .47.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78">&#91;78&#93;</a></sup>
</p><p>Lanreotide is the first and only FDA approved antitumor therapy demonstrating a statistically significant progression-free survival benefit in a combined population of patients with GEP-NETS.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>Other medications that block particular secretory effects can sometimes relieve symptoms.<sup id="cite_ref-Benson2010_49-1" class="reference"><a href="#cite_note-Benson2010-49">&#91;49&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Chemotherapy">Chemotherapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=22" title="Edit section: Chemotherapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Interferon" title="Interferon">Interferon</a> is sometimes used to treat GEP-NETs.<sup id="cite_ref-Öberg2005a_79-0" class="reference"><a href="#cite_note-Öberg2005a-79">&#91;79&#93;</a></sup> Its effectiveness is somewhat uncertain, but low doses can be <a href="/wiki/Titration" title="Titration">titrated</a> within each person, often considering the effect on the blood <a href="/wiki/Leukocyte" class="mw-redirect" title="Leukocyte">leukocyte</a> count;<sup id="cite_ref-Öberg2005a_79-1" class="reference"><a href="#cite_note-Öberg2005a-79">&#91;79&#93;</a></sup> Interferon is often used in combination with other agents, especially somatostatin analogs such as octreotide.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p>
<h4><span class="mw-headline" id="Gastrointestinal_neuroendocrine_tumors">Gastrointestinal neuroendocrine tumors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=23" title="Edit section: Gastrointestinal neuroendocrine tumors">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Most gastrointestinal carcinoid tumors tend not to respond to chemotherapy agents,<sup id="cite_ref-Benson2010_49-2" class="reference"><a href="#cite_note-Benson2010-49">&#91;49&#93;</a></sup> showing 10 to 20% response rates that are typically less than 6 months. Combining chemotherapy medications has not usually been of significant improvement<sup id="cite_ref-Benson2010_49-3" class="reference"><a href="#cite_note-Benson2010-49">&#91;49&#93;</a></sup> showing 25 to 35% response rates that are typically less than 9 months.
</p><p>The exceptions are poorly <a href="/wiki/Cellular_differentiation" title="Cellular differentiation">differentiated</a> (high-<a href="/wiki/Grading_(tumors)" title="Grading (tumors)">grade</a> or <a href="/wiki/Anaplastic" class="mw-redirect" title="Anaplastic">anaplastic</a>) metastatic disease, where <a href="/wiki/Cisplatin" title="Cisplatin">cisplatin</a> with <a href="/wiki/Etoposide" title="Etoposide">etoposide</a> may be used<sup id="cite_ref-Benson2010_49-4" class="reference"><a href="#cite_note-Benson2010-49">&#91;49&#93;</a></sup> and <a href="/wiki/Somatostatin" title="Somatostatin">Somatostatin</a> Receptor Scintigraphy (SSRS) negative tumors which had a response rate in excess of 70% compared to 10% in strongly positive SRSS carcinoid tumors.<sup id="cite_ref-Ramage2005_1-12" class="reference"><a href="#cite_note-Ramage2005-1">&#91;1&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="PanNETs">PanNETs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=24" title="Edit section: PanNETs">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Pancreatic_neuroendocrine_tumor#Treatment" title="Pancreatic neuroendocrine tumor">Pancreatic neuroendocrine tumor §&#160;Treatment</a></div>
<p><a href="/wiki/Targeted_therapy" title="Targeted therapy">Targeted therapy</a> with <a href="/wiki/Everolimus" title="Everolimus">everolimus</a> (Afinitor) and <a href="/wiki/Sunitinib" title="Sunitinib">sunitinib</a> (Sutent) is approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> in unresectable, locally advanced or <a href="/wiki/Metastasis" title="Metastasis">metastatic</a> PanNETs. Some PanNETs are more responsive to <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> than gastroenteric <a href="/wiki/Carcinoid" title="Carcinoid">carcinoid</a> tumors. Several agents have shown activity<sup id="cite_ref-Benson2010_49-5" class="reference"><a href="#cite_note-Benson2010-49">&#91;49&#93;</a></sup> and combining several medicines, particularly <a href="/wiki/Doxorubicin" title="Doxorubicin">doxorubicin</a> with <a href="/wiki/Streptozocin" class="mw-redirect" title="Streptozocin">streptozocin</a> and <a href="/wiki/Fluorouracil" title="Fluorouracil">fluorouracil</a> (5-FU or f5U), is often more effective. Although marginally effective in well-differentiated PETs, <a href="/wiki/Cisplatin" title="Cisplatin">cisplatin</a> with <a href="/wiki/Etoposide" title="Etoposide">etoposide</a> is active in poorly differentiated neuroendocrine cancers (PDNECs).<sup id="cite_ref-Benson2010_49-6" class="reference"><a href="#cite_note-Benson2010-49">&#91;49&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Radionuclide_therapy">Radionuclide therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=25" title="Edit section: Radionuclide therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Peptide_receptor_radionuclide_therapy" title="Peptide receptor radionuclide therapy">Peptide receptor radionuclide therapy</a> (PRRT) is a type of <a href="/wiki/Radioisotope_therapy" class="mw-redirect" title="Radioisotope therapy">radioisotope therapy</a> (RIT)<sup id="cite_ref-Rufini_6-1" class="reference"><a href="#cite_note-Rufini-6">&#91;6&#93;</a></sup> in which a peptide or hormone <a href="/wiki/Conjugation_(biochemistry)" class="mw-redirect" title="Conjugation (biochemistry)">conjugated</a> to a <a href="/wiki/Radionuclide" title="Radionuclide">radionuclide</a> or <a href="/wiki/Radioligand" title="Radioligand">radioligand</a> is given <a href="/wiki/Intravenously" class="mw-redirect" title="Intravenously">intravenously</a>, the peptide or neuroamine hormone previously having shown good uptake of a tracer dose, using Somatostatin receptor imaging as detailed above. This type of <a href="/wiki/Radiotherapy" class="mw-redirect" title="Radiotherapy">radiotherapy</a> is a systemic therapy and will impact somatostatin positive disease.<sup id="cite_ref-80" class="reference"><a href="#cite_note-80">&#91;80&#93;</a></sup> The peptide receptor may be bound to <a href="/wiki/Lutetium_(177Lu)_DOTA-octreotate" class="mw-redirect" title="Lutetium (177Lu) DOTA-octreotate">lutetium-177</a>, <a href="/wiki/Yttrium-90" title="Yttrium-90">yttrium-90</a>, <a href="/wiki/Indium-111" title="Indium-111">indium-111</a> and other isotopes including alpha emitters.<sup id="cite_ref-81" class="reference"><a href="#cite_note-81">&#91;81&#93;</a></sup> This is a highly targeted and effective therapy with minimal side effects in tumors with high levels of somatostatin cell surface expression, because the radiation is absorbed at the sites of the tumor, or excreted in the urine. The radioactively labelled hormones enter the tumor cells which, together with nearby cells, are damaged by the attached radiation. Not all cells are immediately killed; cell death can go on for up to two years.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p>PRRT was initially used for low grade NETs. It is also very useful in more aggressive NETs such as Grade 2 and 3 NETs<sup id="cite_ref-82" class="reference"><a href="#cite_note-82">&#91;82&#93;</a></sup><sup id="cite_ref-83" class="reference"><a href="#cite_note-83">&#91;83&#93;</a></sup> provided they demonstrate high uptake on SSTR imaging to suggest benefit.
</p>
<h3><span class="mw-headline" id="Hepatic_artery">Hepatic artery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=26" title="Edit section: Hepatic artery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Hepatic_artery_embolization" title="Hepatic artery embolization">Hepatic artery embolization</a></div>
<p>Metastases to the liver can be treated by several types of hepatic artery treatments based on the observation that tumor cells get nearly all their nutrients from the hepatic artery, while the normal cells of the liver get about 70–80 percent of their nutrients and 50% their oxygen supply from the portal vein, and thus can survive with the hepatic artery effectively blocked.<sup id="cite_ref-Pommier_46-3" class="reference"><a href="#cite_note-Pommier-46">&#91;46&#93;</a></sup><sup id="cite_ref-Fong_84-0" class="reference"><a href="#cite_note-Fong-84">&#91;84&#93;</a></sup>
</p>
<ul><li><b>Hepatic artery embolization</b> (HAE) occludes the blood flow to the tumors, achieving significant tumor shrinkage in over 80%.<sup id="cite_ref-Kvols_48-7" class="reference"><a href="#cite_note-Kvols-48">&#91;48&#93;</a></sup> In hepatic artery chemotherapy, the chemotherapy agents are given into the hepatic artery, often by steady infusion over hours or even days. Compared with systemic chemotherapy, a higher proportion of the chemotherapy agents are (in theory) delivered to the lesions in the liver.<sup id="cite_ref-Fong_84-1" class="reference"><a href="#cite_note-Fong-84">&#91;84&#93;</a></sup></li>
<li><b>Hepatic artery chemoembolization</b> (HACE), sometimes called transarterial chemoembolization (TACE), combines hepatic artery embolization with hepatic artery chemoinfusion: embospheres bound with chemotherapy agents, injected into the hepatic artery, lodge in downstream capillaries. The spheres not only block blood flow to the lesions, but by halting the chemotherapy agents in the neighborhood of the lesions, they provide a much better targeting leverage than chemoinfusion provides.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup></li>
<li><b><a href="/wiki/Selective_internal_radiation_therapy" title="Selective internal radiation therapy">Selective internal radiation therapy</a></b> (SIRT)<sup id="cite_ref-Welsh2006_85-0" class="reference"><a href="#cite_note-Welsh2006-85">&#91;85&#93;</a></sup> for neuroendocrine metastases to the liver<sup id="cite_ref-VdW2009-page321_86-0" class="reference"><a href="#cite_note-VdW2009-page321-86">&#91;86&#93;</a></sup> delivers radioactive microsphere therapy (RMT) by injection into the hepatic artery, lodging (as with HAE and HACE) in downstream capillaries. In contrast to hormone-delivered <a href="/wiki/Radiotherapy" class="mw-redirect" title="Radiotherapy">radiotherapy</a>, the lesions need not overexpress peptide receptors. The mechanical targeting delivers the radiation from the yttrium-labeled microspheres selectively to the tumors without unduly affecting the normal liver.<sup id="cite_ref-Salem2002_87-0" class="reference"><a href="#cite_note-Salem2002-87">&#91;87&#93;</a></sup> This type of treatment is FDA approved for liver metastases secondary to colorectal carcinoma and is under investigation for treatment of other liver malignancies, including neuroendocrine malignancies.<sup id="cite_ref-Welsh2006_85-1" class="reference"><a href="#cite_note-Welsh2006-85">&#91;85&#93;</a></sup></li></ul>
<h3><span class="mw-headline" id="Other_therapies">Other therapies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=27" title="Edit section: Other therapies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Radiofrequency_ablation" title="Radiofrequency ablation">Radiofrequency ablation</a> (RFA) is used when a patient has relatively few metastases.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2012)">citation needed</span></a></i>&#93;</sup> In RFA, a needle is inserted into the center of the lesion and current is applied to generate heat; the tumor cells are killed by cooking.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p><a href="/wiki/Cryoablation" title="Cryoablation">Cryoablation</a> is similar to RFA; an endothermic substance<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (October 2012)">citation needed</span></a></i>&#93;</sup> is injected into the tumors to kill by freezing. Cryoablation has been less successful for GEP-NETs than RFA.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (January 2012)">citation needed</span></a></i>&#93;</sup>
</p><p>AdVince, a type of <a href="/wiki/Gene_therapy" title="Gene therapy">gene therapy</a> using a genetically modified <a href="/wiki/Oncolytic_adenovirus" title="Oncolytic adenovirus">oncolytic adenovirus</a><sup id="cite_ref-88" class="reference"><a href="#cite_note-88">&#91;88&#93;</a></sup> and supported by the <a href="/wiki/Crowdfunding" title="Crowdfunding">crowdfunding</a> campaign iCancer<sup id="cite_ref-89" class="reference"><a href="#cite_note-89">&#91;89&#93;</a></sup> was used in a Phase 1 trial against NET in 2016.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">&#91;90&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=28" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Although estimates vary, the annual <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">incidence</a> of clinically significant neuroendocrine tumors is approximately 2.5–5 per 100,000;<sup id="cite_ref-Öberg2011_91-0" class="reference"><a href="#cite_note-Öberg2011-91">&#91;91&#93;</a></sup> two thirds are carcinoid tumors and one third are other NETs.
</p><p>The <a href="/wiki/Prevalence" title="Prevalence">prevalence</a> has been estimated as 35 per 100,000,<sup id="cite_ref-Öberg2011_91-1" class="reference"><a href="#cite_note-Öberg2011-91">&#91;91&#93;</a></sup> and may be considerably higher if clinically silent tumors are included. An <a href="/wiki/Autopsy" title="Autopsy">autopsy</a> study of the pancreas in people who died from unrelated causes discovered a remarkably high incidence of tiny asymptomatic NETs. Routine microscopic study of three random sections of the pancreas found NETs in 1.6%, and multiple sections identified NETs in 10%.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92">&#91;92&#93;</a></sup> As diagnostic imaging increases in sensitivity, such as <a href="/wiki/Endoscopy" title="Endoscopy">endoscopic</a> <a href="/wiki/Ultrasonography" class="mw-redirect" title="Ultrasonography">ultrasonography</a>, very small, clinically insignificant NETs may be coincidentally discovered; being unrelated to symptoms, such neoplasms may not require surgical excision.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=29" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Small intestinal neuroendocrine tumors were first distinguished from other tumors in 1907.<sup id="cite_ref-Modlin_93-0" class="reference"><a href="#cite_note-Modlin-93">&#91;93&#93;</a></sup><sup id="cite_ref-Arnold_45-1" class="reference"><a href="#cite_note-Arnold-45">&#91;45&#93;</a></sup> They were named carcinoid tumors because their slow growth was considered to be "cancer-like" rather than truly cancerous.<sup id="cite_ref-Arnold_45-2" class="reference"><a href="#cite_note-Arnold-45">&#91;45&#93;</a></sup>
</p><p>However, in 1938 it was recognized that some of these small bowel tumors could be malignant.<sup id="cite_ref-Modlin_93-1" class="reference"><a href="#cite_note-Modlin-93">&#91;93&#93;</a></sup><sup id="cite_ref-Arnold_45-3" class="reference"><a href="#cite_note-Arnold-45">&#91;45&#93;</a></sup> Despite the differences between these two original categories, and further complexities due to subsequent inclusion of other NETs of pancreas and pulmonary origin, all NETs are sometimes (incorrectly) subsumed into the term "carcinoid".<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (November 2015)">citation needed</span></a></i>&#93;</sup>
</p><p><a href="/wiki/Enterochromaffin" class="mw-redirect" title="Enterochromaffin">Enterochromaffin</a> cells, which give rise to carcinoid tumors, were identified in 1897 by <a href="/wiki/Nikolai_Kulchitsky" title="Nikolai Kulchitsky">Nikolai Kulchitsky</a> and their secretion of <a href="/wiki/Serotonin" title="Serotonin">serotonin</a> was established in 1953<sup id="cite_ref-Modlin_93-2" class="reference"><a href="#cite_note-Modlin-93">&#91;93&#93;</a></sup> when the "flushing" effect of serotonin had become clinically recognized. Carcinoid heart disease was identified in 1952, and carcinoid fibrosis in 1961.<sup id="cite_ref-Modlin_93-3" class="reference"><a href="#cite_note-Modlin-93">&#91;93&#93;</a></sup>
</p><p>Neuroendocrine tumors were sometimes called <a href="/wiki/Apudoma" title="Apudoma">APUDomas</a> because these cells often show <a href="/wiki/Amine" title="Amine"><u><b>a</b></u>mine</a> <u><b>p</b></u>recursor (<a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a> and <a href="/wiki/5-hydroxytryptophan" class="mw-redirect" title="5-hydroxytryptophan">5-hydroxytryptophan</a>) <u><b>u</b></u>ptake and <u><b>d</b></u>ecarboxylation to produce biogenic amines such as <a href="/wiki/Catecholamine" title="Catecholamine">catecholamines</a> and <a href="/wiki/Serotonin" title="Serotonin">serotonin</a>. Although this behavior was also part of the disproven hypothesis that these cells might all <a href="/wiki/Embryology" title="Embryology">embryologically</a> arise from the <a href="/wiki/Neural_crest" title="Neural crest">neural crest</a>,<sup id="cite_ref-Langley1994_56-1" class="reference"><a href="#cite_note-Langley1994-56">&#91;56&#93;</a></sup><sup id="cite_ref-Warner_67-2" class="reference"><a href="#cite_note-Warner-67">&#91;67&#93;</a></sup><sup id="cite_ref-Öberg1998_68-1" class="reference"><a href="#cite_note-Öberg1998-68">&#91;68&#93;</a></sup> neuroendocrine cells sometimes produce various types of hormones and amines,<sup id="cite_ref-Öberg1998_68-2" class="reference"><a href="#cite_note-Öberg1998-68">&#91;68&#93;</a></sup> and they can also have strong receptors for other hormones to which they respond.
</p><p>There have been multiple nomenclature systems for these tumors,<sup id="cite_ref-Klimstra2010_2-3" class="reference"><a href="#cite_note-Klimstra2010-2">&#91;2&#93;</a></sup> and the differences between these schema have often been confusing. Nonetheless, these systems all distinguish between well-<a href="/wiki/Cellular_differentiation" title="Cellular differentiation">differentiated</a> (low and intermediate-<a href="/wiki/Grading_(tumors)" title="Grading (tumors)">grade</a>) and poorly differentiated (high-grade) NETs. Cellular proliferative rate is of considerable significance in this <a href="/wiki/Prognosis" title="Prognosis">prognostic assessment</a>.<sup id="cite_ref-Klimstra2010_2-4" class="reference"><a href="#cite_note-Klimstra2010-2">&#91;2&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=30" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist" style="list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-Ramage2005-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ramage2005_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Ramage2005_1-12"><sup><i><b>m</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFRamageDaviesArdill2005" class="citation journal cs1">Ramage JK, Davies AH, Ardill J,  et al. (June 2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1867801">"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours"</a>. <i>Gut</i>. 54. <b>54</b> (Suppl 4): iv1–iv16. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fgut.2004.053314">10.1136/gut.2004.053314</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1867801">1867801</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15888809">15888809</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gut&amp;rft.atitle=Guidelines+for+the+management+of+gastroenteropancreatic+neuroendocrine+%28including+carcinoid%29+tumours&amp;rft.volume=54&amp;rft.issue=Suppl+4&amp;rft.pages=iv1-iv16&amp;rft.date=2005-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1867801&amp;rft_id=info%3Apmid%2F15888809&amp;rft_id=info%3Adoi%2F10.1136%2Fgut.2004.053314&amp;rft.aulast=Ramage&amp;rft.aufirst=JK&amp;rft.au=Davies%2C+AH&amp;rft.au=Ardill%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1867801&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r982806391">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style></span>
</li>
<li id="cite_note-Klimstra2010-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Klimstra2010_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Klimstra2010_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Klimstra2010_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Klimstra2010_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Klimstra2010_2-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFKlimstraModlinCoppolaLloyd2010" class="citation journal cs1">Klimstra, D.S.; Modlin, I.R.; Coppola, D.; Lloyd, R.V.; Suster, S. (2010). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/cfd1c2def7a1431ebe21eb891ff979a4f9ec79b2">"The Pathologic Classification of Neuroendocrine Tumors"</a>. <i>Pancreas</i>. <b>39</b> (6): 707–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMPA.0b013e3181ec124e">10.1097/MPA.0b013e3181ec124e</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20664470">20664470</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3735444">3735444</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pancreas&amp;rft.atitle=The+Pathologic+Classification+of+Neuroendocrine+Tumors&amp;rft.volume=39&amp;rft.issue=6&amp;rft.pages=707-12&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3735444&amp;rft_id=info%3Apmid%2F20664470&amp;rft_id=info%3Adoi%2F10.1097%2FMPA.0b013e3181ec124e&amp;rft.aulast=Klimstra&amp;rft.aufirst=D.S.&amp;rft.au=Modlin%2C+I.R.&amp;rft.au=Coppola%2C+D.&amp;rft.au=Lloyd%2C+R.V.&amp;rft.au=Suster%2C+S.&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2Fcfd1c2def7a1431ebe21eb891ff979a4f9ec79b2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Tan2011-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tan2011_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tan2011_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Tan2011_3-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFTanTan2011" class="citation journal cs1">Tan, E.H.; Tan, C. (2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3095463">"Imaging of gastroenteropancreatic neuroendocrine tumors"</a>. <i>World Journal of Clinical Oncology</i>. <b>2</b> (1): 28–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.5306%2Fwjco.v2.i1.28">10.5306/wjco.v2.i1.28</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3095463">3095463</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21603312">21603312</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=World+Journal+of+Clinical+Oncology&amp;rft.atitle=Imaging+of+gastroenteropancreatic+neuroendocrine+tumors&amp;rft.volume=2&amp;rft.issue=1&amp;rft.pages=28-43&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3095463&amp;rft_id=info%3Apmid%2F21603312&amp;rft_id=info%3Adoi%2F10.5306%2Fwjco.v2.i1.28&amp;rft.aulast=Tan&amp;rft.aufirst=E.H.&amp;rft.au=Tan%2C+C.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3095463&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-vanEeden2007-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-vanEeden2007_4-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFVan_EedenOfferhausHartBoerrigter2007" class="citation journal cs1">Van Eeden, S.; Offerhaus, G.J.A.; Hart, A.A.M.; Boerrigter, L.; Nederlof, P.M.; Porter, E.; Van Velthuysen, M.L.F. (2007). "Goblet cell carcinoid of the appendix: A specific type of carcinoma". <i>Histopathology</i>. <b>51</b> (6): 763–73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1365-2559.2007.02883.x">10.1111/j.1365-2559.2007.02883.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18042066">18042066</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Histopathology&amp;rft.atitle=Goblet+cell+carcinoid+of+the+appendix%3A+A+specific+type+of+carcinoma&amp;rft.volume=51&amp;rft.issue=6&amp;rft.pages=763-73&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2559.2007.02883.x&amp;rft_id=info%3Apmid%2F18042066&amp;rft.aulast=Van+Eeden&amp;rft.aufirst=S.&amp;rft.au=Offerhaus%2C+G.J.A.&amp;rft.au=Hart%2C+A.A.M.&amp;rft.au=Boerrigter%2C+L.&amp;rft.au=Nederlof%2C+P.M.&amp;rft.au=Porter%2C+E.&amp;rft.au=Van+Velthuysen%2C+M.L.F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Liu2001-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Liu2001_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Liu2001_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFLiuSturgisGrzybicki2001" class="citation journal cs1">Liu Y, Sturgis CD, Grzybicki DM,  et al. (September 2001). "Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma". <i>Mod. Pathol</i>. <b>14</b> (9): 880–85. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fmodpathol.3880406">10.1038/modpathol.3880406</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11557784">11557784</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24740130">24740130</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mod.+Pathol.&amp;rft.atitle=Microtubule-associated+protein-2%3A+a+new+sensitive+and+specific+marker+for+pulmonary+carcinoid+tumor+and+small+cell+carcinoma&amp;rft.volume=14&amp;rft.issue=9&amp;rft.pages=880-85&amp;rft.date=2001-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24740130&amp;rft_id=info%3Apmid%2F11557784&amp;rft_id=info%3Adoi%2F10.1038%2Fmodpathol.3880406&amp;rft.aulast=Liu&amp;rft.aufirst=Y&amp;rft.au=Sturgis%2C+CD&amp;rft.au=Grzybicki%2C+DM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Rufini-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rufini_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rufini_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFRufiniCalcagniBaum2006" class="citation journal cs1">Rufini V, Calcagni ML, Baum RP (July 2006). "Imaging of neuroendocrine tumors". <i>Semin Nucl Med</i>. <b>36</b> (3): 228–47. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.semnuclmed.2006.03.007">10.1053/j.semnuclmed.2006.03.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16762613">16762613</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Semin+Nucl+Med&amp;rft.atitle=Imaging+of+neuroendocrine+tumors&amp;rft.volume=36&amp;rft.issue=3&amp;rft.pages=228-47&amp;rft.date=2006-07&amp;rft_id=info%3Adoi%2F10.1053%2Fj.semnuclmed.2006.03.007&amp;rft_id=info%3Apmid%2F16762613&amp;rft.aulast=Rufini&amp;rft.aufirst=V&amp;rft.au=Calcagni%2C+ML&amp;rft.au=Baum%2C+RP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite id="CITEREFSoga2003" class="citation journal cs1">Soga, J. (2003). "Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases". <i><a href="/wiki/Journal_of_Experimental_%26_Clinical_Cancer_Research" title="Journal of Experimental &amp; Clinical Cancer Research">Journal of Experimental &amp; Clinical Cancer Research</a></i>. <b>22</b> (4): 517–30. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15053292">15053292</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Experimental+%26+Clinical+Cancer+Research&amp;rft.atitle=Carcinoids+and+their+variant+endocrinomas.+An+analysis+of+11842+reported+cases&amp;rft.volume=22&amp;rft.issue=4&amp;rft.pages=517-30&amp;rft.date=2003&amp;rft_id=info%3Apmid%2F15053292&amp;rft.aulast=Soga&amp;rft.aufirst=J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Soga1999-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-Soga1999_8-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFSogaYakuwaOsaka1999" class="citation journal cs1">Soga, J.; Yakuwa, Y.; Osaka, M. (1999). "Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: A comparative study between typical carcinoids and atypical varieties". <i>Annals of Thoracic and Cardiovascular Surgery</i>. <b>5</b> (5): 285–92. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10550713">10550713</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Thoracic+and+Cardiovascular+Surgery&amp;rft.atitle=Evaluation+of+342+cases+of+mediastinal%2Fthymic+carcinoids+collected+from+literature%3A+A+comparative+study+between+typical+carcinoids+and+atypical+varieties&amp;rft.volume=5&amp;rft.issue=5&amp;rft.pages=285-92&amp;rft.date=1999&amp;rft_id=info%3Apmid%2F10550713&amp;rft.aulast=Soga&amp;rft.aufirst=J.&amp;rft.au=Yakuwa%2C+Y.&amp;rft.au=Osaka%2C+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Öberg2008-BronchThymusESMO-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Öberg2008-BronchThymusESMO_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Öberg2008-BronchThymusESMO_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFObergJelicEsmo_Guidelines_Working2008" class="citation journal cs1">Oberg, K.; Jelic, S.; Esmo Guidelines Working, G. (2008). "Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up". <i>Annals of Oncology</i>. <b>19</b>: ii102–ii103. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fannonc%2Fmdn116">10.1093/annonc/mdn116</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18456740">18456740</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Oncology&amp;rft.atitle=Neuroendocrine+bronchial+and+thymic+tumors%3A+ESMO+Clinical+Recommendation+for+diagnosis%2C+treatment+and+follow-up&amp;rft.volume=19&amp;rft.pages=ii102-ii103&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdn116&amp;rft_id=info%3Apmid%2F18456740&amp;rft.aulast=Oberg&amp;rft.aufirst=K.&amp;rft.au=Jelic%2C+S.&amp;rft.au=Esmo+Guidelines+Working%2C+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Beasley2005-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Beasley2005_10-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBeasleyBrambillaTravis2005" class="citation journal cs1">Beasley, M.; Brambilla, E.; Travis, W. (2005). "The 2004 World Health Organization classification of lung tumors". <i>Seminars in Roentgenology</i>. <b>40</b> (2): 90–97. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.ro.2005.01.001">10.1053/j.ro.2005.01.001</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15898407">15898407</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Roentgenology&amp;rft.atitle=The+2004+World+Health+Organization+classification+of+lung+tumors&amp;rft.volume=40&amp;rft.issue=2&amp;rft.pages=90-97&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1053%2Fj.ro.2005.01.001&amp;rft_id=info%3Apmid%2F15898407&amp;rft.aulast=Beasley&amp;rft.aufirst=M.&amp;rft.au=Brambilla%2C+E.&amp;rft.au=Travis%2C+W.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Gustafsson2008-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gustafsson2008_11-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFGustafssonKiddChanMalfertheiner2008" class="citation journal cs1">Gustafsson, B.I.; Kidd, M.; Chan, A.; Malfertheiner, M.V.; Modlin, I.M. (2008). "Bronchopulmonary neuroendocrine tumors". <i>Cancer</i>. <b>113</b> (1): 5–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fcncr.23542">10.1002/cncr.23542</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18473355">18473355</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=Bronchopulmonary+neuroendocrine+tumors&amp;rft.volume=113&amp;rft.issue=1&amp;rft.pages=5-21&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.23542&amp;rft_id=info%3Apmid%2F18473355&amp;rft.aulast=Gustafsson&amp;rft.aufirst=B.I.&amp;rft.au=Kidd%2C+M.&amp;rft.au=Chan%2C+A.&amp;rft.au=Malfertheiner%2C+M.V.&amp;rft.au=Modlin%2C+I.M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Wick1992-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wick1992_12-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFWickBergHertz1992" class="citation journal cs1">Wick, M.; Berg, L.; Hertz, M. (1992). "Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors". <i>American Journal of Clinical Pathology</i>. <b>97</b> (6): 796–805. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fajcp%2F97.6.796">10.1093/ajcp/97.6.796</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/1317668">1317668</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Journal+of+Clinical+Pathology&amp;rft.atitle=Large+cell+carcinoma+of+the+lung+with+neuroendocrine+differentiation.+A+comparison+with+large+cell+%22undifferentiated%22+pulmonary+tumors&amp;rft.volume=97&amp;rft.issue=6&amp;rft.pages=796-805&amp;rft.date=1992&amp;rft_id=info%3Adoi%2F10.1093%2Fajcp%2F97.6.796&amp;rft_id=info%3Apmid%2F1317668&amp;rft.aulast=Wick&amp;rft.aufirst=M.&amp;rft.au=Berg%2C+L.&amp;rft.au=Hertz%2C+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Massironi2008-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Massironi2008_13-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMassironiSciolaPeracchiCiafardini2008" class="citation journal cs1">Massironi, S.; Sciola, V.; Peracchi, M.; Ciafardini, C.; Spampatti, M.; Conte, D. (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2744160">"Neuroendocrine tumors of the gastro-entero-pancreatic system"</a>. <i>World Journal of Gastroenterology</i>. <b>14</b> (35): 5377–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3748%2Fwjg.14.5377">10.3748/wjg.14.5377</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2744160">2744160</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18803349">18803349</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=World+Journal+of+Gastroenterology&amp;rft.atitle=Neuroendocrine+tumors+of+the+gastro-entero-pancreatic+system&amp;rft.volume=14&amp;rft.issue=35&amp;rft.pages=5377-84&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2744160&amp;rft_id=info%3Apmid%2F18803349&amp;rft_id=info%3Adoi%2F10.3748%2Fwjg.14.5377&amp;rft.aulast=Massironi&amp;rft.aufirst=S.&amp;rft.au=Sciola%2C+V.&amp;rft.au=Peracchi%2C+M.&amp;rft.au=Ciafardini%2C+C.&amp;rft.au=Spampatti%2C+M.&amp;rft.au=Conte%2C+D.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2744160&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Modlin2008-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Modlin2008_14-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFModlinObergChungJensen2008" class="citation journal cs1">Modlin, I.M.; Oberg, K.; Chung, D.C.; Jensen, R.T.; De Herder, W.W.; <a href="/wiki/Rajesh_Thakker" title="Rajesh Thakker">Thakker, R.V.</a>; Caplin, M.; Delle Fave, G.; Kaltsas, G.A.; Krenning, E.P.; Moss, S.F.; Nilsson, O.; Rindi, G.; Salazar, R.; Ruszniewski, P.; Sundin, A. (2008). "Gastroenteropancreatic neuroendocrine tumours". <i>The Lancet Oncology</i>. <b>9</b> (1): 61–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1470-2045%2807%2970410-2">10.1016/S1470-2045(07)70410-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18177818">18177818</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet+Oncology&amp;rft.atitle=Gastroenteropancreatic+neuroendocrine+tumours&amp;rft.volume=9&amp;rft.issue=1&amp;rft.pages=61-72&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1016%2FS1470-2045%2807%2970410-2&amp;rft_id=info%3Apmid%2F18177818&amp;rft.aulast=Modlin&amp;rft.aufirst=I.M.&amp;rft.au=Oberg%2C+K.&amp;rft.au=Chung%2C+D.C.&amp;rft.au=Jensen%2C+R.T.&amp;rft.au=De+Herder%2C+W.W.&amp;rft.au=Thakker%2C+R.V.&amp;rft.au=Caplin%2C+M.&amp;rft.au=Delle+Fave%2C+G.&amp;rft.au=Kaltsas%2C+G.A.&amp;rft.au=Krenning%2C+E.P.&amp;rft.au=Moss%2C+S.F.&amp;rft.au=Nilsson%2C+O.&amp;rft.au=Rindi%2C+G.&amp;rft.au=Salazar%2C+R.&amp;rft.au=Ruszniewski%2C+P.&amp;rft.au=Sundin%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Metz2008-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-Metz2008_15-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMetzJensen2008" class="citation journal cs1">Metz, D.C.; Jensen, R.T. (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2612755">"Gastrointestinal Neuroendocrine Tumors: Pancreatic Endocrine Tumors"</a>. <i>Gastroenterology</i>. <b>135</b> (5): 1469–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.gastro.2008.05.047">10.1053/j.gastro.2008.05.047</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2612755">2612755</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18703061">18703061</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterology&amp;rft.atitle=Gastrointestinal+Neuroendocrine+Tumors%3A+Pancreatic+Endocrine+Tumors&amp;rft.volume=135&amp;rft.issue=5&amp;rft.pages=1469-92&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2612755&amp;rft_id=info%3Apmid%2F18703061&amp;rft_id=info%3Adoi%2F10.1053%2Fj.gastro.2008.05.047&amp;rft.aulast=Metz&amp;rft.aufirst=D.C.&amp;rft.au=Jensen%2C+R.T.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2612755&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Griniatsos2010-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-Griniatsos2010_16-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFGriniatsosMichail2010" class="citation journal cs1">Griniatsos, J.; Michail, O. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2999180">"Appendiceal neuroendocrine tumors: Recent insights and clinical implications"</a>. <i>World Journal of Gastrointestinal Oncology</i>. <b>2</b> (4): 192–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4251%2Fwjgo.v2.i4.192">10.4251/wjgo.v2.i4.192</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2999180">2999180</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21160597">21160597</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=World+Journal+of+Gastrointestinal+Oncology&amp;rft.atitle=Appendiceal+neuroendocrine+tumors%3A+Recent+insights+and+clinical+implications&amp;rft.volume=2&amp;rft.issue=4&amp;rft.pages=192-96&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2999180&amp;rft_id=info%3Apmid%2F21160597&amp;rft_id=info%3Adoi%2F10.4251%2Fwjgo.v2.i4.192&amp;rft.aulast=Griniatsos&amp;rft.aufirst=J.&amp;rft.au=Michail%2C+O.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2999180&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Ni2010-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ni2010_17-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFNiShengDu2010" class="citation journal cs1">Ni, S.; Sheng, W.; Du, X. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2852818">"Pathologic research update of colorectal neuroendocrine tumors"</a>. <i>World Journal of Gastroenterology</i>. <b>16</b> (14): 1713–19. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3748%2Fwjg.v16.i14.1713">10.3748/wjg.v16.i14.1713</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2852818">2852818</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20380002">20380002</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=World+Journal+of+Gastroenterology&amp;rft.atitle=Pathologic+research+update+of+colorectal+neuroendocrine+tumors&amp;rft.volume=16&amp;rft.issue=14&amp;rft.pages=1713-19&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852818&amp;rft_id=info%3Apmid%2F20380002&amp;rft_id=info%3Adoi%2F10.3748%2Fwjg.v16.i14.1713&amp;rft.aulast=Ni&amp;rft.aufirst=S.&amp;rft.au=Sheng%2C+W.&amp;rft.au=Du%2C+X.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2852818&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Konishi2010-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-Konishi2010_18-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFKonishiWatanabeNagawaOya2010" class="citation journal cs1">Konishi, T.; Watanabe, T.; Nagawa, H.; Oya, M.; Ueno, M.; Kuroyanagi, H.; Fujimoto, Y.; Akiyoshi, T.; Yamaguchi, T.; Muto, T. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2999232">"Treatment of colorectal carcinoids: A new paradigm"</a>. <i>World Journal of Gastrointestinal Surgery</i>. <b>2</b> (5): 153–56. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4240%2Fwjgs.v2.i5.153">10.4240/wjgs.v2.i5.153</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2999232">2999232</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21160865">21160865</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=World+Journal+of+Gastrointestinal+Surgery&amp;rft.atitle=Treatment+of+colorectal+carcinoids%3A+A+new+paradigm&amp;rft.volume=2&amp;rft.issue=5&amp;rft.pages=153-56&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2999232&amp;rft_id=info%3Apmid%2F21160865&amp;rft_id=info%3Adoi%2F10.4240%2Fwjgs.v2.i5.153&amp;rft.aulast=Konishi&amp;rft.aufirst=T.&amp;rft.au=Watanabe%2C+T.&amp;rft.au=Nagawa%2C+H.&amp;rft.au=Oya%2C+M.&amp;rft.au=Ueno%2C+M.&amp;rft.au=Kuroyanagi%2C+H.&amp;rft.au=Fujimoto%2C+Y.&amp;rft.au=Akiyoshi%2C+T.&amp;rft.au=Yamaguchi%2C+T.&amp;rft.au=Muto%2C+T.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2999232&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Soga2002-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-Soga2002_19-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFSoga2002" class="citation journal cs1">Soga, J. (2002). "Primary hepatic endocrinomas (carcinoids and variant neoplasms). A statistical evaluation of 126 reported cases". <i>Journal of Experimental &amp; Clinical Cancer Research</i>. <b>21</b> (4): 457–68. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12636090">12636090</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Experimental+%26+Clinical+Cancer+Research&amp;rft.atitle=Primary+hepatic+endocrinomas+%28carcinoids+and+variant+neoplasms%29.+A+statistical+evaluation+of+126+reported+cases&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=457-68&amp;rft.date=2002&amp;rft_id=info%3Apmid%2F12636090&amp;rft.aulast=Soga&amp;rft.aufirst=J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite id="CITEREFC.M.V.2004" class="citation journal cs1">C., C.; M., N.; V., M. (2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2020649">"Primary hepatic carcinoid tumours"</a>. <i>HPB</i>. <b>6</b> (1): 13–17. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F13651820310017228">10.1080/13651820310017228</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2020649">2020649</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18333038">18333038</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=HPB&amp;rft.atitle=Primary+hepatic+carcinoid+tumours&amp;rft.volume=6&amp;rft.issue=1&amp;rft.pages=13-17&amp;rft.date=2004&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2020649&amp;rft_id=info%3Apmid%2F18333038&amp;rft_id=info%3Adoi%2F10.1080%2F13651820310017228&amp;rft.aulast=C.&amp;rft.aufirst=C.&amp;rft.au=M.%2C+N.&amp;rft.au=V.%2C+M.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2020649&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite id="CITEREFMoriuraIkedaHiraiNaiki1993" class="citation journal cs1">Moriura, S.; Ikeda, S.; Hirai, M.; Naiki, K.; Fujioka, T.; Yokochi, K.; Gotou, S. (1993). "Hepatic gastronoma". <i>Cancer</i>. <b>72</b> (5): 1547–50. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F1097-0142%2819930901%2972%3A5%3C1547%3A%3AAID-CNCR2820720510%3E3.0.CO%3B2-C">10.1002/1097-0142(19930901)72:5&#60;1547::AID-CNCR2820720510&#62;3.0.CO;2-C</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/8348490">8348490</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=Hepatic+gastronoma&amp;rft.volume=72&amp;rft.issue=5&amp;rft.pages=1547-50&amp;rft.date=1993&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142%2819930901%2972%3A5%3C1547%3A%3AAID-CNCR2820720510%3E3.0.CO%3B2-C&amp;rft_id=info%3Apmid%2F8348490&amp;rft.aulast=Moriura&amp;rft.aufirst=S.&amp;rft.au=Ikeda%2C+S.&amp;rft.au=Hirai%2C+M.&amp;rft.au=Naiki%2C+K.&amp;rft.au=Fujioka%2C+T.&amp;rft.au=Yokochi%2C+K.&amp;rft.au=Gotou%2C+S.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite id="CITEREFSoga2003" class="citation journal cs1">Soga, J. (2003). "Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases". <i>Journal of Experimental &amp; Clinical Cancer Research</i>. <b>22</b> (1): 5–15. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12725316">12725316</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Experimental+%26+Clinical+Cancer+Research&amp;rft.atitle=Primary+endocrinomas+%28carcinoids+and+variant+neoplasms%29+of+the+gallbladder.+A+statistical+evaluation+of+138+reported+cases&amp;rft.volume=22&amp;rft.issue=1&amp;rft.pages=5-15&amp;rft.date=2003&amp;rft_id=info%3Apmid%2F12725316&amp;rft.aulast=Soga&amp;rft.aufirst=J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite id="CITEREFSogaOsakaYakuwa2001" class="citation journal cs1">Soga, J.; Osaka, M.; Yakuwa, Y. (2001). "Gut-endocrinomas (carcinoids and related endocrine variants) of the breast: An analysis of 310 reported cases". <i>International Surgery</i>. <b>86</b> (1): 26–32. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11890336">11890336</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Surgery&amp;rft.atitle=Gut-endocrinomas+%28carcinoids+and+related+endocrine+variants%29+of+the+breast%3A+An+analysis+of+310+reported+cases&amp;rft.volume=86&amp;rft.issue=1&amp;rft.pages=26-32&amp;rft.date=2001&amp;rft_id=info%3Apmid%2F11890336&amp;rft.aulast=Soga&amp;rft.aufirst=J.&amp;rft.au=Osaka%2C+M.&amp;rft.au=Yakuwa%2C+Y.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Murali2006-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Murali2006_24-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMuraliKnealeLalakDelprado2006" class="citation journal cs1">Murali, R.; Kneale, K.; Lalak, N.; Delprado, W. (2006). <a rel="nofollow" class="external text" href="https://www.archivesofpathology.org/doi/full/10.1043/1543-2165%282006%29130%5B1693%3ACTOTUT%5D2.0.CO%3B2">"Carcinoid tumors of the urinary tract and prostate"</a>. <i>Archives of Pathology &amp; Laboratory Medicine</i>. <b>130</b> (11): 1693–1706. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1043%2F1543-2165%282006%29130%5B1693%3ACTOTUT%5D2.0.CO%3B2">10.1043/1543-2165(2006)130&#91;1693:CTOTUT&#93;2.0.CO;2</a> (inactive 2020-08-24). <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1543-2165">1543-2165</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17076534">17076534</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Pathology+%26+Laboratory+Medicine&amp;rft.atitle=Carcinoid+tumors+of+the+urinary+tract+and+prostate&amp;rft.volume=130&amp;rft.issue=11&amp;rft.pages=1693-1706&amp;rft.date=2006&amp;rft.issn=1543-2165&amp;rft_id=info%3Apmid%2F17076534&amp;rft_id=info%3Adoi%2F10.1043%2F1543-2165%282006%29130%5B1693%3ACTOTUT%5D2.0.CO%3B2&amp;rft.aulast=Murali&amp;rft.aufirst=R.&amp;rft.au=Kneale%2C+K.&amp;rft.au=Lalak%2C+N.&amp;rft.au=Delprado%2C+W.&amp;rft_id=https%3A%2F%2Fwww.archivesofpathology.org%2Fdoi%2Ffull%2F10.1043%2F1543-2165%25282006%2529130%255B1693%253ACTOTUT%255D2.0.CO%253B2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: DOI inactive as of August 2020 (<a href="/wiki/Category:CS1_maint:_DOI_inactive_as_of_August_2020" title="Category:CS1 maint: DOI inactive as of August 2020">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Mikuz1993-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mikuz1993_25-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFMikuz1993" class="citation journal cs1">Mikuz, G. (1993). "Non-urothelial tumors of the urinary tract". <i>Verhandlungen der Deutschen Gesellschaft für Pathologie</i>. <b>77</b>: 180–98. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/7511278">7511278</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Verhandlungen+der+Deutschen+Gesellschaft+f%C3%BCr+Pathologie&amp;rft.atitle=Non-urothelial+tumors+of+the+urinary+tract&amp;rft.volume=77&amp;rft.pages=180-98&amp;rft.date=1993&amp;rft_id=info%3Apmid%2F7511278&amp;rft.aulast=Mikuz&amp;rft.aufirst=G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Soga2001Cerv-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-Soga2001Cerv_26-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFSogaOsakaYakuwa2001" class="citation journal cs1">Soga, J.; Osaka, M.; Yakuwa, Y. (2001). "Gut-endocrinomas (carcinoids and related endocrine variants) of the uterine cervix: An analysis of 205 reported cases". <i>Journal of Experimental &amp; Clinical Cancer Research</i>. <b>20</b> (3): 327–34. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11718210">11718210</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Experimental+%26+Clinical+Cancer+Research&amp;rft.atitle=Gut-endocrinomas+%28carcinoids+and+related+endocrine+variants%29+of+the+uterine+cervix%3A+An+analysis+of+205+reported+cases&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=327-34&amp;rft.date=2001&amp;rft_id=info%3Apmid%2F11718210&amp;rft.aulast=Soga&amp;rft.aufirst=J.&amp;rft.au=Osaka%2C+M.&amp;rft.au=Yakuwa%2C+Y.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><cite id="CITEREFUsmaniOreviStefanelliZaniboni2019" class="citation journal cs1">Usmani, S; Orevi, M; Stefanelli, A; Zaniboni, A; Gofrit, ON; Bnà, C; Illuminati, S; Lojacono, G; Noventa, S; Savelli, G (June 2019). "Neuroendocrine differentiation in castration resistant prostate cancer. Nuclear medicine radiopharmaceuticals and imaging techniques: A narrative review". <i>Critical Reviews in Oncology/Hematology</i>. <b>138</b>: 29–37. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.critrevonc.2019.03.005">10.1016/j.critrevonc.2019.03.005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31092382">31092382</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Critical+Reviews+in+Oncology%2FHematology&amp;rft.atitle=Neuroendocrine+differentiation+in+castration+resistant+prostate+cancer.+Nuclear+medicine+radiopharmaceuticals+and+imaging+techniques%3A+A+narrative+review.&amp;rft.volume=138&amp;rft.pages=29-37&amp;rft.date=2019-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.critrevonc.2019.03.005&amp;rft_id=info%3Apmid%2F31092382&amp;rft.aulast=Usmani&amp;rft.aufirst=S&amp;rft.au=Orevi%2C+M&amp;rft.au=Stefanelli%2C+A&amp;rft.au=Zaniboni%2C+A&amp;rft.au=Gofrit%2C+ON&amp;rft.au=Bn%C3%A0%2C+C&amp;rft.au=Illuminati%2C+S&amp;rft.au=Lojacono%2C+G&amp;rft.au=Noventa%2C+S&amp;rft.au=Savelli%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><cite id="CITEREFDaviesBeltranZoubeidi2018" class="citation journal cs1">Davies, AH; Beltran, H; Zoubeidi, A (May 2018). "Cellular plasticity and the neuroendocrine phenotype in prostate cancer". <i>Nature Reviews. Urology</i>. <b>15</b> (5): 271–86. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrurol.2018.22">10.1038/nrurol.2018.22</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29460922">29460922</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4732323">4732323</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Urology&amp;rft.atitle=Cellular+plasticity+and+the+neuroendocrine+phenotype+in+prostate+cancer.&amp;rft.volume=15&amp;rft.issue=5&amp;rft.pages=271-86&amp;rft.date=2018-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4732323&amp;rft_id=info%3Apmid%2F29460922&amp;rft_id=info%3Adoi%2F10.1038%2Fnrurol.2018.22&amp;rft.aulast=Davies&amp;rft.aufirst=AH&amp;rft.au=Beltran%2C+H&amp;rft.au=Zoubeidi%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Jensen2008-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jensen2008_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jensen2008_29-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jensen2008_29-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Jensen2008_29-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Jensen2008_29-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFJensenBernaBinghamNorton2008" class="citation journal cs1">Jensen, R.T.; Berna, M.J.; Bingham, D.B.; Norton, J.A. (2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2574000">"Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies"</a>. <i>Cancer</i>. <b>113</b> (7 Suppl): 1807–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fcncr.23648">10.1002/cncr.23648</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2574000">2574000</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18798544">18798544</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=Inherited+pancreatic+endocrine+tumor+syndromes%3A+Advances+in+molecular+pathogenesis%2C+diagnosis%2C+management%2C+and+controversies&amp;rft.volume=113&amp;rft.issue=7+Suppl&amp;rft.pages=1807-43&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2574000&amp;rft_id=info%3Apmid%2F18798544&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.23648&amp;rft.aulast=Jensen&amp;rft.aufirst=R.T.&amp;rft.au=Berna%2C+M.J.&amp;rft.au=Bingham%2C+D.B.&amp;rft.au=Norton%2C+J.A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2574000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Hirsch2001-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hirsch2001_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hirsch2001_30-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFHirschMurphyRadcliffe2001" class="citation journal cs1">Hirsch, N.P.; Murphy, A.; Radcliffe, J. (2001). "Neurofibromatosis: Clinical presentations and anaesthetic implications". <i>British Journal of Anaesthesia</i>. <b>86</b> (4): 555–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbja%2F86.4.555">10.1093/bja/86.4.555</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11573632">11573632</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Anaesthesia&amp;rft.atitle=Neurofibromatosis%3A+Clinical+presentations+and+anaesthetic+implications&amp;rft.volume=86&amp;rft.issue=4&amp;rft.pages=555-64&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1093%2Fbja%2F86.4.555&amp;rft_id=info%3Apmid%2F11573632&amp;rft.aulast=Hirsch&amp;rft.aufirst=N.P.&amp;rft.au=Murphy%2C+A.&amp;rft.au=Radcliffe%2C+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Lodish2010-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lodish2010_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lodish2010_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lodish2010_31-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFLodishStratakis2010" class="citation journal cs1">Lodish, M.B.; Stratakis, C.A. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2939061">"Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes"</a>. <i>Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism</i>. <b>24</b> (3): 439–49. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.beem.2010.02.002">10.1016/j.beem.2010.02.002</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2939061">2939061</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20833335">20833335</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Best+Practice+%26+Research+Clinical+Endocrinology+%26+Metabolism&amp;rft.atitle=Endocrine+tumours+in+neurofibromatosis+type+1%2C+tuberous+sclerosis+and+related+syndromes&amp;rft.volume=24&amp;rft.issue=3&amp;rft.pages=439-49&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2939061&amp;rft_id=info%3Apmid%2F20833335&amp;rft_id=info%3Adoi%2F10.1016%2Fj.beem.2010.02.002&amp;rft.aulast=Lodish&amp;rft.aufirst=M.B.&amp;rft.au=Stratakis%2C+C.A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2939061&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Dworakowska2008-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dworakowska2008_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dworakowska2008_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFDworakowskaGrossman2008" class="citation journal cs1">Dworakowska, D.; Grossman, A.B. (2008). "Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review". <i>Endocrine-Related Cancer</i>. <b>16</b> (1): 45–58. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1677%2FERC-08-0142">10.1677/ERC-08-0142</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18978035">18978035</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine-Related+Cancer&amp;rft.atitle=Are+neuroendocrine+tumours+a+feature+of+tuberous+sclerosis%3F+A+systematic+review&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=45-58&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1677%2FERC-08-0142&amp;rft_id=info%3Apmid%2F18978035&amp;rft.aulast=Dworakowska&amp;rft.aufirst=D.&amp;rft.au=Grossman%2C+A.B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-OMIM160980-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-OMIM160980_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OMIM160980_33-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">OMIM - Online Mendelian Inheritance in Man. Carney Complex, type 1; CNC1 (OMIM 160980) <a rel="nofollow" class="external text" href="http://www.omim.org/entry/160980">omim.org</a></span>
</li>
<li id="cite_note-OMIM605244-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-OMIM605244_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OMIM605244_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">OMIM – Online Mendelian Inheritance in Man. Carney Complex, type 2; CNC2 (OMIM 605244)</span>
</li>
<li id="cite_note-WHO_grade-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-WHO_grade_35-0">^</a></b></span> <span class="reference-text">&gt;<cite id="CITEREFBosmanCarneiroHrubanTheise2010" class="citation book cs1">Bosman, Fred T.; Carneiro, Fatima; Hruban, Ralph H.; Theise, Neil D., eds. (2010). <i>WHO Classification of Tumours of the Digestive System</i> (4 ed.). Lyon: <a href="/wiki/International_Agency_for_Research_on_Cancer" title="International Agency for Research on Cancer">International Agency for Research on Cancer</a>. pp.&#160;13–14. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-92-832-2432-7" title="Special:BookSources/978-92-832-2432-7"><bdi>978-92-832-2432-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=WHO+Classification+of+Tumours+of+the+Digestive+System&amp;rft.place=Lyon&amp;rft.pages=13-14&amp;rft.edition=4&amp;rft.pub=International+Agency+for+Research+on+Cancer&amp;rft.date=2010&amp;rft.isbn=978-92-832-2432-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><cite id="CITEREFBasturkYangTangHruban2015" class="citation journal cs1">Basturk, O; Yang, Z; Tang, LH; Hruban, RH; Adsay, V; McCall, CM; Krasinskas, AM; Jang, KT; Frankel, WL; Balci, S; Sigel, C; Klimstra, DS (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4398606">"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms"</a>. <i>The American Journal of Surgical Pathology</i>. <b>39</b> (5): 683–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FPAS.0000000000000408">10.1097/PAS.0000000000000408</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4398606">4398606</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25723112">25723112</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Surgical+Pathology&amp;rft.atitle=The+high-grade+%28WHO+G3%29+pancreatic+neuroendocrine+tumor+category+is+morphologically+and+biologically+heterogenous+and+includes+both+well+differentiated+and+poorly+differentiated+neoplasms.&amp;rft.volume=39&amp;rft.issue=5&amp;rft.pages=683-90&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4398606&amp;rft_id=info%3Apmid%2F25723112&amp;rft_id=info%3Adoi%2F10.1097%2FPAS.0000000000000408&amp;rft.aulast=Basturk&amp;rft.aufirst=O&amp;rft.au=Yang%2C+Z&amp;rft.au=Tang%2C+LH&amp;rft.au=Hruban%2C+RH&amp;rft.au=Adsay%2C+V&amp;rft.au=McCall%2C+CM&amp;rft.au=Krasinskas%2C+AM&amp;rft.au=Jang%2C+KT&amp;rft.au=Frankel%2C+WL&amp;rft.au=Balci%2C+S&amp;rft.au=Sigel%2C+C&amp;rft.au=Klimstra%2C+DS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4398606&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite id="CITEREFAmin2017" class="citation book cs1">Amin, Mahul B., ed. (2017). <i>AJCC Cancer Staging Manual</i> (8 ed.). <a href="/wiki/Springer_Science%2BBusiness_Media" title="Springer Science+Business Media">Springer</a>. p.&#160;351. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-319-40617-6" title="Special:BookSources/978-3-319-40617-6"><bdi>978-3-319-40617-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=AJCC+Cancer+Staging+Manual&amp;rft.pages=351&amp;rft.edition=8&amp;rft.pub=Springer&amp;rft.date=2017&amp;rft.isbn=978-3-319-40617-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><cite id="CITEREFAmin2017" class="citation book cs1">Amin, Mahul B., ed. (2017). "29 – Neuroendocrine Tumors of the Stomach". <i>AJCC Cancer Staging Manual</i> (8 ed.). <a href="/wiki/Springer_Science%2BBusiness_Media" title="Springer Science+Business Media">Springer</a>. p.&#160;355. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-319-40617-6" title="Special:BookSources/978-3-319-40617-6"><bdi>978-3-319-40617-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=29+%E2%80%93+Neuroendocrine+Tumors+of+the+Stomach&amp;rft.btitle=AJCC+Cancer+Staging+Manual&amp;rft.pages=355&amp;rft.edition=8&amp;rft.pub=Springer&amp;rft.date=2017&amp;rft.isbn=978-3-319-40617-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite id="CITEREFAmin2017" class="citation book cs1">Amin, Mahul B., ed. (2017). "30 – Neuroendocrine Tumors of the Duodenum &amp; Ampulla of Vater". <i>AJCC Cancer Staging Manual</i> (8 ed.). <a href="/wiki/Springer_Science%2BBusiness_Media" title="Springer Science+Business Media">Springer</a>. p.&#160;369. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-319-40617-6" title="Special:BookSources/978-3-319-40617-6"><bdi>978-3-319-40617-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=30+%E2%80%93+Neuroendocrine+Tumors+of+the+Duodenum+%26+Ampulla+of+Vater&amp;rft.btitle=AJCC+Cancer+Staging+Manual&amp;rft.pages=369&amp;rft.edition=8&amp;rft.pub=Springer&amp;rft.date=2017&amp;rft.isbn=978-3-319-40617-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text">AJCC, 8th edition: <cite id="CITEREFDavid_S_Klimstra,_Zhaohai_Yang" class="citation web cs1">David S Klimstra, Zhaohai Yang. <a rel="nofollow" class="external text" href="https://www.uptodate.com/contents/pathology-classification-and-grading-of-neuroendocrine-neoplasms-arising-in-the-digestive-system">"Pathology, classification, and grading of neuroendocrine neoplasms arising in the digestive system"</a>. <i><a href="/wiki/UpToDate" title="UpToDate">UpToDate</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=UpToDate&amp;rft.atitle=Pathology%2C+classification%2C+and+grading+of+neuroendocrine+neoplasms+arising+in+the+digestive+system&amp;rft.au=David+S+Klimstra%2C+Zhaohai+Yang&amp;rft_id=https%3A%2F%2Fwww.uptodate.com%2Fcontents%2Fpathology-classification-and-grading-of-neuroendocrine-neoplasms-arising-in-the-digestive-system&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/> This topic last updated: Oct 29, 2019.</span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><cite id="CITEREFAmin2017" class="citation book cs1">Amin, Mahul B., ed. (2017). "32 – Neuroendocrine Tumors of the Appendix". <i>AJCC Cancer Staging Manual</i> (8 ed.). <a href="/wiki/Springer_Science%2BBusiness_Media" title="Springer Science+Business Media">Springer</a>. p.&#160;392. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-319-40617-6" title="Special:BookSources/978-3-319-40617-6"><bdi>978-3-319-40617-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=32+%E2%80%93+Neuroendocrine+Tumors+of+the+Appendix&amp;rft.btitle=AJCC+Cancer+Staging+Manual&amp;rft.pages=392&amp;rft.edition=8&amp;rft.pub=Springer&amp;rft.date=2017&amp;rft.isbn=978-3-319-40617-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite id="CITEREFAmin2017" class="citation book cs1">Amin, Mahul B., ed. (2017). "33 – Neuroendocrine Tumors of the Colon and Rectum". <i>AJCC Cancer Staging Manual</i> (8 ed.). <a href="/wiki/Springer_Science%2BBusiness_Media" title="Springer Science+Business Media">Springer</a>. p.&#160;399. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-319-40617-6" title="Special:BookSources/978-3-319-40617-6"><bdi>978-3-319-40617-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=33+%E2%80%93+Neuroendocrine+Tumors+of+the+Colon+and+Rectum&amp;rft.btitle=AJCC+Cancer+Staging+Manual&amp;rft.pages=399&amp;rft.edition=8&amp;rft.pub=Springer&amp;rft.date=2017&amp;rft.isbn=978-3-319-40617-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><cite id="CITEREFAmin2017" class="citation book cs1">Amin, Mahul B., ed. (2017). "30 – Neuroendocrine Tumors of the Pancreas". <i>AJCC Cancer Staging Manual</i> (8 ed.). <a href="/wiki/Springer_Science%2BBusiness_Media" title="Springer Science+Business Media">Springer</a>. pp.&#160;415–16. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-319-40617-6" title="Special:BookSources/978-3-319-40617-6"><bdi>978-3-319-40617-6</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=30+%E2%80%93+Neuroendocrine+Tumors+of+the+Pancreas&amp;rft.btitle=AJCC+Cancer+Staging+Manual&amp;rft.pages=415-16&amp;rft.edition=8&amp;rft.pub=Springer&amp;rft.date=2017&amp;rft.isbn=978-3-319-40617-6&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Kimura1991-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kimura1991_44-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFKimuraKurodaMorioka1991" class="citation journal cs1">Kimura W, Kuroda A, Morioka Y (July 1991). "Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases". <i>Dig. Dis. Sci</i>. <b>36</b> (7): 933–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF01297144">10.1007/BF01297144</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/2070707">2070707</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20567425">20567425</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Dig.+Dis.+Sci.&amp;rft.atitle=Clinical+pathology+of+endocrine+tumors+of+the+pancreas.+Analysis+of+autopsy+cases&amp;rft.volume=36&amp;rft.issue=7&amp;rft.pages=933-42&amp;rft.date=1991-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20567425&amp;rft_id=info%3Apmid%2F2070707&amp;rft_id=info%3Adoi%2F10.1007%2FBF01297144&amp;rft.aulast=Kimura&amp;rft.aufirst=W&amp;rft.au=Kuroda%2C+A&amp;rft.au=Morioka%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/> "[In] 800 autopsy cases, ... incidence of tumor was 10% (6/60) in individuals having histiological studies of all sections of the pancreas"</span>
</li>
<li id="cite_note-Arnold-45"><span class="mw-cite-backlink">^ <a href="#cite_ref-Arnold_45-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Arnold_45-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Arnold_45-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Arnold_45-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFArnoldGökeWiedBehr2003" class="citation book cs1">Arnold R, Göke R, Wied M, Behr T (2003). "Chapter 15 Neuroendocrine Gastro-Entero-Pancreatic (GEP) Tumors".  In Scheppach W, Bresalier RS, Tytgat GN (eds.). <i>Gastrointestinal and Liver Tumors</i>. Berlin: Springer. pp.&#160;195–233. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-540-43462-7" title="Special:BookSources/978-3-540-43462-7"><bdi>978-3-540-43462-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+15+Neuroendocrine+Gastro-Entero-Pancreatic+%28GEP%29+Tumors&amp;rft.btitle=Gastrointestinal+and+Liver+Tumors&amp;rft.place=Berlin&amp;rft.pages=195-233&amp;rft.pub=Springer&amp;rft.date=2003&amp;rft.isbn=978-3-540-43462-7&amp;rft.aulast=Arnold&amp;rft.aufirst=R&amp;rft.au=G%C3%B6ke%2C+R&amp;rft.au=Wied%2C+M&amp;rft.au=Behr%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Pommier-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pommier_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pommier_46-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Pommier_46-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Pommier_46-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">Pommier R. 2003. The role of surgery and chemoembolization in the management of carcinoid. California Carcinoid Fighters Conference. October 25, <a rel="nofollow" class="external text" href="http://www.carcinoid.org/content/role-surgery-and-chemoembolization-management-carcinoid">carcinoid.org</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150915090206/http://www.carcinoid.org/content/role-surgery-and-chemoembolization-management-carcinoid">Archived</a> 2015-09-15 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-HC-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-HC_47-0">^</a></b></span> <span class="reference-text">Health Communities. Carcinoid Tumor Overview. <a rel="nofollow" class="external text" href="http://www.healthcommunities.com/carcinoid-malignancy/carcinoid-malignancy-overview.shtml">healthcommunities.com</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120303205216/http://www.healthcommunities.com/carcinoid-malignancy/carcinoid-malignancy-overview.shtml">Archived</a> 2012-03-03 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-Kvols-48"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kvols_48-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kvols_48-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kvols_48-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Kvols_48-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Kvols_48-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Kvols_48-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Kvols_48-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Kvols_48-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text">Kvols LK. 2002. Carcinoid Tumors and the Carcinoid Syndrome: What's New in the Therapeutic Pipeline. (The Carcinoid Cancer Foundation: Carcinoid Symposium 2002) <a rel="nofollow" class="external text" href="http://www.carcinoid.org/content/carcinoid-tumors-and-carcinoid-syndrome-whats-new-therapeutic-pipeline">carcinoid.org</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150105014851/http://www.carcinoid.org/content/carcinoid-tumors-and-carcinoid-syndrome-whats-new-therapeutic-pipeline">Archived</a> 2015-01-05 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-Benson2010-49"><span class="mw-cite-backlink">^ <a href="#cite_ref-Benson2010_49-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Benson2010_49-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Benson2010_49-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Benson2010_49-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Benson2010_49-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Benson2010_49-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Benson2010_49-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text">Benson AB, Myerson RJ, and Sasson AR. Pancreatic, neuroendocrine GI, and adrenal cancers. Cancer Management: A Multidisciplinary Approach 13th edition 2010; <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/><a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-615-41824-7" title="Special:BookSources/978-0-615-41824-7">978-0-615-41824-7</a> Text is available electronically (but may require free registration) at <a rel="nofollow" class="external text" href="http://www.cancernetwork.com/cancer-management/pancreatic/article/10165/1802606">Infosite</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110515111725/http://www.cancernetwork.com/cancer-management/pancreatic/article/10165/1802606">Archived</a> 2011-05-15 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>, cancernetwork.com; accessed November 8, 2015.</span>
</li>
<li id="cite_note-PDQ-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-PDQ_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PDQ_50-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ) Health Professional Version. National Cancer Institute. March 7, 2014. <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032521/can">ncbi.nlm.nih.gov</a></span>
</li>
<li id="cite_note-Burns2012-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-Burns2012_51-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBurnsEdil2012" class="citation journal cs1">Burns WR, Edil BH (March 2012). "Neuroendocrine pancreatic tumors: guidelines for management and update". <i>Current Treatment Options in Oncology</i>. <b>13</b> (1): 24–34. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs11864-011-0172-2">10.1007/s11864-011-0172-2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22198808">22198808</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7329783">7329783</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Treatment+Options+in+Oncology&amp;rft.atitle=Neuroendocrine+pancreatic+tumors%3A+guidelines+for+management+and+update&amp;rft.volume=13&amp;rft.issue=1&amp;rft.pages=24-34&amp;rft.date=2012-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7329783&amp;rft_id=info%3Apmid%2F22198808&amp;rft_id=info%3Adoi%2F10.1007%2Fs11864-011-0172-2&amp;rft.aulast=Burns&amp;rft.aufirst=WR&amp;rft.au=Edil%2C+BH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><cite id="CITEREFKlimstraModlinCoppola2010" class="citation journal cs1">Klimstra DS, Modlin IR, Coppola D,  et al. (August 2010). <a rel="nofollow" class="external text" href="http://www.seen.es/docs/apartados/470/The_Pathologic_Classification_of_Neuroendocrine.2.pdf">"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems"</a> <span class="cs1-format">(PDF)</span>. <i>Pancreas</i>. <b>39</b> (6): 707–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMPA.0b013e3181ec124e">10.1097/MPA.0b013e3181ec124e</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20664470">20664470</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3735444">3735444</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pancreas&amp;rft.atitle=The+pathologic+classification+of+neuroendocrine+tumors%3A+a+review+of+nomenclature%2C+grading%2C+and+staging+systems&amp;rft.volume=39&amp;rft.issue=6&amp;rft.pages=707-12&amp;rft.date=2010-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3735444&amp;rft_id=info%3Apmid%2F20664470&amp;rft_id=info%3Adoi%2F10.1097%2FMPA.0b013e3181ec124e&amp;rft.aulast=Klimstra&amp;rft.aufirst=DS&amp;rft.au=Modlin%2C+IR&amp;rft.au=Coppola%2C+D&amp;rft_id=http%3A%2F%2Fwww.seen.es%2Fdocs%2Fapartados%2F470%2FThe_Pathologic_Classification_of_Neuroendocrine.2.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Bostanci-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bostanci_53-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBostanci_A2005" class="citation journal cs1">Bostanci A (2005). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/173e585970f575331bfda5a62c989dc37ba9b610">"Wildlife biology. A devil of a disease"</a>. <i>Science</i>. <b>307</b> (5712): 1035. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.307.5712.1035">10.1126/science.307.5712.1035</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15718445">15718445</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:54100368">54100368</a>. <q>The tumors [of Devil facial tumor disease] have been characterized as a neuroendocrine cancer</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Wildlife+biology.+A+devil+of+a+disease&amp;rft.volume=307&amp;rft.issue=5712&amp;rft.pages=1035&amp;rft.date=2005&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A54100368&amp;rft_id=info%3Apmid%2F15718445&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.307.5712.1035&amp;rft.au=Bostanci+A&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F173e585970f575331bfda5a62c989dc37ba9b610&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-BBC_2010-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-BBC_2010_54-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFKinver2010" class="citation news cs1">Kinver, Mark (January 1, 2010). <a rel="nofollow" class="external text" href="http://news.bbc.co.uk/2/hi/science/nature/8433645.stm">"Tasmanian devil facial cancer origins 'identified<span class="cs1-kern-right">'</span>"</a>. BBC. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100102052045/http://news.bbc.co.uk/2/hi/science/nature/8433645.stm">Archived</a> from the original on January 2, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Tasmanian+devil+facial+cancer+origins+%27identified%27&amp;rft.date=2010-01-01&amp;rft.aulast=Kinver&amp;rft.aufirst=Mark&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fscience%2Fnature%2F8433645.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Time_2010-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-Time_2010_55-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFWalsh2010" class="citation news cs1">Walsh, Bryan (January 1, 2010). <a rel="nofollow" class="external text" href="http://www.time.com/time/health/article/0,8599,1950787,00.html?xid=rss-topstories">"Decoding the Tasmanian Devil's Deadly Cancer"</a>. Time. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100108083306/http://www.time.com/time/health/article/0,8599,1950787,00.html?xid=rss-topstories">Archived</a> from the original on January 8, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Decoding+the+Tasmanian+Devil%27s+Deadly+Cancer&amp;rft.date=2010-01-01&amp;rft.aulast=Walsh&amp;rft.aufirst=Bryan&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fhealth%2Farticle%2F0%2C8599%2C1950787%2C00.html%3Fxid%3Drss-topstories&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Langley1994-56"><span class="mw-cite-backlink">^ <a href="#cite_ref-Langley1994_56-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Langley1994_56-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFLangley1994" class="citation journal cs1">Langley, K. (1994). "The Neuroendocrine Concept Today". <i>Annals of the New York Academy of Sciences</i>. <b>733</b> (1): 1–17. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1994NYASA.733....1L">1994NYASA.733....1L</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1749-6632.1994.tb17251.x">10.1111/j.1749-6632.1994.tb17251.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/7978856">7978856</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+the+New+York+Academy+of+Sciences&amp;rft.atitle=The+Neuroendocrine+Concept+Today&amp;rft.volume=733&amp;rft.issue=1&amp;rft.pages=1-17&amp;rft.date=1994&amp;rft_id=info%3Apmid%2F7978856&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1749-6632.1994.tb17251.x&amp;rft_id=info%3Abibcode%2F1994NYASA.733....1L&amp;rft.aulast=Langley&amp;rft.aufirst=K.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Ferolla2008-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ferolla2008_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ferolla2008_57-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFFerollaFaggianoMansuetoAvenia2008" class="citation journal cs1">Ferolla, P.; Faggiano, A.; Mansueto, G.; Avenia, N.; Cantelmi, M.; Giovenali, P.; Del Basso De Caro ML; Milone, F.; Scarpelli, G.; Masone, S.; Santeusanio, F.; Lombardi, G.; Angeletti, G.; Colao, A. (2008). "The biological characterization of neuroendocrine tumors: The role of neuroendocrine markers". <i><a href="/wiki/Journal_of_Endocrinological_Investigation" title="Journal of Endocrinological Investigation">Journal of Endocrinological Investigation</a></i>. <b>31</b> (3): 277–86. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fbf03345602">10.1007/bf03345602</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18401212">18401212</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25108086">25108086</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Endocrinological+Investigation&amp;rft.atitle=The+biological+characterization+of+neuroendocrine+tumors%3A+The+role+of+neuroendocrine+markers&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=277-86&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25108086&amp;rft_id=info%3Apmid%2F18401212&amp;rft_id=info%3Adoi%2F10.1007%2Fbf03345602&amp;rft.aulast=Ferolla&amp;rft.aufirst=P.&amp;rft.au=Faggiano%2C+A.&amp;rft.au=Mansueto%2C+G.&amp;rft.au=Avenia%2C+N.&amp;rft.au=Cantelmi%2C+M.&amp;rft.au=Giovenali%2C+P.&amp;rft.au=Del+Basso+De+Caro+ML&amp;rft.au=Milone%2C+F.&amp;rft.au=Scarpelli%2C+G.&amp;rft.au=Masone%2C+S.&amp;rft.au=Santeusanio%2C+F.&amp;rft.au=Lombardi%2C+G.&amp;rft.au=Angeletti%2C+G.&amp;rft.au=Colao%2C+A.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><cite id="CITEREFPrince" class="citation web cs1">Prince, Jim McMorran, Damian Crowther, Stew McMorran, Steve Youngmin, Ian Wacogne, Jon Pleat, Clive. <a rel="nofollow" class="external text" href="http://www.gpnotebook.co.uk/simplepage.cfm?ID=953155609">"investigations – General Practice Notebook"</a>. <i>www.gpnotebook.co.uk</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170224053811/http://www.gpnotebook.co.uk/simplepage.cfm?ID=953155609">Archived</a> from the original on 2017-02-24<span class="reference-accessdate">. Retrieved <span class="nowrap">2017-02-23</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.gpnotebook.co.uk&amp;rft.atitle=investigations+%E2%80%93+General+Practice+Notebook&amp;rft.aulast=Prince&amp;rft.aufirst=Jim+McMorran%2C+Damian+Crowther%2C+Stew+McMorran%2C+Steve+Youngmin%2C+Ian+Wacogne%2C+Jon+Pleat%2C+Clive&amp;rft_id=http%3A%2F%2Fwww.gpnotebook.co.uk%2Fsimplepage.cfm%3FID%3D953155609&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Öberg2005b-59"><span class="mw-cite-backlink">^ <a href="#cite_ref-Öberg2005b_59-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Öberg2005b_59-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFOberg,_K2005" class="citation journal cs1">Oberg, K (July 2005). "Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment". <i>Current Opinion in Oncology</i>. <b>17</b> (4): 386–91. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01.cco.0000167739.56948.a9">10.1097/01.cco.0000167739.56948.a9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15933475">15933475</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:208286399">208286399</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Oncology&amp;rft.atitle=Neuroendocrine+tumors+of+the+gastrointestinal+tract%3A+recent+advances+in+molecular+genetics%2C+diagnosis%2C+and+treatment&amp;rft.volume=17&amp;rft.issue=4&amp;rft.pages=386-91&amp;rft.date=2005-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A208286399&amp;rft_id=info%3Apmid%2F15933475&amp;rft_id=info%3Adoi%2F10.1097%2F01.cco.0000167739.56948.a9&amp;rft.au=Oberg%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><cite id="CITEREFvan_EssenSundinKrenningKwekkeboom2014" class="citation journal cs1">van Essen, Martijn; Sundin, Anders; Krenning, Eric P.; Kwekkeboom, Dik J. (February 2014). "Neuroendocrine tumours: the role of imaging for diagnosis and therapy". <i>Nature Reviews Endocrinology</i>. <b>10</b> (2): 102–14. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrendo.2013.246">10.1038/nrendo.2013.246</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1759-5029">1759-5029</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24322649">24322649</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:40129404">40129404</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Endocrinology&amp;rft.atitle=Neuroendocrine+tumours%3A+the+role+of+imaging+for+diagnosis+and+therapy&amp;rft.volume=10&amp;rft.issue=2&amp;rft.pages=102-14&amp;rft.date=2014-02&amp;rft.issn=1759-5029&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A40129404&amp;rft_id=info%3Apmid%2F24322649&amp;rft_id=info%3Adoi%2F10.1038%2Fnrendo.2013.246&amp;rft.aulast=van+Essen&amp;rft.aufirst=Martijn&amp;rft.au=Sundin%2C+Anders&amp;rft.au=Krenning%2C+Eric+P.&amp;rft.au=Kwekkeboom%2C+Dik+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Ga68SSTR-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ga68SSTR_61-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFHofmanKongNeelsEu2012" class="citation journal cs1">Hofman, M.S.; Kong, G.; Neels, O.C.; Eu, P.; Hong, E.; Hicks, R.J. (2012). "High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours". <i>Journal of Medical Imaging and Radiation Oncology</i>. <b>56</b> (1): 40–47. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1754-9485.2011.02327.x">10.1111/j.1754-9485.2011.02327.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22339744">22339744</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Medical+Imaging+and+Radiation+Oncology&amp;rft.atitle=High+management+impact+of+Ga-68+DOTATATE+%28GaTate%29+PET%2FCT+for+imaging+neuroendocrine+and+other+somatostatin+expressing+tumours&amp;rft.volume=56&amp;rft.issue=1&amp;rft.pages=40-47&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1754-9485.2011.02327.x&amp;rft_id=info%3Apmid%2F22339744&amp;rft.aulast=Hofman&amp;rft.aufirst=M.S.&amp;rft.au=Kong%2C+G.&amp;rft.au=Neels%2C+O.C.&amp;rft.au=Eu%2C+P.&amp;rft.au=Hong%2C+E.&amp;rft.au=Hicks%2C+R.J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-FDGPET-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDGPET_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDGPET_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFHofmanHicks2012" class="citation journal cs1">Hofman, M.S.; Hicks, R.J. (2012). <a rel="nofollow" class="external text" href="http://www.discoverymedicine.com/Michael-S-Hofman/2012/07/26/changing-paradigms-with-molecular-imaging-of-neuroendocrine-tumors">"Changing paradigms with molecular imaging of neuroendocrine tumors"</a>. <i>Discovery Medicine</i>. <b>14</b> (74): 71–81. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22846204">22846204</a><span class="reference-accessdate">. Retrieved <span class="nowrap">November 8,</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Discovery+Medicine&amp;rft.atitle=Changing+paradigms+with+molecular+imaging+of+neuroendocrine+tumors&amp;rft.volume=14&amp;rft.issue=74&amp;rft.pages=71-81&amp;rft.date=2012&amp;rft_id=info%3Apmid%2F22846204&amp;rft.aulast=Hofman&amp;rft.aufirst=M.S.&amp;rft.au=Hicks%2C+R.J.&amp;rft_id=http%3A%2F%2Fwww.discoverymedicine.com%2FMichael-S-Hofman%2F2012%2F07%2F26%2Fchanging-paradigms-with-molecular-imaging-of-neuroendocrine-tumors&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><cite id="CITEREFNilicaWaitzStevanovicUprimny2016" class="citation journal cs1">Nilica, Bernhard; Waitz, Dietmar; Stevanovic, Vlado; Uprimny, Christian; Kendler, Dorota; Buxbaum, Sabine; Warwitz, Boris; Gerardo, Llanos; Henninger, Benjamin (2016-08-01). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4932132">"Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle"</a>. <i>European Journal of Nuclear Medicine and Molecular Imaging</i>. <b>43</b> (9): 1585–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00259-016-3328-2">10.1007/s00259-016-3328-2</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1619-7070">1619-7070</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4932132">4932132</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26922350">26922350</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Nuclear+Medicine+and+Molecular+Imaging&amp;rft.atitle=Direct+comparison+of+68Ga-DOTA-TOC+and+18F-FDG+PET%2FCT+in+the+follow-up+of+patients+with+neuroendocrine+tumour+treated+with+the+first+full+peptide+receptor+radionuclide+therapy+cycle&amp;rft.volume=43&amp;rft.issue=9&amp;rft.pages=1585-92&amp;rft.date=2016-08-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4932132&amp;rft.issn=1619-7070&amp;rft_id=info%3Apmid%2F26922350&amp;rft_id=info%3Adoi%2F10.1007%2Fs00259-016-3328-2&amp;rft.aulast=Nilica&amp;rft.aufirst=Bernhard&amp;rft.au=Waitz%2C+Dietmar&amp;rft.au=Stevanovic%2C+Vlado&amp;rft.au=Uprimny%2C+Christian&amp;rft.au=Kendler%2C+Dorota&amp;rft.au=Buxbaum%2C+Sabine&amp;rft.au=Warwitz%2C+Boris&amp;rft.au=Gerardo%2C+Llanos&amp;rft.au=Henninger%2C+Benjamin&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4932132&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Berretta2010-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-Berretta2010_64-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFBerretta2010" class="citation journal cs1">Berretta, M. (2010). "Biomarkers in neuroendocrine tumors". <i>Frontiers in Bioscience</i>. <b>S2</b>: 332–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2741%2Fs68">10.2741/s68</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20036951">20036951</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Bioscience&amp;rft.atitle=Biomarkers+in+neuroendocrine+tumors&amp;rft.volume=S2&amp;rft.pages=332-42&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.2741%2Fs68&amp;rft_id=info%3Apmid%2F20036951&amp;rft.aulast=Berretta&amp;rft.aufirst=M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><cite id="CITEREFMukhopadhyayDermawanLaniganFarver2018" class="citation journal cs1">Mukhopadhyay S, Dermawan JK, Lanigan CP, Farver CF (August 2018). "Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections". <i>Modern Pathology</i>. <b>32</b> (1): 100–09. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41379-018-0122-7">10.1038/s41379-018-0122-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30154579">30154579</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52110673">52110673</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Modern+Pathology&amp;rft.atitle=Insulinoma-associated+protein+1+%28INSM1%29+is+a+sensitive+and+highly+specific+marker+of+neuroendocrine+differentiation+in+primary+lung+neoplasms%3A+an+immunohistochemical+study+of+345+cases%2C+including+292+whole-tissue+sections&amp;rft.volume=32&amp;rft.issue=1&amp;rft.pages=100-09&amp;rft.date=2018-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52110673&amp;rft_id=info%3Apmid%2F30154579&amp;rft_id=info%3Adoi%2F10.1038%2Fs41379-018-0122-7&amp;rft.aulast=Mukhopadhyay&amp;rft.aufirst=S&amp;rft.au=Dermawan%2C+JK&amp;rft.au=Lanigan%2C+CP&amp;rft.au=Farver%2C+CF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><cite id="CITEREFCameron_K_Tebbi,_MD;_Chief_Editor:_Max_J_Coppes,_MD,_PhD,_MBA2014" class="citation web cs1">Cameron K Tebbi, MD; Chief Editor: Max J Coppes, MD, PhD, MBA;  et al. (1 Apr 2014). <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/986050-overview">"Carcinoid Tumor"</a>. <i>Medscape.com</i>. WebMD LLC. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20141215204328/http://emedicine.medscape.com/article/986050-overview">Archived</a> from the original on 15 December 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">3 September</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medscape.com&amp;rft.atitle=Carcinoid+Tumor&amp;rft.date=2014-04-01&amp;rft.au=Cameron+K+Tebbi%2C+MD%3B+Chief+Editor%3A+Max+J+Coppes%2C+MD%2C+PhD%2C+MBA&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F986050-overview&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><span class="cs1-maint citation-comment">CS1 maint: multiple names: authors list (<a href="/wiki/Category:CS1_maint:_multiple_names:_authors_list" title="Category:CS1 maint: multiple names: authors list">link</a>)</span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Warner-67"><span class="mw-cite-backlink">^ <a href="#cite_ref-Warner_67-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Warner_67-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Warner_67-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFWarner2005" class="citation journal cs1">Warner, R.R.P. (2005). "Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant Advances". <i>Gastroenterology</i>. <b>128</b> (6): 1668–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.gastro.2005.03.078">10.1053/j.gastro.2005.03.078</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15887158">15887158</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterology&amp;rft.atitle=Enteroendocrine+Tumors+Other+Than+Carcinoid%3A+A+Review+of+Clinically+Significant+Advances&amp;rft.volume=128&amp;rft.issue=6&amp;rft.pages=1668-84&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1053%2Fj.gastro.2005.03.078&amp;rft_id=info%3Apmid%2F15887158&amp;rft.aulast=Warner&amp;rft.aufirst=R.R.P.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Öberg1998-68"><span class="mw-cite-backlink">^ <a href="#cite_ref-Öberg1998_68-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Öberg1998_68-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Öberg1998_68-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFÖberg1998" class="citation journal cs1">Öberg, K. (1998). "Carcinoid Tumors: Current Concepts in Diagnosis and Treatment". <i>The Oncologist</i>. <b>3</b> (5): 339–45. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1634%2Ftheoncologist.3-5-339">10.1634/theoncologist.3-5-339</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/10388123">10388123</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Oncologist&amp;rft.atitle=Carcinoid+Tumors%3A+Current+Concepts+in+Diagnosis+and+Treatment&amp;rft.volume=3&amp;rft.issue=5&amp;rft.pages=339-45&amp;rft.date=1998&amp;rft_id=info%3Adoi%2F10.1634%2Ftheoncologist.3-5-339&amp;rft_id=info%3Apmid%2F10388123&amp;rft.aulast=%C3%96berg&amp;rft.aufirst=K.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-ESMO-NEC2010-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-ESMO-NEC2010_69-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFObergAkerstromRindiJelic2010" class="citation journal cs1">Oberg, K.; Akerstrom, G.; Rindi, G.; Jelic, S.; Esmo Guidelines Working, G. (2010). "Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". <i>Annals of Oncology</i>. <b>21</b>: v223–v227. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fannonc%2Fmdq192">10.1093/annonc/mdq192</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20555086">20555086</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Oncology&amp;rft.atitle=Neuroendocrine+gastroenteropancreatic+tumours%3A+ESMO+Clinical+Practice+Guidelines+for+diagnosis%2C+treatment+and+follow-up&amp;rft.volume=21&amp;rft.pages=v223-v227&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdq192&amp;rft_id=info%3Apmid%2F20555086&amp;rft.aulast=Oberg&amp;rft.aufirst=K.&amp;rft.au=Akerstrom%2C+G.&amp;rft.au=Rindi%2C+G.&amp;rft.au=Jelic%2C+S.&amp;rft.au=Esmo+Guidelines+Working%2C+G.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-NCCN-NEC2011-1-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCCN-NEC2011-1_70-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf">nccn.org</a></span>
</li>
<li id="cite_note-NCI-ICT-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCI-ICT_71-0">^</a></b></span> <span class="reference-text">National Cancer Institute.
Islet Cell Tumors (Endocrine Pancreas) <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/isletcell">cancer.gov</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110607014639/http://www.cancer.gov/cancertopics/types/isletcell">Archived</a> 2011-06-07 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-NCI-GICarcin-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCI-GICarcin_72-0">^</a></b></span> <span class="reference-text">National Cancer Institute. Gastrointestinal Carcinoid Tumors Treatment <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/gastrointestinalcarcinoid/HealthProfessional">cancer.gov</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110627175816/http://www.cancer.gov/cancertopics/pdq/treatment/gastrointestinalcarcinoid/HealthProfessional">Archived</a> 2011-06-27 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-NCI-Merkel-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCI-Merkel_73-0">^</a></b></span> <span class="reference-text">National Cancer Institute. Merkel cell tumors, <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/pdq/treatment/merkelcell/Patient">cancer.gov</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110607040331/http://www.cancer.gov/cancertopics/pdq/treatment/merkelcell/Patient">Archived</a> 2011-06-07 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-NCI-PheoParag-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCI-PheoParag_74-0">^</a></b></span> <span class="reference-text">National Cancer Institute. Pheochromocytoma and Paraganglioma <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/pheochromocytoma">cancer.gov</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110607014552/http://www.cancer.gov/cancertopics/types/pheochromocytoma">Archived</a> 2011-06-07 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a></span>
</li>
<li id="cite_note-NCCN_NET201501-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCCN_NET201501_75-0">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf">"Neuroendocrine tumors, NCCN Guidelines Version 1.2015"</a> <span class="cs1-format">(PDF)</span>. <i>NCCN Guidelines</i>. National Comprehensive Cancer Network, Inc. November 11, 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">December 25,</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NCCN+Guidelines&amp;rft.atitle=Neuroendocrine+tumors%2C+NCCN+Guidelines+Version+1.2015&amp;rft.date=2014-11-11&amp;rft_id=http%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fpdf%2Fneuroendocrine.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Öberg2004-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-Öberg2004_76-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFObergKvolsCaplinDelle_Fave2004" class="citation journal cs1">Oberg, K.; Kvols, L.; Caplin, M.; Delle Fave, G.; De Herder, W.; Rindi, G.; Ruszniewski, P.; Woltering, E.; Wiedenmann, B. (2004). "Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system". <i>Annals of Oncology</i>. <b>15</b> (6): 966–73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fannonc%2Fmdh216">10.1093/annonc/mdh216</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15151956">15151956</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Oncology&amp;rft.atitle=Consensus+report+on+the+use+of+somatostatin+analogs+for+the+management+of+neuroendocrine+tumors+of+the+gastroenteropancreatic+system&amp;rft.volume=15&amp;rft.issue=6&amp;rft.pages=966-73&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdh216&amp;rft_id=info%3Apmid%2F15151956&amp;rft.aulast=Oberg&amp;rft.aufirst=K.&amp;rft.au=Kvols%2C+L.&amp;rft.au=Caplin%2C+M.&amp;rft.au=Delle+Fave%2C+G.&amp;rft.au=De+Herder%2C+W.&amp;rft.au=Rindi%2C+G.&amp;rft.au=Ruszniewski%2C+P.&amp;rft.au=Woltering%2C+E.&amp;rft.au=Wiedenmann%2C+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.asco.org/ASCOv2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=63&amp;abstractID=10363">asco.org</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120323004430/http://www.asco.org/ASCOv2/Meetings/Abstracts?&amp;vmview=abst_detail_view&amp;confID=63&amp;abstractID=10363">Archived</a> 2012-03-23 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>; accessed November 8, 2015.</span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><cite id="CITEREFCaplinPavelCwikla2014" class="citation journal cs1">Caplin ME, Pavel M, Cwikla JB,  et al. (July 17, 2014). "Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors". <i>The New England Journal of Medicine</i>. <b>371</b> (3): 224–33. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1316158">10.1056/NEJMoa1316158</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25014687">25014687</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Lanreotide+in+Metastatic+Enteropancreatic+Neuroendocrine+Tumors&amp;rft.volume=371&amp;rft.issue=3&amp;rft.pages=224-33&amp;rft.date=2014-07-17&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1316158&amp;rft_id=info%3Apmid%2F25014687&amp;rft.aulast=Caplin&amp;rft.aufirst=ME&amp;rft.au=Pavel%2C+M&amp;rft.au=Cwikla%2C+JB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Öberg2005a-79"><span class="mw-cite-backlink">^ <a href="#cite_ref-Öberg2005a_79-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Öberg2005a_79-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Öberg K. Neuroendocrine Gastroenteropancreatic Tumours: Current Views on Diagnosis and Treatment. Business Briefing. European Oncology Review 2005; pp. 1–6.</span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><cite id="CITEREFStrosbergEl-HaddadWolinHendifar2017" class="citation journal cs1">Strosberg, Jonathan; El-Haddad, Ghassan; Wolin, Edward; Hendifar, Andrew; Yao, James; Chasen, Beth; Mittra, Erik; Kunz, Pamela L.; Kulke, Matthew H. (2017-01-11). <a rel="nofollow" class="external text" href="https://kclpure.kcl.ac.uk/portal/en/publications/phase-3-trial-of-177ludotatate-for-midgut-neuroendocrine-tumors(9f59c0b9-2d1d-4a73-81c2-b1e18fedb527).html">"Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors"</a>. <i>New England Journal of Medicine</i>. <b>376</b> (2): 125–35. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2Fnejmoa1607427">10.1056/nejmoa1607427</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="//hdl.handle.net/2445%2F125256">2445/125256</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5895095">5895095</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28076709">28076709</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Phase+3+Trial+of+177Lu-Dotatate+for+Midgut+Neuroendocrine+Tumors&amp;rft.volume=376&amp;rft.issue=2&amp;rft.pages=125-35&amp;rft.date=2017-01-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5895095&amp;rft_id=info%3Apmid%2F28076709&amp;rft_id=info%3Ahdl%2F2445%2F125256&amp;rft_id=info%3Adoi%2F10.1056%2Fnejmoa1607427&amp;rft.aulast=Strosberg&amp;rft.aufirst=Jonathan&amp;rft.au=El-Haddad%2C+Ghassan&amp;rft.au=Wolin%2C+Edward&amp;rft.au=Hendifar%2C+Andrew&amp;rft.au=Yao%2C+James&amp;rft.au=Chasen%2C+Beth&amp;rft.au=Mittra%2C+Erik&amp;rft.au=Kunz%2C+Pamela+L.&amp;rft.au=Kulke%2C+Matthew+H.&amp;rft_id=https%3A%2F%2Fkclpure.kcl.ac.uk%2Fportal%2Fen%2Fpublications%2Fphase-3-trial-of-177ludotatate-for-midgut-neuroendocrine-tumors%289f59c0b9-2d1d-4a73-81c2-b1e18fedb527%29.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><cite id="CITEREFKratochwilGieselBruchertseiferMier2014" class="citation journal cs1">Kratochwil, C.; Giesel, F. L.; Bruchertseifer, F.; Mier, W.; Apostolidis, C.; Boll, R.; Murphy, K.; Haberkorn, U.; Morgenstern, A. (2014-11-01). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4525192">"213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience"</a>. <i>European Journal of Nuclear Medicine and Molecular Imaging</i>. <b>41</b> (11): 2106–19. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00259-014-2857-9">10.1007/s00259-014-2857-9</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1619-7070">1619-7070</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4525192">4525192</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25070685">25070685</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Nuclear+Medicine+and+Molecular+Imaging&amp;rft.atitle=213Bi-DOTATOC+receptor-targeted+alpha-radionuclide+therapy+induces+remission+in+neuroendocrine+tumours+refractory+to+beta+radiation%3A+a+first-in-human+experience&amp;rft.volume=41&amp;rft.issue=11&amp;rft.pages=2106-19&amp;rft.date=2014-11-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4525192&amp;rft.issn=1619-7070&amp;rft_id=info%3Apmid%2F25070685&amp;rft_id=info%3Adoi%2F10.1007%2Fs00259-014-2857-9&amp;rft.aulast=Kratochwil&amp;rft.aufirst=C.&amp;rft.au=Giesel%2C+F.+L.&amp;rft.au=Bruchertseifer%2C+F.&amp;rft.au=Mier%2C+W.&amp;rft.au=Apostolidis%2C+C.&amp;rft.au=Boll%2C+R.&amp;rft.au=Murphy%2C+K.&amp;rft.au=Haberkorn%2C+U.&amp;rft.au=Morgenstern%2C+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4525192&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><cite id="CITEREFKashyapHofmanMichaelKong2015" class="citation journal cs1">Kashyap, R; Hofman, M. S.; Michael, M; Kong, G; Akhurst, T; Eu, P; Zannino, D; Hicks, R. J. (2015). "Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours". <i>European Journal of Nuclear Medicine and Molecular Imaging</i>. <b>42</b> (2): 176–85. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00259-014-2906-4">10.1007/s00259-014-2906-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25209134">25209134</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20740102">20740102</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Nuclear+Medicine+and+Molecular+Imaging&amp;rft.atitle=Favourable+outcomes+of+%28177%29Lu-octreotate+peptide+receptor+chemoradionuclide+therapy+in+patients+with+FDG-avid+neuroendocrine+tumours&amp;rft.volume=42&amp;rft.issue=2&amp;rft.pages=176-85&amp;rft.date=2015&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20740102&amp;rft_id=info%3Apmid%2F25209134&amp;rft_id=info%3Adoi%2F10.1007%2Fs00259-014-2906-4&amp;rft.aulast=Kashyap&amp;rft.aufirst=R&amp;rft.au=Hofman%2C+M.+S.&amp;rft.au=Michael%2C+M&amp;rft.au=Kong%2C+G&amp;rft.au=Akhurst%2C+T&amp;rft.au=Eu%2C+P&amp;rft.au=Zannino%2C+D&amp;rft.au=Hicks%2C+R.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-83">^</a></b></span> <span class="reference-text"><cite id="CITEREFHofmanMichaelKashyapHicks2015" class="citation journal cs1">Hofman, M. S.; Michael, M; Kashyap, R; Hicks, R. J. (2015). "Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT)". <i>Journal of Nuclear Medicine</i>. <b>56</b> (6): 968–69. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2967%2Fjnumed.115.154500">10.2967/jnumed.115.154500</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25814516">25814516</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207407820">207407820</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Nuclear+Medicine&amp;rft.atitle=Modifying+the+Poor+Prognosis+Associated+with+18F-FDG-Avid+NET+with+Peptide+Receptor+Chemo-Radionuclide+Therapy+%28PRCRT%29&amp;rft.volume=56&amp;rft.issue=6&amp;rft.pages=968-69&amp;rft.date=2015&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207407820&amp;rft_id=info%3Apmid%2F25814516&amp;rft_id=info%3Adoi%2F10.2967%2Fjnumed.115.154500&amp;rft.aulast=Hofman&amp;rft.aufirst=M.+S.&amp;rft.au=Michael%2C+M&amp;rft.au=Kashyap%2C+R&amp;rft.au=Hicks%2C+R.+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Fong-84"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fong_84-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fong_84-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Fong, T and Schoenfield LJ. Arterial Chemotherapy Infusion of the Liver (and) Chemoembolization of the Liver (TACE) <a rel="nofollow" class="external text" href="http://www.medicinenet.com/chemo_infusion_and_chemoembolization_of_liver/article.htm">medicinenet.com</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20141224070514/http://www.medicinenet.com/chemo_infusion_and_chemoembolization_of_liver/article.htm">Archived</a> 2014-12-24 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>; accessed November 8, 2015.</span>
</li>
<li id="cite_note-Welsh2006-85"><span class="mw-cite-backlink">^ <a href="#cite_ref-Welsh2006_85-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Welsh2006_85-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFWelshKennedyThomadsen2006" class="citation journal cs1">Welsh, J.; Kennedy, A.; Thomadsen, B. (2006). "Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma". <i>International Journal of Radiation OncologyBiologyPhysics</i>. <b>66</b> (2): S62–S73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ijrobp.2005.09.011">10.1016/j.ijrobp.2005.09.011</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16979443">16979443</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Radiation+OncologyBiologyPhysics&amp;rft.atitle=Selective+internal+radiation+therapy+%28SIRT%29+for+liver+metastases+secondary+to+colorectal+adenocarcinoma&amp;rft.volume=66&amp;rft.issue=2&amp;rft.pages=S62-S73&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ijrobp.2005.09.011&amp;rft_id=info%3Apmid%2F16979443&amp;rft.aulast=Welsh&amp;rft.aufirst=J.&amp;rft.au=Kennedy%2C+A.&amp;rft.au=Thomadsen%2C+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-VdW2009-page321-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-VdW2009-page321_86-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFVan_De_WieleDefreynePeetersLambert2009" class="citation journal cs1">Van De Wiele, C.; Defreyne, L.; Peeters, M.; Lambert, B. (2009). "Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors". <i>The Quarterly Journal of Nuclear Medicine and Molecular Imaging</i>. <b>53</b> (3): 317–24. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19521311">19521311</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Quarterly+Journal+of+Nuclear+Medicine+and+Molecular+Imaging&amp;rft.atitle=Yttrium-90+labelled+resin+microspheres+for+treatment+of+primary+and+secondary+malignant+liver+tumors&amp;rft.volume=53&amp;rft.issue=3&amp;rft.pages=317-24&amp;rft.date=2009&amp;rft_id=info%3Apmid%2F19521311&amp;rft.aulast=Van+De+Wiele&amp;rft.aufirst=C.&amp;rft.au=Defreyne%2C+L.&amp;rft.au=Peeters%2C+M.&amp;rft.au=Lambert%2C+B.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Salem2002-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-Salem2002_87-0">^</a></b></span> <span class="reference-text"><cite id="CITEREFSalemThurstonCarrGoin2002" class="citation journal cs1">Salem, R.; Thurston, K.; Carr, B.; Goin, J.; Geschwind, J. (2002). "Yttrium-90 microspheres: Radiation therapy for unresectable liver cancer". <i>Journal of Vascular and Interventional Radiology</i>. <b>13</b> (9 Pt 2): S223–S229. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1051-0443%2807%2961790-4">10.1016/S1051-0443(07)61790-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12354840">12354840</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Vascular+and+Interventional+Radiology&amp;rft.atitle=Yttrium-90+microspheres%3A+Radiation+therapy+for+unresectable+liver+cancer&amp;rft.volume=13&amp;rft.issue=9+Pt+2&amp;rft.pages=S223-S229&amp;rft.date=2002&amp;rft_id=info%3Adoi%2F10.1016%2FS1051-0443%2807%2961790-4&amp;rft_id=info%3Apmid%2F12354840&amp;rft.aulast=Salem&amp;rft.aufirst=R.&amp;rft.au=Thurston%2C+K.&amp;rft.au=Carr%2C+B.&amp;rft.au=Goin%2C+J.&amp;rft.au=Geschwind%2C+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><cite id="CITEREFMasters2014" class="citation web cs1">Masters, Alexander (2014-10-14). <a rel="nofollow" class="external text" href="http://mosaicscience.com/story/plutocratic-proposal">"A plutocratic proposal"</a>. <i>Mosaic</i>. The Wellcome Trust. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160529021009/http://mosaicscience.com/story/plutocratic-proposal">Archived</a> from the original on 2016-05-29<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-07-03</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mosaic&amp;rft.atitle=A+plutocratic+proposal&amp;rft.date=2014-10-14&amp;rft.aulast=Masters&amp;rft.aufirst=Alexander&amp;rft_id=http%3A%2F%2Fmosaicscience.com%2Fstory%2Fplutocratic-proposal&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://icancer.org.uk/about/">"iCancer web site"</a>. <i>icancer.org.uk</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160714143714/http://icancer.org.uk/about/">Archived</a> from the original on 2016-07-14<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-07-03</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=icancer.org.uk&amp;rft.atitle=iCancer+web+site&amp;rft_id=http%3A%2F%2Ficancer.org.uk%2Fabout%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><cite id="CITEREFMasters2016" class="citation web cs1"><a href="/wiki/Alexander_Masters" title="Alexander Masters">Masters, Alexander</a> (2016-07-02). <a rel="nofollow" class="external text" href="https://www.telegraph.co.uk/men/health/can-crowdfunding-really-cure-cancer-alexander-masters-investigat/">"Can crowdfunding really cure cancer? Alexander Masters investigates a pioneering new project"</a>. The Telegraph. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20160703115042/http://www.telegraph.co.uk/men/health/can-crowdfunding-really-cure-cancer-alexander-masters-investigat/">Archived</a> from the original on 2016-07-03<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-07-03</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Can+crowdfunding+really+cure+cancer%3F+Alexander+Masters+investigates+a+pioneering+new+project&amp;rft.pub=The+Telegraph&amp;rft.date=2016-07-02&amp;rft.aulast=Masters&amp;rft.aufirst=Alexander&amp;rft_id=https%3A%2F%2Fwww.telegraph.co.uk%2Fmen%2Fhealth%2Fcan-crowdfunding-really-cure-cancer-alexander-masters-investigat%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Öberg2011-91"><span class="mw-cite-backlink">^ <a href="#cite_ref-Öberg2011_91-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Öberg2011_91-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFÖbergCastellano2011" class="citation journal cs1">Öberg, K.; Castellano, D. (2011). "Current knowledge on diagnosis and staging of neuroendocrine tumors". <i>Cancer and Metastasis Reviews</i>. <b>30</b>: 3–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs10555-011-9292-1">10.1007/s10555-011-9292-1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21311954">21311954</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:29720754">29720754</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+and+Metastasis+Reviews&amp;rft.atitle=Current+knowledge+on+diagnosis+and+staging+of+neuroendocrine+tumors&amp;rft.volume=30&amp;rft.pages=3-7&amp;rft.date=2011&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29720754&amp;rft_id=info%3Apmid%2F21311954&amp;rft_id=info%3Adoi%2F10.1007%2Fs10555-011-9292-1&amp;rft.aulast=%C3%96berg&amp;rft.aufirst=K.&amp;rft.au=Castellano%2C+D.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><cite id="CITEREFKimuraKurodaMorioka1991" class="citation journal cs1">Kimura, W.; Kuroda, A.; Morioka, Y. (1991). "Clinical pathology of endocrine tumors of the pancreas". <i>Digestive Diseases and Sciences</i>. <b>36</b> (7): 933–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2FBF01297144">10.1007/BF01297144</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/2070707">2070707</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20567425">20567425</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Digestive+Diseases+and+Sciences&amp;rft.atitle=Clinical+pathology+of+endocrine+tumors+of+the+pancreas&amp;rft.volume=36&amp;rft.issue=7&amp;rft.pages=933-42&amp;rft.date=1991&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20567425&amp;rft_id=info%3Apmid%2F2070707&amp;rft_id=info%3Adoi%2F10.1007%2FBF01297144&amp;rft.aulast=Kimura&amp;rft.aufirst=W.&amp;rft.au=Kuroda%2C+A.&amp;rft.au=Morioka%2C+Y.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
<li id="cite_note-Modlin-93"><span class="mw-cite-backlink">^ <a href="#cite_ref-Modlin_93-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Modlin_93-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Modlin_93-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Modlin_93-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite id="CITEREFModlinShapiroKidd2004" class="citation journal cs1">Modlin, I.M.; Shapiro, M.D.; Kidd, M. (2004). "Siegfried oberndorfer: Origins and perspectives of carcinoid tumors". <i>Human Pathology</i>. <b>35</b> (12): 1440–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.humpath.2004.09.018">10.1016/j.humpath.2004.09.018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15619202">15619202</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Pathology&amp;rft.atitle=Siegfried+oberndorfer%3A+Origins+and+perspectives+of+carcinoid+tumors&amp;rft.volume=35&amp;rft.issue=12&amp;rft.pages=1440-51&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.1016%2Fj.humpath.2004.09.018&amp;rft_id=info%3Apmid%2F15619202&amp;rft.aulast=Modlin&amp;rft.aufirst=I.M.&amp;rft.au=Shapiro%2C+M.D.&amp;rft.au=Kidd%2C+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANeuroendocrine+tumor" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r982806391"/></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit&amp;section=31" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000">
<tbody><tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" decoding="async" width="30" height="40" class="noviewer" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Neuroendocrine_tumors" class="extiw" title="commons:Category:Neuroendocrine tumors"><span style="">Neuroendocrine tumors</span></a></b></i>.</td></tr>
</tbody></table>
<ul><li><a rel="nofollow" class="external text" href="http://www.netcancerawareness.org">The Neuroendocrine Cancer Awareness Network (NCAN)</a></li>
<li><a rel="nofollow" class="external text" href="https://curlie.org/Health/Conditions_and_Diseases/Cancer/Gastrointestinal/Pancreatic/Neuroendocrine/">Neuroendocrine tumor</a> at <a href="/wiki/Curlie" class="mw-redirect" title="Curlie">Curlie</a></li>
<li><a rel="nofollow" class="external text" href="http://www.netrf.org">Neuroendocrine Tumor Research Foundation</a></li></ul>
<table class="infobox" style="width:22em;width:100%; margin:0.5em 0 0.5em 0;"><tbody><tr><th scope="row">Classification</th><td style="text-align:left;"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q1981276" class="extiw" title="d:Q1981276">D</a></div><div class="hlist hlist-separated" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10-CM" title="ICD-10-CM">10-CM</a></b>: <a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/C7A.0">C7A.0</a>-<a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/C7A.8">C7A.8</a>, <a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/C7B.0">C7B.0</a>-<a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/C7B.8">C7B.8</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=209">209</a></li><li><b><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></b>: <a rel="nofollow" class="external text" href="https://progenetix.org/subsets/?term_id=icdom:8013_3">M8013/3</a>, <a rel="nofollow" class="external text" href="https://progenetix.org/subsets/?term_id=icdom:8041_3">M8041/3</a>, <a rel="nofollow" class="external text" href="https://progenetix.org/subsets/?term_id=icdom:8246_3">M8246/3</a>, <a rel="nofollow" class="external text" href="https://progenetix.org/subsets/?term_id=icdom:8247_3">M8247/3</a>, <a rel="nofollow" class="external text" href="https://progenetix.org/subsets/?term_id=icdom:8574_3">M8574/3</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D018358">D018358</a></li></ul></div></td></tr></tbody></table>
<div role="navigation" class="navbox" aria-labelledby="Glandular_and_epithelial_cancer" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div class="plainlinks hlist navbar mini"><ul><li class="nv-view"><a href="/wiki/Template:Epithelial_neoplasms" title="Template:Epithelial neoplasms"><abbr title="View this template" style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Epithelial_neoplasms" title="Template talk:Epithelial neoplasms"><abbr title="Discuss this template" style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Epithelial_neoplasms&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;">e</abbr></a></li></ul></div><div id="Glandular_and_epithelial_cancer" style="font-size:114%;margin:0 4em">Glandular and epithelial <a href="/wiki/Cancer" title="Cancer">cancer</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epithelium" title="Epithelium">Epithelium</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Papilloma" title="Papilloma">Papilloma</a>/<a href="/wiki/Carcinoma" title="Carcinoma">carcinoma</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Small-cell_carcinoma" title="Small-cell carcinoma">Small-cell carcinoma</a></li>
<li><a href="/wiki/Combined_small-cell_carcinoma" class="mw-redirect" title="Combined small-cell carcinoma">Combined small-cell carcinoma</a></li>
<li><a href="/wiki/Verrucous_carcinoma" title="Verrucous carcinoma">Verrucous carcinoma</a></li>
<li><a href="/wiki/Squamous_cell_carcinoma" title="Squamous cell carcinoma">Squamous cell carcinoma</a></li>
<li><a href="/wiki/Basal-cell_carcinoma" title="Basal-cell carcinoma">Basal-cell carcinoma</a></li>
<li><a href="/wiki/Transitional_cell_carcinoma" title="Transitional cell carcinoma">Transitional cell carcinoma</a></li>
<li><a href="/wiki/Inverted_papilloma" title="Inverted papilloma">Inverted papilloma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Complex_and_mixed_tumor" class="mw-redirect" title="Complex and mixed tumor">Complex epithelial</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Warthin%27s_tumor" title="Warthin&#39;s tumor">Warthin's tumor</a></li>
<li><a href="/wiki/Thymoma" title="Thymoma">Thymoma</a></li>
<li><a href="/wiki/Bartholin_gland_carcinoma" title="Bartholin gland carcinoma">Bartholin gland carcinoma</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Gland" title="Gland">Glands</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Adenomas/adenocarcinomas" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Adenoma" title="Adenoma">Adenomas</a>/<br /><a href="/wiki/Adenocarcinoma" title="Adenocarcinoma">adenocarcinomas</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Digestive_system_neoplasm" title="Digestive system neoplasm">Gastrointestinal</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>tract:</i> <a href="/wiki/Linitis_plastica" title="Linitis plastica">Linitis plastica</a></li>
<li><a href="/wiki/Familial_adenomatous_polyposis" title="Familial adenomatous polyposis">Familial adenomatous polyposis</a></li></ul>
<ul><li><i>pancreas</i>
<ul><li><a href="/wiki/Insulinoma" title="Insulinoma">Insulinoma</a></li>
<li><a href="/wiki/Glucagonoma" title="Glucagonoma">Glucagonoma</a></li>
<li><a href="/wiki/Gastrinoma" title="Gastrinoma">Gastrinoma</a></li>
<li><a href="/wiki/VIPoma" title="VIPoma">VIPoma</a></li>
<li><a href="/wiki/Somatostatinoma" title="Somatostatinoma">Somatostatinoma</a></li></ul></li></ul>
<ul><li><a href="/wiki/Cholangiocarcinoma" title="Cholangiocarcinoma">Cholangiocarcinoma</a></li>
<li><a href="/wiki/Klatskin_tumor" title="Klatskin tumor">Klatskin tumor</a></li>
<li><a href="/wiki/Hepatocellular_adenoma" title="Hepatocellular adenoma">Hepatocellular adenoma</a>/<a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">Hepatocellular carcinoma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Urogenital_neoplasm" title="Urogenital neoplasm">Urogenital</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Renal_cell_carcinoma" title="Renal cell carcinoma">Renal cell carcinoma</a></li>
<li><a href="/wiki/Endometrioid_tumor" title="Endometrioid tumor">Endometrioid tumor</a></li>
<li><a href="/wiki/Renal_oncocytoma" title="Renal oncocytoma">Renal oncocytoma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Endocrine_gland_neoplasm" title="Endocrine gland neoplasm">Endocrine</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Prolactinoma" title="Prolactinoma">Prolactinoma</a></li>
<li><a href="/wiki/Multiple_endocrine_neoplasia" title="Multiple endocrine neoplasia">Multiple endocrine neoplasia</a></li>
<li><a href="/wiki/Adrenocortical_adenoma" title="Adrenocortical adenoma">Adrenocortical adenoma</a>/<a href="/wiki/Adrenocortical_carcinoma" title="Adrenocortical carcinoma">Adrenocortical carcinoma</a></li>
<li><a href="/wiki/H%C3%BCrthle_cell" title="Hürthle cell">Hürthle cell</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other/multiple</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a class="mw-selflink selflink">Neuroendocrine tumor</a>
<ul><li><a href="/wiki/Carcinoid" title="Carcinoid">Carcinoid</a></li></ul></li>
<li><a href="/wiki/Adenoid_cystic_carcinoma" title="Adenoid cystic carcinoma">Adenoid cystic carcinoma</a></li>
<li><a href="/wiki/Oncocytoma" title="Oncocytoma">Oncocytoma</a></li>
<li><a href="/wiki/Clear-cell_adenocarcinoma" title="Clear-cell adenocarcinoma">Clear-cell adenocarcinoma</a></li>
<li><a href="/wiki/Apudoma" title="Apudoma">Apudoma</a></li>
<li><a href="/wiki/Adenoid_cystic_carcinoma" title="Adenoid cystic carcinoma">Cylindroma</a></li>
<li><a href="/wiki/Papillary_hidradenoma" title="Papillary hidradenoma">Papillary hidradenoma</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Adnexal and<br />skin appendage</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>sweat gland</i>
<ul><li><a href="/wiki/Hidrocystoma" title="Hidrocystoma">Hidrocystoma</a></li>
<li><a href="/wiki/Syringoma" title="Syringoma">Syringoma</a></li></ul></li>
<li><a href="/wiki/Syringocystadenoma_papilliferum" title="Syringocystadenoma papilliferum">Syringocystadenoma papilliferum</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Cystic, mucinous,<br />and serous</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cystic" class="mw-redirect" title="Cystic">Cystic</a> general</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Cystadenoma" title="Cystadenoma">Cystadenoma</a>/<a href="/wiki/Cystadenocarcinoma" title="Cystadenocarcinoma">Cystadenocarcinoma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Mucous_gland" title="Mucous gland">Mucinous</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Signet_ring_cell_carcinoma" title="Signet ring cell carcinoma">Signet ring cell carcinoma</a>
<ul><li><a href="/wiki/Krukenberg_tumor" title="Krukenberg tumor">Krukenberg tumor</a></li></ul></li>
<li><span class="wrap"><a href="/wiki/Mucinous_cystadenoma" title="Mucinous cystadenoma">Mucinous cystadenoma</a> / <a href="/wiki/Mucinous_cystadenocarcinoma" title="Mucinous cystadenocarcinoma">Mucinous cystadenocarcinoma</a></span>
<ul><li><a href="/wiki/Pseudomyxoma_peritonei" title="Pseudomyxoma peritonei">Pseudomyxoma peritonei</a></li></ul></li>
<li><a href="/wiki/Mucoepidermoid_carcinoma" title="Mucoepidermoid carcinoma">Mucoepidermoid carcinoma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Serous_gland" title="Serous gland">Serous</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><span class="wrap"><a href="/wiki/Ovarian_serous_cystadenoma" title="Ovarian serous cystadenoma">Ovarian serous cystadenoma</a> / <a href="/wiki/Pancreatic_serous_cystadenoma" title="Pancreatic serous cystadenoma">Pancreatic serous cystadenoma</a> / <a href="/wiki/Serous_cystadenocarcinoma" title="Serous cystadenocarcinoma">Serous cystadenocarcinoma</a> / <a href="/wiki/Papillary_serous_cystadenocarcinoma" title="Papillary serous cystadenocarcinoma">Papillary serous cystadenocarcinoma</a> </span></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Ductal, lobular,<br />and medullary</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Ductal_carcinoma" title="Ductal carcinoma">Ductal carcinoma</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Mammary_ductal_carcinoma" class="mw-redirect" title="Mammary ductal carcinoma">Mammary ductal carcinoma</a></li>
<li><a href="/wiki/Pancreatic_ductal_carcinoma" class="mw-redirect" title="Pancreatic ductal carcinoma">Pancreatic ductal carcinoma</a></li>
<li><a href="/wiki/Comedocarcinoma" title="Comedocarcinoma">Comedocarcinoma</a></li>
<li><span class="wrap"><a href="/wiki/Paget%27s_disease_of_the_breast" title="Paget&#39;s disease of the breast">Paget's disease of the breast</a> / <a href="/wiki/Extramammary_Paget%27s_disease" title="Extramammary Paget&#39;s disease">Extramammary Paget's disease</a></span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Lobular_carcinoma" title="Lobular carcinoma">Lobular carcinoma</a></th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Lobular_carcinoma_in_situ" title="Lobular carcinoma in situ">Lobular carcinoma in situ</a></li>
<li><a href="/wiki/Invasive_lobular_carcinoma" title="Invasive lobular carcinoma">Invasive lobular carcinoma</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Medullary_carcinoma" title="Medullary carcinoma">Medullary carcinoma</a></th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Medullary_carcinoma_of_the_breast" title="Medullary carcinoma of the breast">Medullary carcinoma of the breast</a></li>
<li><a href="/wiki/Medullary_thyroid_cancer" title="Medullary thyroid cancer">Medullary thyroid cancer</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Acinus" title="Acinus">Acinar</a> cell</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="/wiki/Acinic_cell_carcinoma" title="Acinic cell carcinoma">Acinic cell carcinoma</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw2373
Cached time: 20201016044804
Cache expiry: 2592000
Dynamic content: false
Complications: [vary‐revision‐sha1]
CPU time usage: 1.264 seconds
Real time usage: 1.465 seconds
Preprocessor visited node count: 9817/1000000
Post‐expand include size: 307437/2097152 bytes
Template argument size: 17576/2097152 bytes
Highest expansion depth: 16/40
Expensive parser function count: 6/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 306552/5000000 bytes
Lua time usage: 0.661/10.000 seconds
Lua memory usage: 8.49 MB/50 MB
Number of Wikibase entities loaded: 2/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1243.533      1 -total
 52.43%  652.004      1 Template:Reflist
 32.25%  401.048     61 Template:Cite_journal
 17.48%  217.344     22 Template:Citation_needed
 13.84%  172.101     22 Template:Fix
 10.33%  128.496      2 Template:Infobox
  8.32%  103.417      1 Template:Infobox_medical_condition_(new)
  7.13%   88.605     44 Template:Category_handler
  5.70%   70.826     22 Template:Delink
  5.14%   63.963      6 Template:Navbox
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:5615288-0!canonical and timestamp 20201016044802 and revision id 980427152
 -->
</div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Neuroendocrine_tumor&amp;oldid=980427152">https://en.wikipedia.org/w/index.php?title=Neuroendocrine_tumor&amp;oldid=980427152</a>"</div></div>
		<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Nervous_system_neoplasia" title="Category:Nervous system neoplasia">Nervous system neoplasia</a></li><li><a href="/wiki/Category:Endocrine_neoplasia" title="Category:Endocrine neoplasia">Endocrine neoplasia</a></li><li><a href="/wiki/Category:Pancreatic_cancer" title="Category:Pancreatic cancer">Pancreatic cancer</a></li><li><a href="/wiki/Category:Infectious_causes_of_cancer" title="Category:Infectious causes of cancer">Infectious causes of cancer</a></li><li><a href="/wiki/Category:Neuroendocrinology" title="Category:Neuroendocrinology">Neuroendocrinology</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_DOI_inactive_as_of_August_2020" title="Category:CS1 maint: DOI inactive as of August 2020">CS1 maint: DOI inactive as of August 2020</a></li><li><a href="/wiki/Category:Webarchive_template_wayback_links" title="Category:Webarchive template wayback links">Webarchive template wayback links</a></li><li><a href="/wiki/Category:CS1_maint:_multiple_names:_authors_list" title="Category:CS1 maint: multiple names: authors list">CS1 maint: multiple names: authors list</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_June_2013" title="Category:Articles with unsourced statements from June 2013">Articles with unsourced statements from June 2013</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_November_2015" title="Category:Articles with unsourced statements from November 2015">Articles with unsourced statements from November 2015</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_November_2015" title="Category:Articles needing additional references from November 2015">Articles needing additional references from November 2015</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_May_2011" title="Category:Articles with unsourced statements from May 2011">Articles with unsourced statements from May 2011</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_October_2012" title="Category:Articles with unsourced statements from October 2012">Articles with unsourced statements from October 2012</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_January_2012" title="Category:Articles with unsourced statements from January 2012">Articles with unsourced statements from January 2012</a></li><li><a href="/wiki/Category:Commons_category_link_is_on_Wikidata" title="Category:Commons category link is on Wikidata">Commons category link is on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_Curlie_links" title="Category:Articles with Curlie links">Articles with Curlie links</a></li></ul></div></div>
	</div>
</div>
<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

<div id="mw-navigation">
	<h2>Navigation menu</h2>
	<div id="mw-head">
		<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-personal" class="mw-portlet mw-portlet-personal vector-menu" aria-labelledby="p-personal-label" role="navigation" 
	 >
	<h3 id="p-personal-label">
		<span>Personal tools</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="pt-anonuserpage">Not logged in</li><li id="pt-anontalk"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n">Talk</a></li><li id="pt-anoncontribs"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y">Contributions</a></li><li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Neuroendocrine+tumor" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Neuroendocrine+tumor" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o">Log in</a></li></ul>
		
	</div>
</nav>

		<div id="left-navigation">
			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-namespaces" class="mw-portlet mw-portlet-namespaces vector-menu vector-menu-tabs" aria-labelledby="p-namespaces-label" role="navigation" 
	 >
	<h3 id="p-namespaces-label">
		<span>Namespaces</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="ca-nstab-main" class="selected"><a href="/wiki/Neuroendocrine_tumor" title="View the content page [c]" accesskey="c">Article</a></li><li id="ca-talk"><a href="/wiki/Talk:Neuroendocrine_tumor" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t">Talk</a></li></ul>
		
	</div>
</nav>

			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-variants" class="mw-portlet mw-portlet-variants emptyPortlet vector-menu vector-menu-dropdown" aria-labelledby="p-variants-label" role="navigation" 
	 >
	<input type="checkbox" class="vector-menu-checkbox" aria-labelledby="p-variants-label" />
	<h3 id="p-variants-label">
		<span>Variants</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

		</div>
		<div id="right-navigation">
			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-views" class="mw-portlet mw-portlet-views vector-menu vector-menu-tabs" aria-labelledby="p-views-label" role="navigation" 
	 >
	<h3 id="p-views-label">
		<span>Views</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="ca-view" class="selected"><a href="/wiki/Neuroendocrine_tumor">Read</a></li><li id="ca-edit"><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=edit" title="Edit this page [e]" accesskey="e">Edit</a></li><li id="ca-history"><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=history" title="Past revisions of this page [h]" accesskey="h">View history</a></li></ul>
		
	</div>
</nav>

			<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-cactions" class="mw-portlet mw-portlet-cactions emptyPortlet vector-menu vector-menu-dropdown" aria-labelledby="p-cactions-label" role="navigation" 
	 >
	<input type="checkbox" class="vector-menu-checkbox" aria-labelledby="p-cactions-label" />
	<h3 id="p-cactions-label">
		<span>More</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

			<div id="p-search" role="search">
	<h3 >
		<label for="searchInput">Search</label>
	</h3>
	<form action="/w/index.php" id="searchform">
		<div id="simpleSearch" data-search-loc="header-navigation">
			<input type="search" name="search" placeholder="Search Wikipedia" title="Search Wikipedia [f]" accesskey="f" id="searchInput"/>
			<input type="hidden" name="title" value="Special:Search">
			<input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton"/>
			<input type="submit" name="go" value="Go" title="Go to a page with this exact name if it exists" id="searchButton" class="searchButton"/>
		</div>
	</form>
</div>

		</div>
	</div>
	
<div id="mw-panel">
	<div id="p-logo" role="banner">
		<a  title="Visit the main page" class="mw-wiki-logo" href="/wiki/Main_Page"></a>
	</div>
	<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-navigation" class="mw-portlet mw-portlet-navigation vector-menu vector-menu-portal portal portal-first" aria-labelledby="p-navigation-label" role="navigation" 
	 >
	<h3 id="p-navigation-label">
		<span>Navigation</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Articles related to current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x">Random article</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works">About Wikipedia</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact us</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation">Donate</a></li></ul>
		
	</div>
</nav>

	<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-interaction" class="mw-portlet mw-portlet-interaction vector-menu vector-menu-portal portal" aria-labelledby="p-interaction-label" role="navigation" 
	 >
	<h3 id="p-interaction-label">
		<span>Contribute</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-introduction"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia">Learn to edit</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r">Recent changes</a></li><li id="n-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Add images or other media for use on Wikipedia">Upload file</a></li></ul>
		
	</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-tb" class="mw-portlet mw-portlet-tb vector-menu vector-menu-portal portal" aria-labelledby="p-tb-label" role="navigation" 
	 >
	<h3 id="p-tb-label">
		<span>Tools</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Neuroendocrine_tumor" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Neuroendocrine_tumor" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Neuroendocrine_tumor&amp;oldid=980427152" title="Permanent link to this revision of this page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Neuroendocrine_tumor&amp;action=info" title="More information about this page">Page information</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Neuroendocrine_tumor&amp;id=980427152&amp;wpFormIdentifier=titleform" title="Information on how to cite this page">Cite this page</a></li><li id="t-wikibase"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q1981276" title="Structured data on this page hosted by Wikidata [g]" accesskey="g">Wikidata item</a></li></ul>
		
	</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-coll-print_export" class="mw-portlet mw-portlet-coll-print_export vector-menu vector-menu-portal portal" aria-labelledby="p-coll-print_export-label" role="navigation" 
	 >
	<h3 id="p-coll-print_export-label">
		<span>Print/export</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Neuroendocrine_tumor&amp;action=show-download-screen" title="Download this page as a PDF file">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Neuroendocrine_tumor&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li></ul>
		
	</div>
</nav>
<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-wikibase-otherprojects" class="mw-portlet mw-portlet-wikibase-otherprojects vector-menu vector-menu-portal portal" aria-labelledby="p-wikibase-otherprojects-label" role="navigation" 
	 >
	<h3 id="p-wikibase-otherprojects-label">
		<span>In other projects</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li class="wb-otherproject-link wb-otherproject-commons"><a href="https://commons.wikimedia.org/wiki/Category:Neuroendocrine_tumors" hreflang="en">Wikimedia Commons</a></li></ul>
		
	</div>
</nav>

	<!-- Please do not use role attribute as CSS selector, it is deprecated. -->
<nav id="p-lang" class="mw-portlet mw-portlet-lang vector-menu vector-menu-portal portal" aria-labelledby="p-lang-label" role="navigation" 
	 >
	<h3 id="p-lang-label">
		<span>Languages</span>
	</h3>
	<div class="vector-menu-content">
		<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-ar"><a href="https://ar.wikipedia.org/wiki/%D8%A3%D9%88%D8%B1%D8%A7%D9%85_%D8%A7%D9%84%D8%BA%D8%AF%D8%AF_%D8%A7%D9%84%D8%B9%D8%B5%D8%A8%D9%8A%D8%A9_%D8%A7%D9%84%D8%B5%D9%85%D8%A7%D8%A1" title="أورام الغدد العصبية الصماء – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="https://ca.wikipedia.org/wiki/Tumor_neuroendocr%C3%AD" title="Tumor neuroendocrí – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target">Català</a></li><li class="interlanguage-link interwiki-de"><a href="https://de.wikipedia.org/wiki/Neuroendokriner_Tumor" title="Neuroendokriner Tumor – German" lang="de" hreflang="de" class="interlanguage-link-target">Deutsch</a></li><li class="interlanguage-link interwiki-fr"><a href="https://fr.wikipedia.org/wiki/Tumeur_neuroendocrinienne" title="Tumeur neuroendocrinienne – French" lang="fr" hreflang="fr" class="interlanguage-link-target">Français</a></li><li class="interlanguage-link interwiki-ko"><a href="https://ko.wikipedia.org/wiki/%EC%8B%A0%EA%B2%BD%EB%82%B4%EB%B6%84%EB%B9%84_%EC%A2%85%EC%96%91" title="신경내분비 종양 – Korean" lang="ko" hreflang="ko" class="interlanguage-link-target">한국어</a></li><li class="interlanguage-link interwiki-it"><a href="https://it.wikipedia.org/wiki/Tumori_neuroendocrini" title="Tumori neuroendocrini – Italian" lang="it" hreflang="it" class="interlanguage-link-target">Italiano</a></li><li class="interlanguage-link interwiki-lt"><a href="https://lt.wikipedia.org/wiki/Neuroendokrinin%C4%97s_neoplazijos" title="Neuroendokrininės neoplazijos – Lithuanian" lang="lt" hreflang="lt" class="interlanguage-link-target">Lietuvių</a></li><li class="interlanguage-link interwiki-nl"><a href="https://nl.wikipedia.org/wiki/Neuro-endocriene_tumor" title="Neuro-endocriene tumor – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="https://ja.wikipedia.org/wiki/%E7%A5%9E%E7%B5%8C%E5%86%85%E5%88%86%E6%B3%8C%E8%85%AB%E7%98%8D" title="神経内分泌腫瘍 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="https://no.wikipedia.org/wiki/Nevroendokrine_svulster" title="Nevroendokrine svulster – Norwegian Bokmål" lang="nb" hreflang="nb" class="interlanguage-link-target">Norsk bokmål</a></li><li class="interlanguage-link interwiki-pl"><a href="https://pl.wikipedia.org/wiki/Guzy_neuroendokrynne_przewodu_pokarmowego" title="Guzy neuroendokrynne przewodu pokarmowego – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="https://pt.wikipedia.org/wiki/Tumor_neuroend%C3%B3crino" title="Tumor neuroendócrino – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target">Português</a></li><li class="interlanguage-link interwiki-simple"><a href="https://simple.wikipedia.org/wiki/Neuroendocrine_tumor" title="Neuroendocrine tumor – Simple English" lang="en-simple" hreflang="en-simple" class="interlanguage-link-target">Simple English</a></li><li class="interlanguage-link interwiki-fi"><a href="https://fi.wikipedia.org/wiki/Neuroendokriininen_kasvain" title="Neuroendokriininen kasvain – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target">Suomi</a></li><li class="interlanguage-link interwiki-uk"><a href="https://uk.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B9%D1%80%D0%BE%D0%B5%D0%BD%D0%B4%D0%BE%D0%BA%D1%80%D0%B8%D0%BD%D0%BD%D0%B0_%D0%BF%D1%83%D1%85%D0%BB%D0%B8%D0%BD%D0%B0" title="Нейроендокринна пухлина – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target">Українська</a></li><li class="interlanguage-link interwiki-zh"><a href="https://zh.wikipedia.org/wiki/%E7%A5%9E%E7%B6%93%E5%85%A7%E5%88%86%E6%B3%8C%E8%85%AB%E7%98%A4" title="神經內分泌腫瘤 – Chinese" lang="zh" hreflang="zh" class="interlanguage-link-target">中文</a></li></ul>
		<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q1981276#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
	</div>
</nav>

</div>

</div>
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info" >
	<li id="footer-info-lastmod"> This page was last edited on 26 September 2020, at 13:34<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places" >
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Neuroendocrine_tumor&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></li>
</ul>

	<div style="clear: both;"></div>
</footer>


<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"1.264","walltime":"1.465","ppvisitednodes":{"value":9817,"limit":1000000},"postexpandincludesize":{"value":307437,"limit":2097152},"templateargumentsize":{"value":17576,"limit":2097152},"expansiondepth":{"value":16,"limit":40},"expensivefunctioncount":{"value":6,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":306552,"limit":5000000},"entityaccesscount":{"value":2,"limit":400},"timingprofile":["100.00% 1243.533      1 -total"," 52.43%  652.004      1 Template:Reflist"," 32.25%  401.048     61 Template:Cite_journal"," 17.48%  217.344     22 Template:Citation_needed"," 13.84%  172.101     22 Template:Fix"," 10.33%  128.496      2 Template:Infobox","  8.32%  103.417      1 Template:Infobox_medical_condition_(new)","  7.13%   88.605     44 Template:Category_handler","  5.70%   70.826     22 Template:Delink","  5.14%   63.963      6 Template:Navbox"]},"scribunto":{"limitreport-timeusage":{"value":"0.661","limit":"10.000"},"limitreport-memusage":{"value":8905508,"limit":52428800}},"cachereport":{"origin":"mw2373","timestamp":"20201016044804","ttl":2592000,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Neuroendocrine tumor","url":"https:\/\/en.wikipedia.org\/wiki\/Neuroendocrine_tumor","sameAs":"http:\/\/www.wikidata.org\/entity\/Q1981276","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q1981276","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2006-06-18T19:50:44Z","dateModified":"2020-09-26T13:34:10Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/4\/4d\/Small_intestine_neuroendocrine_tumour_high_mag.jpg","headline":"endocrine gland cancer that has material basis in neuroendocrine cells"}</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":213,"wgHostname":"mw2258"});});</script>
</body></html>